UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 27,~~June 26, 2020 Commission File Number: 001-36223

Aramark

(Exact name of registrant as specified in its charter)

Delaware

20-8236097

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

2400 Market Street

19103

Philadelphia,

Pennsylvania

(Address of principal executive offices)

(Zip Code)

(215) 238-3000

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on which Registered

Common Stock,

par value $0.01 per share

ARMK

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

As of ~~April~~July 24, 2020, the number of shares of the registrant's common stock outstanding is ~~252,615,882.~~252,975,615.

Table of Contents

Special Note About Forward-Looking Statements

This report includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current views as to future events and financial performance with respect to, without limitation, conditions in our industry, our operations, our economic performance and financial condition, including, in particular, with respect to, without limitation, the impact of COVID-19 on our business, financial performance and operating results, anticipated effects of our adoption of new accounting standards, the expected impact of strategic portfolio actions, the benefits and costs of our acquisitions of each of Avendra, LLC ("Avendra") and AmeriPride Services, Inc. ("AmeriPride"), as well as statements regarding these companies' services and products and statements relating to our business and growth strategy. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as "outlook," "aim," "anticipate," "are or remain or continue to be confident," "have confidence," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "see," "look to" and other words and terms of similar meaning or the negative versions of such words.

Forward-looking statements speak only as of the date made. All statements we make relating to our estimated and projected earnings, costs, expenditures, cash flows, growth rates, financial results and our estimated benefits and costs of our acquisitions are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could affect or could continue to affect our results or the costs and benefits of the acquisitions include without limitation: the severity and duration of the COVID-19 pandemic; the pandemic's impact on the U.S. and global economies, including particularly the client sectors we serve and governmental responses to the pandemic; unfavorable economic conditions; natural disasters, global calamities, pandemics, sports strikes and other adverse incidents; the failure to retain current clients, renew existing client contracts and obtain new client contracts; the manner and timing of benefits we expect to receive under the CARES ~~Act;~~Act or other government programs; a determination by clients to reduce their outsourcing or use of preferred vendors; competition in our industries; increased operating costs and obstacles to cost recovery due to the pricing and cancellation terms of our food and support services contracts; the inability to achieve cost savings through our cost reduction efforts; our expansion strategy; our ability to successfully integrate the businesses of Avendra and AmeriPride and costs and timing related thereto; the risk of unanticipated restructuring costs or assumption of undisclosed liabilities; the risk that we are unable to achieve the anticipated benefits (including tax benefits) and synergies of the acquisition of AmeriPride and Avendra including whether the transactions will be accretive and within the expected timeframes; the availability of sufficient cash to repay certain indebtedness and our decision to utilize the cash for that purpose; the failure to maintain food safety throughout our supply chain, food-borne illness concerns and claims of illness or injury; governmental regulations including those relating to food and beverages, the environment, wage and hour and government contracting; liability associated with noncompliance with applicable law or other governmental regulations; new interpretations of or changes in the enforcement of the government regulatory framework; currency risks and other risks associated with international operations, including Foreign Corrupt Practices Act, U.K. Bribery Act and other anti-corruption law compliance; continued or further unionization of our workforce; liability resulting from our participation in multiemployer defined benefit pension plans; risks associated with suppliers from whom our products are sourced; disruptions to our relationship with, or to the business of, our primary distributor; the inability to hire and retain sufficient qualified personnel or increases in labor costs; healthcare reform legislation; the contract intensive nature of our business, which may lead to client disputes; seasonality; a cybersecurity incident or other disruptions in the availability of our computer systems or privacy breaches; failure to maintain effective internal controls; our leverage, including our recent significantly increased borrowings; the inability to generate sufficient cash to service all of our indebtedness; debt agreements that limit our flexibility in operating our business; our ability to attract new or maintain existing customer and supplier relationships at reasonable cost, our ability to retain key personnel and other factors set forth in this Quarterly Report on Form 10-Q under the headings Part II, Item 1A "Risk Factors" and Part I, Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations" and under the headings Item 1A "Risk Factors," Item 3 "Legal Proceedings" and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" and other sections of our Annual Report on Form 10-K, filed with the SEC on November 26, 2019 as such factors may be updated from time to time in our other periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov and which may be obtained by contacting Aramark's investor relations department via its website www.aramark.com. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this report and in our other filings with the SEC. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included herein or that may be made elsewhere from time to time by, or on behalf of, us. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, changes in our expectations, or otherwise, except as required by law.

PART I

Item 1. Financial Statements

~~ARAMARK AND SUBSIDIARIES~~

~~CONDENSED CONSOLIDATED BALANCE SHEETS~~

~~(Unaudited)~~

~~(in thousands, except share amounts)~~

March 27, 2020 September 27, 2019
ASSETS
Current Assets:
Cash and cash equivalents $ 1,202,964 $ 246,643
Receivables (less allowances: 2020 - $45,283; 2019 - $49,566) 1,850,980 1,806,964
Inventories 403,799 411,319
Prepayments and other current assets 198,592 193,461
Total current assets 3,656,335 2,658,387
Property and Equipment, net 2,129,306 2,181,762
Goodwill 5,319,626 5,518,800
Other Intangible Assets 1,986,079 2,033,566
Operating Lease Right-of-use Assets (see Note 8) 579,719 —
Other Assets 1,176,433 1,343,806
$ 14,847,498 $ 13,736,321
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Current maturities of long-term borrowings $ 103,406 $ 69,928
Current operating lease liabilities (see Note 8) 75,705 —
Accounts payable 793,464 999,517
Accrued expenses and other current liabilities 1,325,282 1,635,853
Total current liabilities 2,297,857 2,705,298
Long-Term Borrowings 7,862,587 6,612,239
Noncurrent Operating Lease Liabilities (see Note 8) 354,833 —
Deferred Income Taxes and Other Noncurrent Liabilities 1,152,550 1,088,822
Redeemable Noncontrolling Interest 10,226 9,915
Stockholders' Equity:
Common stock, par value $0.01 (authorized: 600,000,000 shares; issued: 2020—290,166,384 shares and 2019—282,919,536 shares; and outstanding: 2020—252,579,469 shares and 2019—247,756,091 shares)
2,902 2,829
Capital surplus 3,384,981 3,236,450
Retained earnings 993,046 1,107,029
Accumulated other comprehensive loss (304,010) (216,965)
Treasury stock (shares held in treasury: 2020—37,586,915 shares and 2019—35,163,445 shares) (907,474) (809,296)
Total stockholders' equity 3,169,445 3,320,047
$ 14,847,498 $ 13,736,321

~~The accompanying notes are an integral part of these condensed consolidated financial statements.~~

~~Table of Contents~~

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands, except share amounts)


	June 26, 2020		September 27, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$	2,417,255	$	246,643
Receivables (less allowances: 2020 - $73,038; 2019 - $49,566)	1,423,190		1,806,964
Inventories	426,766		411,319
Prepayments and other current assets	289,933		193,461
Total current assets	4,557,144		2,658,387
Property and Equipment, net	2,066,359		2,181,762
Goodwill	5,325,048		5,518,800
Other Intangible Assets	1,958,035		2,033,566
Operating Lease Right-of-use Assets (see Note 8)	551,002		—
Other Assets	1,164,485		1,343,806
	$	15,622,073	$	13,736,321
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Current maturities of long-term borrowings	$	90,112	$	69,928
Current operating lease liabilities (see Note 8)	74,971		—
Accounts payable	618,136		999,517
Accrued expenses and other current liabilities	1,336,095		1,635,853
Total current liabilities	2,119,314		2,705,298
Long-Term Borrowings	9,169,502		6,612,239
Noncurrent Operating Lease Liabilities (see Note 8)	336,915		—
Deferred Income Taxes and Other Noncurrent Liabilities	1,090,642		1,088,822
Redeemable Noncontrolling Interest	10,358		9,915
Stockholders' Equity:
Common stock, par value $0.01 (authorized: 600,000,000 shares; issued: 2020—290,558,042 shares and 2019—282,919,536 shares; and outstanding: 2020—252,937,875 shares and 2019—247,756,091 shares)	2,906		2,829
Capital surplus	3,399,703		3,236,450
Retained earnings	708,803		1,107,029
Accumulated other comprehensive loss	(307,924)		(216,965)
Treasury stock (shares held in treasury: 2020—37,620,167 shares and 2019—35,163,445 shares)	(908,146)		(809,296)
Total stockholders' equity	2,895,342		3,320,047
	$	15,622,073	$	13,736,321

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME

(Unaudited)

(in thousands, except per share data)


		Three Months Ended							Three Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
Revenue	Revenue	$	3,731,559	$	3,999,987	Revenue	$	2,152,253	$	4,010,761
Costs and Expenses:	Costs and Expenses:					Costs and Expenses:
Cost of services provided	Cost of services provided	3,407,589		3,639,959		Cost of services provided	2,265,614		3,594,978
Depreciation and amortization	Depreciation and amortization	147,975		147,908		Depreciation and amortization	148,060		148,779
Selling and general corporate expenses	Selling and general corporate expenses	75,071		88,285		Selling and general corporate expenses	66,176		78,185
Goodwill impairment		198,600		—
Gain on sale of Healthcare Technologies		—		1,000

		3,829,235		3,877,152			2,479,850		3,821,942
Operating (loss) income	Operating (loss) income	(97,676)		122,835		Operating (loss) income	(327,597)		188,819
Interest and Other Financing Costs, net	Interest and Other Financing Costs, net	99,822		84,178		Interest and Other Financing Costs, net	94,235		82,220
(Loss) Income Before Income Taxes	(Loss) Income Before Income Taxes	(197,498)		38,657		(Loss) Income Before Income Taxes	(421,832)		106,599
Provision for Income Taxes		4,523		9,347
(Benefit) Provision for Income Taxes						(Benefit) Provision for Income Taxes	(165,524)		23,535
Net (loss) income	Net (loss) income	(202,021)		29,310		Net (loss) income	(256,308)		83,064
Less: Net income (loss) attributable to noncontrolling interest		239		(43)
Less: Net income attributable to noncontrolling interest						Less: Net income attributable to noncontrolling interest	132		109
Net (loss) income attributable to Aramark stockholders	Net (loss) income attributable to Aramark stockholders	$	(202,260)	$	29,353	Net (loss) income attributable to Aramark stockholders	$	(256,440)	$	82,955

(Loss) Earnings per share attributable to Aramark stockholders:	(Loss) Earnings per share attributable to Aramark stockholders:					(Loss) Earnings per share attributable to Aramark stockholders:
Basic	Basic	$	(0.80)	$	0.12	Basic	$	(1.01)	$	0.34
Diluted	Diluted	$	(0.80)	$	0.12	Diluted	$	(1.01)	$	0.33
Weighted Average Shares Outstanding:	Weighted Average Shares Outstanding:					Weighted Average Shares Outstanding:
Basic	Basic	252,354		246,217		Basic	252,943		246,928
Diluted	Diluted	252,354		250,347		Diluted	252,943		251,147

		Six Months Ended							Nine Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
Revenue	Revenue	$	7,985,156	$	8,265,336	Revenue	$	10,137,409	$	12,276,097
Costs and Expenses:	Costs and Expenses:					Costs and Expenses:
Cost of services provided	Cost of services provided	7,175,702		7,434,404		Cost of services provided	9,441,316		11,029,382
Depreciation and amortization	Depreciation and amortization	295,911		298,629		Depreciation and amortization	443,971		447,408
Selling and general corporate expenses	Selling and general corporate expenses	158,326		192,415		Selling and general corporate expenses	224,502		270,600
Goodwill impairment	Goodwill impairment	198,600		—		Goodwill impairment	198,600		—
Gain on sale of Healthcare Technologies	Gain on sale of Healthcare Technologies	—		(156,309)		Gain on sale of Healthcare Technologies	—		(156,309)
		7,828,539		7,769,139			10,308,389		11,591,081
Operating income		156,617		496,197
Operating (loss) income						Operating (loss) income	(170,980)		685,016
Interest and Other Financing Costs, net	Interest and Other Financing Costs, net	179,407		167,155		Interest and Other Financing Costs, net	273,642		249,375
(Loss) Income Before Income Taxes	(Loss) Income Before Income Taxes	(22,790)		329,042		(Loss) Income Before Income Taxes	(444,622)		435,641
Provision for Income Taxes		33,348		49,054
(Benefit) Provision for Income Taxes						(Benefit) Provision for Income Taxes	(132,176)		72,589
Net (loss) income	Net (loss) income	(56,138)		279,988		Net (loss) income	(312,446)		363,052
Less: Net income (loss) attributable to noncontrolling interest		361		(49)
Less: Net income attributable to noncontrolling interest						Less: Net income attributable to noncontrolling interest	493		60
Net (loss) income attributable to Aramark stockholders	Net (loss) income attributable to Aramark stockholders	$	(56,499)	$	280,037	Net (loss) income attributable to Aramark stockholders	$	(312,939)	$	362,992

(Loss) Earnings per share attributable to Aramark stockholders:	(Loss) Earnings per share attributable to Aramark stockholders:					(Loss) Earnings per share attributable to Aramark stockholders:
Basic	Basic	$	(0.23)	$	1.14	Basic	$	(1.25)	$	1.47
Diluted	Diluted	$	(0.23)	$	1.11	Diluted	$	(1.25)	$	1.44
Weighted Average Shares Outstanding:	Weighted Average Shares Outstanding:					Weighted Average Shares Outstanding:
Basic	Basic	250,543		246,540		Basic	251,343		246,665
Diluted	Diluted	250,543		251,355		Diluted	251,343		251,271
The accompanying notes are an integral part of these condensed consolidated financial statements.	The accompanying notes are an integral part of these condensed consolidated financial statements.									The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Unaudited)

(in thousands)


		Three Months Ended							Three Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
Net (loss) income	Net (loss) income	$	(202,021)	$	29,310	Net (loss) income	$	(256,308)	$	83,064
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax					Other comprehensive loss, net of tax
Pension plan adjustments	Pension plan adjustments	(286)		—		Pension plan adjustments	(285)		(179)
Foreign currency translation adjustments	Foreign currency translation adjustments	(41,893)		8,973		Foreign currency translation adjustments	4,115		(2,002)
Fair value of cash flow hedges	Fair value of cash flow hedges	(65,921)		(17,678)		Fair value of cash flow hedges	(7,673)		(26,749)
Share of equity investee's comprehensive (loss) income		(145)		50
Share of equity investee's comprehensive loss						Share of equity investee's comprehensive loss	(71)		(257)
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	(108,245)		(8,655)		Other comprehensive loss, net of tax	(3,914)		(29,187)
Comprehensive (loss) income	Comprehensive (loss) income	(310,266)		20,655		Comprehensive (loss) income	(260,222)		53,877
Less: Net income (loss) attributable to noncontrolling interest		239		(43)
Less: Net income attributable to noncontrolling interest						Less: Net income attributable to noncontrolling interest	132		109
Comprehensive (loss) income attributable to Aramark stockholders	Comprehensive (loss) income attributable to Aramark stockholders	$	(310,505)	$	20,698	Comprehensive (loss) income attributable to Aramark stockholders	$	(260,354)	$	53,768


		Six Months Ended							Nine Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
Net (loss) income	Net (loss) income	$	(56,138)	$	279,988	Net (loss) income	$	(312,446)	$	363,052
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax					Other comprehensive loss, net of tax
Pension plan adjustments	Pension plan adjustments	(571)		753		Pension plan adjustments	(856)		574
Foreign currency translation adjustments	Foreign currency translation adjustments	(27,308)		(9,034)		Foreign currency translation adjustments	(23,193)		(11,036)
Fair value of cash flow hedges	Fair value of cash flow hedges	(59,168)		(41,917)		Fair value of cash flow hedges	(66,841)		(68,666)
Share of equity investee's comprehensive income (loss)		2		(230)
Share of equity investee's comprehensive loss						Share of equity investee's comprehensive loss	(69)		(487)
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	(87,045)		(50,428)		Other comprehensive loss, net of tax	(90,959)		(79,615)
Comprehensive (loss) income	Comprehensive (loss) income	(143,183)		229,560		Comprehensive (loss) income	(403,405)		283,437
Less: Net income (loss) attributable to noncontrolling interest		361		(49)
Less: Net income attributable to noncontrolling interest						Less: Net income attributable to noncontrolling interest	493		60
Comprehensive (loss) income attributable to Aramark stockholders	Comprehensive (loss) income attributable to Aramark stockholders	$	(143,544)	$	229,609	Comprehensive (loss) income attributable to Aramark stockholders	$	(403,898)	$	283,377

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(in thousands)


		Six Months Ended							Nine Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net (loss) income	Net (loss) income	$	(56,138)	$	279,988	Net (loss) income	$	(312,446)	$	363,052
Adjustments to reconcile net income to net cash (used in) provided by operating activities
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities						Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities
Depreciation and amortization	Depreciation and amortization	295,911		298,629		Depreciation and amortization	443,971		447,408
Goodwill impairment		198,600		—
Goodwill impairment and asset write-downs						Goodwill impairment and asset write-downs	244,952		—
Deferred income taxes	Deferred income taxes	17,405		3,475		Deferred income taxes	(66,003)		21,861
Share-based compensation expense	Share-based compensation expense	4,259		33,241		Share-based compensation expense	15,349		48,414
Net gain on sale of Healthcare Technologies	Net gain on sale of Healthcare Technologies	—		(139,165)		Net gain on sale of Healthcare Technologies	—		(139,165)
Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Accounts Receivable	Accounts Receivable	(73,677)		(137,789)		Accounts Receivable	356,436		(88,173)
Inventories	Inventories	5,166		(36,224)		Inventories	(18,620)		(37,133)
Prepayments and Other Current Assets	Prepayments and Other Current Assets	(6,951)		(223)		Prepayments and Other Current Assets	(88,386)		(33,586)
Accounts Payable	Accounts Payable	(218,211)		(86,069)		Accounts Payable	(386,646)		(178,468)
Accrued Expenses	Accrued Expenses	(304,053)		(100,863)		Accrued Expenses	(305,980)		(164,584)
Payments made to clients on contracts	Payments made to clients on contracts	(26,355)		(26,551)		Payments made to clients on contracts	(42,824)		(30,169)
Other operating activities	Other operating activities	72,418		534		Other operating activities	85,352		(1,270)
Net cash (used in) provided by operating activities	Net cash (used in) provided by operating activities	(91,626)		88,983		Net cash (used in) provided by operating activities	(74,845)		208,187
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Purchases of property and equipment and other	Purchases of property and equipment and other	(213,569)		(230,402)		Purchases of property and equipment and other	(298,716)		(340,449)
Disposals of property and equipment	Disposals of property and equipment	8,238		7,556		Disposals of property and equipment	39,341		11,020
Proceeds from divestiture	Proceeds from divestiture	—		293,711		Proceeds from divestiture	—		293,711
Acquisition of certain businesses, net of cash acquired	Acquisition of certain businesses, net of cash acquired	(14,922)		(31,115)		Acquisition of certain businesses, net of cash acquired	(16,734)		(35,515)
Proceeds from governmental agencies related to property and equipment	Proceeds from governmental agencies related to property and equipment	23,550		16,200		Proceeds from governmental agencies related to property and equipment	23,550		16,200
Other investing activities	Other investing activities	115		2,245		Other investing activities	1,228		5,641
Net cash (used in) provided by investing activities		(196,588)		58,195
Net cash used in investing activities						Net cash used in investing activities	(251,331)		(49,392)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from long-term borrowings	Proceeds from long-term borrowings	1,822,955		100,071		Proceeds from long-term borrowings	3,221,329		107,796
Payments of long-term borrowings	Payments of long-term borrowings	(935,258)		(345,458)		Payments of long-term borrowings	(970,616)		(372,168)

Net change in funding under the Receivables Facility	Net change in funding under the Receivables Facility	400,000		205,000		Net change in funding under the Receivables Facility	335,600		255,000
Payments of dividends	Payments of dividends	(55,257)		(54,220)		Payments of dividends	(83,060)		(81,305)
Proceeds from issuance of common stock	Proceeds from issuance of common stock	85,048		10,372		Proceeds from issuance of common stock	88,581		21,339
Repurchase of common stock	Repurchase of common stock	(6,540)		(50,000)		Repurchase of common stock	(6,540)		(50,000)
Other financing activities	Other financing activities	(65,658)		(29,120)		Other financing activities	(89,050)		(31,322)
Net cash provided by (used in) financing activities	Net cash provided by (used in) financing activities	1,245,290		(163,355)		Net cash provided by (used in) financing activities	2,496,244		(150,660)
Effect of foreign exchange rates on cash and cash equivalents	Effect of foreign exchange rates on cash and cash equivalents	(755)		(3,461)		Effect of foreign exchange rates on cash and cash equivalents	544		(3,105)
Increase (decrease) in cash and cash equivalents		956,321		(19,638)
Increase in cash and cash equivalents						Increase in cash and cash equivalents	2,170,612		5,030
Cash and cash equivalents, beginning of period	Cash and cash equivalents, beginning of period	246,643		215,025		Cash and cash equivalents, beginning of period	246,643		215,025
Cash and cash equivalents, end of period	Cash and cash equivalents, end of period	$	1,202,964	$	195,387	Cash and cash equivalents, end of period	$	2,417,255	$	220,055


		Six Months Ended							Nine Months Ended
(dollars in millions)	(dollars in millions)	March 27, 2020		March 29, 2019		(dollars in millions)	June 26, 2020		June 28, 2019
Interest paid	Interest paid	$	179.3	$	180.2	Interest paid	$	254.8	$	248.3
Income taxes paid		$	36.1	$	118.9
Income taxes paid, net of refunds						Income taxes paid, net of refunds	$	30.3	$	137.4

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

~~For the six months ended March 27, 2020~~

(Unaudited)

(in thousands)


		Total Stockholders' Equity		Common Stock		Capital Surplus		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock			Total Stockholders' Equity		Common Stock		Capital Surplus		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock
Balance, September 27, 2019	Balance, September 27, 2019	$	3,320,047	$	2,829	$	3,236,450	$	1,107,029	$	(216,965)	$	(809,296)	Balance, September 27, 2019	$	3,320,047	$	2,829	$	3,236,450	$	1,107,029	$	(216,965)	$	(809,296)

Net income attributable to Aramark stockholders	Net income attributable to Aramark stockholders	145,761						145,761						Net income attributable to Aramark stockholders	145,761						145,761
Other comprehensive income	Other comprehensive income	21,200								21,200				Other comprehensive income	21,200								21,200
Capital contributions from issuance of common stock	Capital contributions from issuance of common stock	60,623		42		60,581								Capital contributions from issuance of common stock	60,623		42		60,581
Share-based compensation expense	Share-based compensation expense	14,116				14,116								Share-based compensation expense	14,116				14,116
Repurchases of Common Stock		(80,459)										(80,459)
Repurchase of common stock														Repurchase of common stock	(80,459)										(80,459)
Payments of dividends	Payments of dividends	(29,712)						(29,712)						Payments of dividends	(29,712)						(29,712)
Balance, December 27, 2019	Balance, December 27, 2019	$	3,451,576	$	2,871	$	3,311,147	$	1,223,078	$	(195,765)	$	(889,755)	Balance, December 27, 2019	$	3,451,576	$	2,871	$	3,311,147	$	1,223,078	$	(195,765)	$	(889,755)
Net loss attributable to Aramark stockholders	Net loss attributable to Aramark stockholders	(202,260)						(202,260)						Net loss attributable to Aramark stockholders	(202,260)						(202,260)
Other comprehensive loss	Other comprehensive loss	(108,245)								(108,245)				Other comprehensive loss	(108,245)								(108,245)
Capital contributions from issuance of common stock	Capital contributions from issuance of common stock	68,908		31		68,877								Capital contributions from issuance of common stock	68,908		31		68,877
Capital contribution from stockholder	Capital contribution from stockholder	14,814				14,814								Capital contribution from stockholder	14,814				14,814
Share-based compensation expense reduction	Share-based compensation expense reduction	(9,857)				(9,857)								Share-based compensation expense reduction	(9,857)				(9,857)
Repurchases of Common Stock		(17,719)										(17,719)
Repurchase of common stock														Repurchase of common stock	(17,719)										(17,719)
Payments of dividends	Payments of dividends	(27,772)						(27,772)						Payments of dividends	(27,772)						(27,772)
Balance, March 27, 2020	Balance, March 27, 2020	$	3,169,445	$	2,902	$	3,384,981	$	993,046	$	(304,010)	$	(907,474)	Balance, March 27, 2020	$	3,169,445	$	2,902	$	3,384,981	$	993,046	$	(304,010)	$	(907,474)
Net loss attributable to Aramark stockholders														Net loss attributable to Aramark stockholders	(256,440)						(256,440)
Other comprehensive loss														Other comprehensive loss	(3,914)								(3,914)
Capital contributions from issuance of common stock														Capital contributions from issuance of common stock	3,636		4		3,632
Share-based compensation expense														Share-based compensation expense	11,090				11,090
Repurchase of common stock														Repurchase of common stock	(672)										(672)
Payments of dividends														Payments of dividends	(27,803)						(27,803)
Balance, June 26, 2020														Balance, June 26, 2020	$	2,895,342	$	2,906	$	3,399,703	$	708,803	$	(307,924)	$	(908,146)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

~~For the six months ended March 29, 2019~~

(Unaudited)

(in thousands)


		Total Stockholders' Equity¹		Common Stock		Capital Surplus		Retained Earnings¹		Accumulated Other Comprehensive Loss		Treasury Stock			Total Stockholders' Equity¹		Common Stock		Capital Surplus		Retained Earnings¹		Accumulated Other Comprehensive Loss		Treasury Stock
Balance, September 28, 2018	Balance, September 28, 2018	$	3,029,558	$	2,793	$	3,132,421	$	710,519	$	(91,223)	$	(724,952)	Balance, September 28, 2018	$	3,029,558	$	2,793	$	3,132,421	$	710,519	$	(91,223)	$	(724,952)
Adoption of new accounting standard	Adoption of new accounting standard	58,395						58,395						Adoption of new accounting standard	58,395						58,395
Net income attributable to Aramark stockholders	Net income attributable to Aramark stockholders	250,682						250,682						Net income attributable to Aramark stockholders	250,682						250,682
Other comprehensive loss	Other comprehensive loss	(41,773)								(41,773)				Other comprehensive loss	(41,773)								(41,773)
Capital contributions from issuance of common stock	Capital contributions from issuance of common stock	3,510		14		3,496								Capital contributions from issuance of common stock	3,510		14		3,496
Share-based compensation expense	Share-based compensation expense	18,562				18,562								Share-based compensation expense	18,562				18,562
Repurchases of Common Stock		(71,884)										(71,884)
Repurchase of common stock														Repurchase of common stock	(71,884)										(71,884)
Payments of dividends	Payments of dividends	(29,157)						(29,157)						Payments of dividends	(29,157)						(29,157)
Balance, December 28, 2018	Balance, December 28, 2018	$	3,217,893	$	2,807	$	3,154,479	$	990,439	$	(132,996)	$	(796,836)	Balance, December 28, 2018	$	3,217,893	$	2,807	$	3,154,479	$	990,439	$	(132,996)	$	(796,836)
Net income attributable to Aramark stockholders	Net income attributable to Aramark stockholders	29,353						29,353						Net income attributable to Aramark stockholders	29,353						29,353
Other comprehensive loss	Other comprehensive loss	(8,655)								(8,655)				Other comprehensive loss	(8,655)								(8,655)
Capital contributions from issuance of common stock	Capital contributions from issuance of common stock	11,790		5		11,785								Capital contributions from issuance of common stock	11,790		5		11,785
Share-based compensation expense	Share-based compensation expense	14,679				14,679								Share-based compensation expense	14,679				14,679
Repurchases of Common Stock		(4,324)										(4,324)
Repurchase of common stock														Repurchase of common stock	(4,324)										(4,324)
Payments of dividends	Payments of dividends	(27,058)						(27,058)						Payments of dividends	(27,058)						(27,058)
Balance, March 29, 2019	Balance, March 29, 2019	$	3,233,680	$	2,812	$	3,180,943	$	992,736	$	(141,651)	$	(801,160)	Balance, March 29, 2019	$	3,233,680	$	2,812	$	3,180,943	$	992,736	$	(141,651)	$	(801,160)

Net income attributable to Aramark stockholders														Net income attributable to Aramark stockholders	82,955						82,955
Other comprehensive loss														Other comprehensive loss	(29,187)								(29,187)
Capital contributions from issuance of common stock														Capital contributions from issuance of common stock	12,290		7		12,283
Share-based compensation expense														Share-based compensation expense	15,173				15,173
Repurchase of common stock														Repurchase of common stock	(1,904)										(1,904)
Payments of dividends														Payments of dividends	(27,085)						(27,085)
Balance, June 28, 2019														Balance, June 28, 2019	$	3,285,922	$	2,819	$	3,208,399	$	1,048,606	$	(170,838)	$	(803,064)

¹May not foot due to rounding.

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

Aramark (the "Company") is a leading global provider of food, facilities and uniform services to education, healthcare, business & industry and sports, leisure & corrections clients. The Company's core market is the United States, which is supplemented by an additional 18-country footprint. The Company operates its business in 3 reportable segments that share many of the same operating characteristics: Food and Support Services United States ("FSS United States"), Food and Support Services International ("FSS International") and Uniform and Career Apparel ("Uniform").

The condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the audited consolidated financial statements, and the notes to those statements, included in the Company's Form 10-K filed with the SEC on November 26, 2019. The Condensed Consolidated Balance Sheet as of September 27, 2019 was derived from audited financial statements which have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. In the opinion of the Company, the statements include all adjustments, which are of a normal, recurring nature, required for a fair presentation for the periods presented. The results of operations for interim periods are not necessarily indicative of the results for a full year, due to the seasonality of some of the Company's business activities, the impact of the COVID-19 pandemic ("COVID-19") and the possibility of changes in general economic conditions.

The condensed consolidated financial statements include the accounts of the Company and all of its subsidiaries in which a controlling financial interest is maintained. All significant intercompany transactions and accounts have been eliminated.

New Accounting Standards Updates

Adopted Standards

In March 2019, the Financial Accounting Standards Board ("FASB") issued an accounting standards update ("ASU") which provided clarification regarding three issues related to the lease recognition standard. The guidance was effective for the Company in the first quarter of fiscal 2020 when the lease accounting standard was adopted. See below for further discussion regarding the impact of this standard.

In July 2018, the FASB issued two ASUs regarding the lease recognition standard. The guidance provided clarification on issues identified regarding the adoption of the standard, provided an additional transition method to adopt the standard and provided an additional practical expedient to lessors. The guidance was effective for the Company in the first quarter of fiscal 2020 when the lease accounting standard was adopted. See below for further discussion regarding the impact of this standard.

In July 2018, the FASB issued an ASU which clarifies, corrects errors in or makes minor improvements to the Accounting Standards Codification. The guidance was effective for the Company either upon issuance or in the first quarter of fiscal 2020, depending on the amendment. There was no impact on the condensed consolidated financial statements related to the amendments that were effective upon issuance of the guidance. The Company adopted the remaining amendments of the pronouncement in the first quarter of fiscal 2020, which did not have a material impact on the condensed consolidated financial statements.

In February 2018, the FASB issued an ASU which allows for the reclassification of stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income to retained earnings. The guidance was effective for the Company in the first quarter of fiscal 2020. The Company adopted the guidance in the first quarter of fiscal 2020, which did not have an impact on the condensed consolidated financial statements. The Company did not elect to reclassify the stranded income tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive income to retained earnings.

In September 2017, the FASB issued an ASU to provide additional implementation guidance with respect to the lease accounting standard. The guidance was effective for the Company in the first quarter of fiscal 2020. The Company adopted the standard in the first quarter of fiscal 2020 in conjunction with the lease recognition standard. See below for further discussion regarding the impact of the lease accounting provisions related to this standard.

In February 2016, the FASB issued an ASU requiring lessees to recognize most leases on their balance sheets as operating lease liabilities with corresponding operating lease right-of-use assets and to disclose key information about lease arrangements. Recognition of expense on the Condensed Consolidated Statements of (Loss) Income continues in a manner similar to previous guidance. The Company adopted this guidance on September 28, 2019 (first day of fiscal 2020).

In connection with the new lease guidance, the Company completed a comprehensive review of its lease arrangements in order to determine the impact of this ASU on its consolidated financial statements and related disclosures. The Company identified

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

and implemented appropriate changes to business processes, controls and systems to support recognition and disclosure under the new standard.

The Company adopted Accounting Standards Codification 842 (“ASC 842” or the "new lease standard") using the modified retrospective transition approach with an adjustment that recognized "Operating Lease Right-of-use Assets," "Current operating lease liabilities" and "Noncurrent Operating Lease Liabilities" on the Condensed Consolidated Balance Sheets on September 28, 2019. Comparative period information and disclosures were not revised as a result of the recognition and measurement of leases. Adoption of the new lease standard resulted in the recognition of operating lease liabilities and associated operating lease right-of-use assets of approximately $416.1 million and $558.5 million, respectively, as of September 28, 2019 on the Condensed Consolidated Balance Sheets. The operating lease right-of-use assets include adjustments for deferred rent, tenant improvement allowances and prepaid rent, including $166.9 million of long-term prepaid rent as of September 28, 2019 associated with certain leases at client locations. There was no material impact to the Condensed Consolidated Statements of (Loss) Income or Condensed Consolidated Statements of Cash Flows as a result of adoption. See Note 8 for further information on the impact of adopting the new lease standard.

Standards Not Yet Adopted (from most to least recent date of issuance)

In March 2020, the FASB issued an ASU which provides optional expedients that may be adopted and applied through December 2022 to assist with the discontinuance of LIBOR. The expedients allow companies to ease the potential accounting burden when modifying contracts and hedging relationships that use LIBOR as a reference rate, if certain criteria are met. During the second quarter of fiscal 2020, the Company adopted the optional expedient to assert probability of forecasted hedged transactions occurring on its interest rate swap derivative contracts regardless of any expected contract modifications related to reference reform. Other optional expedients related to hedging relationships may be contemplated in the future resulting from reference rate reform. The Company reviewed its portfolio of debt agreements, lease agreements and other contracts and determined that only its debt agreements will be impacted by this standard, as the lease agreements and other contracts do not use LIBOR as a reference rate. The Company is currently evaluating the impact of the remaining amendment of this ~~standard on other contracts.~~standard.

In January 2020, the FASB issued an ASU which provides clarification and improvements to existing guidance related to accounting for certain equity securities upon the application or discontinuation of equity method accounting and the measurement of forward contracts and purchased options on certain securities. The guidance is effective for the Company in the first quarter of fiscal 2022 and early adoption is permitted. The Company is currently evaluating the impact of this standard.

In December 2019, the FASB issued an ASU which simplifies the accounting for income taxes and clarifies and amends existing income tax guidance. Impacted areas include intraperiod tax allocations, interim period taxes, deferred tax liabilities with outside basis differences, franchise taxes and transactions which result in the "step-up" of goodwill. The guidance is effective for the Company in the first quarter of fiscal 2022 and early adoption is permitted. The Company is currently evaluating the impact of this standard.

In November 2019, the FASB issued an ASU which provides clarification and improvements to existing guidance related to the credit losses on financial instruments standard. The Company will adopt this guidance in the first quarter of fiscal 2021 when the credit losses on financial instruments standard is adopted. The Company ~~is currently evaluating~~does not anticipate the impact ~~of this standard.~~will be material.

In May 2019, the FASB issued an ASU which provides the option to irrevocably elect to apply the fair value measurement option on an instrument-by-instrument basis for certain financial instruments within the scope of the credit losses on financial instruments standard. The Company will adopt this guidance in the first quarter of fiscal 2021 when the credit losses on financial instruments standard is adopted. The Company ~~is currently evaluating~~does not anticipate the impact ~~of this standard.~~will be material.

In April 2019, the FASB issued an ASU which provides clarification, error corrections and improvements to existing guidance related to the credit losses on financial instruments ASU issued in June 2016, the derivatives and hedging ASU issued in August 2017 and the financial instruments ASU issued in January 2016. The guidance related to the credit losses on financial instruments ASU ~~and the financial instruments ASU~~ will be adopted in the first quarter of fiscal 2021. The Company adopted the guidance related to financial instruments ASU in the first quarter of 2019 and the derivatives and hedging in the first quarter of fiscal 2020, which did not have a material impact on the condensed consolidated financial statements. The Company is currently evaluating the impact of the remaining ~~amendments~~amendment of this standard.

In August 2018, the FASB issued an ASU which adds, modifies and removes several disclosure requirements related to defined benefit pension plans. The guidance is effective for the Company in the first quarter of fiscal 2022 and early adoption is permitted. The Company is currently evaluating the impact of this standard.

In August 2018, the FASB issued an ASU which adds, modifies and removes several disclosure requirements related to fair value measurements. The Company will adopt this guidance in the first quarter of fiscal 2021. The Company is currently evaluating the impact of this standard.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

In June 2016, the FASB issued an ASU to require entities to account for expected credit losses on financial instruments including trade receivables. The Company will adopt this guidance in the first quarter of fiscal 2021. The Company is currently evaluating the impact of this ~~standard.~~

~~Table~~standard, including reviewing its financial instruments to determine the impact the adoption of ~~Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

this ASU will have on its consolidated financial statements and related disclosures. The Company continues to assess the disclosure requirements and implement appropriate changes to business processes, policies, and controls. The Company does not anticipate the impact will be material.

Comprehensive Income (Loss)

Comprehensive income (loss) includes all changes to stockholders' equity during a period, except those resulting from investments by and distributions to stockholders. Components of comprehensive income (loss) include net income (loss), changes in foreign currency translation adjustments (net of tax), pension plan adjustments (net of tax), changes in the fair value of cash flow hedges (net of tax) and changes to the share of any equity investees' comprehensive income (loss) (net of tax).

The summary of the components of comprehensive (loss) income ~~(loss)~~ is as follows (in thousands):


		Three Months Ended															Three Months Ended
		March 27, 2020						March 29, 2019							June 26, 2020				June 28, 2019
		Pre-Tax Amount	Tax Effect	After-Tax Amount		Pre-Tax Amount	Tax Effect	After-Tax Amount			Pre-Tax Amount	Tax Effect	After-Tax Amount		Pre-Tax Amount	Tax Effect	After-Tax Amount
Net (loss) income	Net (loss) income			$	(202,021)			$	29,310	Net (loss) income			$	(256,308)			$	83,064
Pension plan adjustments	Pension plan adjustments	(286)	—	(286)		—	—	—		Pension plan adjustments	(285)	—	(285)		(179)	—	(179)
Foreign currency translation adjustments	Foreign currency translation adjustments	(41,579)	(314)	(41,893)		8,842	131	8,973		Foreign currency translation adjustments	4,239	(124)	4,115		(2,002)	—	(2,002)
Fair value of cash flow hedges	Fair value of cash flow hedges	(89,083)	23,162	(65,921)		(23,851)	6,173	(17,678)		Fair value of cash flow hedges	(10,369)	2,696	(7,673)		(36,089)	9,340	(26,749)
Share of equity investee's comprehensive (loss) income		(145)	—	(145)		50	—	50
Share of equity investee's comprehensive loss										Share of equity investee's comprehensive loss	(71)	—	(71)		(257)	—	(257)
Other comprehensive loss	Other comprehensive loss	(131,093)	22,848	(108,245)		(14,959)	6,304	(8,655)		Other comprehensive loss	(6,486)	2,572	(3,914)		(38,527)	9,340	(29,187)
Comprehensive (loss) income	Comprehensive (loss) income			(310,266)				20,655		Comprehensive (loss) income			(260,222)				53,877
Less: Net income (loss) attributable to noncontrolling interest				239				(43)
Less: Net income attributable to noncontrolling interest										Less: Net income attributable to noncontrolling interest			132				109
Comprehensive (loss) income attributable to Aramark stockholders	Comprehensive (loss) income attributable to Aramark stockholders			$	(310,505)			$	20,698	Comprehensive (loss) income attributable to Aramark stockholders			$	(260,354)			$	53,768

		Six Months Ended															Nine Months Ended
		March 27, 2020						March 29, 2019							June 26, 2020				June 28, 2019
		Pre-Tax Amount	Tax Effect	After-Tax Amount		Pre-Tax Amount	Tax Effect	After-Tax Amount			Pre-Tax Amount	Tax Effect	After-Tax Amount		Pre-Tax Amount	Tax Effect	After-Tax Amount
Net (loss) income	Net (loss) income			$	(56,138)			$	279,988	Net (loss) income			$	(312,446)			$	363,052
Pension plan adjustments	Pension plan adjustments	(571)	—	(571)		753	—	753		Pension plan adjustments	(856)	—	(856)		574	—	574
Foreign currency translation adjustments	Foreign currency translation adjustments	(27,225)	(83)	(27,308)		(9,034)	—	(9,034)		Foreign currency translation adjustments	(22,986)	(207)	(23,193)		(11,036)	—	(11,036)
Fair value of cash flow hedges	Fair value of cash flow hedges	(79,957)	20,789	(59,168)		(56,553)	14,636	(41,917)		Fair value of cash flow hedges	(90,326)	23,485	(66,841)		(92,642)	23,976	(68,666)
Share of equity investee's comprehensive income (loss)		2	—	2		(230)	—	(230)
Share of equity investee's comprehensive loss										Share of equity investee's comprehensive loss	(69)	—	(69)		(487)	—	(487)
Other comprehensive loss	Other comprehensive loss	(107,751)	20,706	(87,045)		(65,064)	14,636	(50,428)		Other comprehensive loss	(114,237)	23,278	(90,959)		(103,591)	23,976	(79,615)
Comprehensive (loss) income	Comprehensive (loss) income			(143,183)				229,560		Comprehensive (loss) income			(403,405)				283,437
Less: Net income (loss) attributable to noncontrolling interest				361				(49)
Less: Net income attributable to noncontrolling interest										Less: Net income attributable to noncontrolling interest			493				60
Comprehensive (loss) income attributable to Aramark stockholders	Comprehensive (loss) income attributable to Aramark stockholders			$	(143,544)			$	229,609	Comprehensive (loss) income attributable to Aramark stockholders			$	(403,898)			$	283,377

Accumulated other comprehensive loss consists of the following (in thousands):


		March 27, 2020		September 27, 2019			June 26, 2020		September 27, 2019
Pension plan adjustments	Pension plan adjustments	$	(47,793)	$	(47,222)	Pension plan adjustments	$	(48,078)	$	(47,222)
Foreign currency translation adjustments	Foreign currency translation adjustments	(155,427)		(128,119)		Foreign currency translation adjustments	(151,312)		(128,119)
Cash flow hedges	Cash flow hedges	(90,224)		(31,056)		Cash flow hedges	(97,897)		(31,056)
Share of equity investee's accumulated other comprehensive loss	Share of equity investee's accumulated other comprehensive loss	(10,566)		(10,568)		Share of equity investee's accumulated other comprehensive loss	(10,637)		(10,568)
		$	(304,010)	$	(216,965)		$	(307,924)	$	(216,965)

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Currency Translation

During fiscal 2018, Argentina was determined to have a highly inflationary economy. As a result, the Company remeasures the financial statements of Argentina's operations in accordance with the accounting guidance for highly inflationary economies.

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

During both the three and ~~six~~nine month periods of fiscal 2020 and 2019, the impact of foreign currency transaction gains and losses were immaterial to the condensed consolidated financial statements.

Current Assets

Beginning in fiscal 2019, the Company began insuring portions of its general liability, automobile liability and workers’ compensation risks through a wholly owned captive insurance subsidiary (the "Captive"), to enhance its risk financing strategies. The Captive is subject to the regulations within its domicile, including regulations relating to levels of liquidity and solvency as such concepts are defined by the regulator. The Captive was in compliance with these regulations as of ~~March 27,~~June 26, 2020. These regulations may have the effect of limiting the Company's ability to access certain cash and cash equivalents held by the Captive for uses other than for the payments of its general liability, automobile liability and workers' compensation claims and related Captive costs. As of ~~March 27,~~June 26, 2020, cash and cash equivalents at the Captive was ~~$68.7~~$59.9 million. The Company is self-insured for a portion of general liability, automobile liability and workers' compensation claims under its insurance arrangements. Self-insurance reserves are recorded based on actuarial analyses.

Property and Equipment

During the third quarter of fiscal 2020, the Company permanently vacated certain rental properties and assets at various locations throughout the United States related to non-core operations and no longer intends to operate or sublease at these locations. Accordingly, the Company recorded a loss on disposal by abandonment of $28.5 million within its FSS United States segment, consisting of right-of-use assets ($10.3 million), leasehold improvements ($17.4 million) and other assets ($0.8 million), which is included in "Costs of services provided" in the Condensed Consolidated Statements of (Loss) Income for both the three and nine months ended June 26, 2020. The Company has a remaining lease liability of $11.3 million related to the abandoned leases, which represents the fixed minimum rental payments contractually required under the leases through February 2025.

During the third quarter of fiscal 2020, the Company received $25.0 million of insurance proceeds from one of its insurance carriers related to property damage and business interruption from a tornado at one of its Uniform market centers in Nashville, Tennessee. These proceeds serve to cover the cost of rebuilding the property and for any incremental expenses the Company incurs to continue servicing its customers at nearby market centers. The Company’s insurance policy provides coverage for the property damage and reimbursement for other expenses and incremental costs that have been incurred related to the damages and losses. The Company recorded a gain during the three and nine months ended June 26, 2020 of approximately $16.3 million from these proceeds, which represents the excess of previously incurred losses, including the write-down of the damaged property and equipment and business interruption expenses. The gain is included in “Costs of services provided” in the Condensed Consolidated Statements of (Loss) Income. The Company allocated $21.5 million of the insurance proceeds to the recovery of the damaged building and equipment and is included within “Net cash used in investing activities” in the Condensed Consolidated Statement of Cash Flows for the nine months ended June 26, 2020. The remaining $3.5 million of insurance proceeds is included within “Net cash (used in) provided by operating activities” to offset the business interruption expenses incurred during the nine months ended June 26, 2020. The claims are ongoing and will be finalized upon completion of the new property. The Company believes the remaining claim amounts in future periods will be recoverable.

Other Assets

Other assets consist primarily of costs to obtain or fulfill contracts, including rental merchandise in-service, long-term receivables, investments in 50% or less owned entities, computer software costs and employee sales commissions. For investments in 50% or less owned entities, other than those accounted for under the equity method of accounting, the Company measures these investments at cost, less any impairment and adjusted for changes in fair value resulting from observable price changes for an identical or a similar investment of the same issuer due to the lack of readily available fair values related to those investments. The carrying amount of equity investments without readily determinable fair values ~~at March 27,~~as of June 26, 2020 and September 27, 2019 was $42.5 million and $42.6 million, respectively.

The Company recorded non-cash asset write-downs within its FSS United States segment of approximately $17.8 million and $21.9 million related to certain information technology assets during the three and nine months ended June 26, 2020, respectively, as a result of management decisions to discontinue use of these solutions and from non-renewal or expirations of contracts with specific vendors. These non-cash charges were recorded to “Costs of services provided” in the Condensed Consolidated Statements of (Loss) Income for the three and nine months ended June 26, 2020.

Impact of COVID-19

COVID-19 has adversely affected global economies, financial markets and the overall environment for the Company and the extent to which it may impact future results of operations and overall financial performance remains uncertain. The Company

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

began experiencing a significant decline in operations due to COVID-19 towards the end of its second quarter of fiscal 2020, which has continued through the third quarter of fiscal 2020. The decline in operations from COVID-19 caused a material deterioration in the Company's revenue, operating income (loss) and net income (loss) for the three and nine months ended June 26, 2020. Our allowance for doubtful accounts increased to $73.0 million as of June 26, 2020 compared to $49.6 million as of September 27, 2019, which includes our current estimates that reflect the continued economic uncertainty resulting from COVID-19. Certain businesses, mainly those related the Company's Sports, Leisure & Correction, Education and Business & Industry sectors, have been more significantly impacted than others and the timeline until the Company can resume normal operations consistent with historical results is uncertain. In response, the Company took significant actions in order to mitigate the negative impacts of COVID-19, including:

•implementing several cost reduction initiatives, including renegotiations of client contracts, salary and other compensation adjustments and reductions to general corporate expenses, as well as headcount reductions (see Note 3);

•strengthening cash position by increasing borrowings (see Note 5); and

•leveraging relief provisions provided under the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") and other foreign governmental programs (see below and Note 9).

The ongoing impact of COVID-19 on the Company's longer-term operational and financial performance will depend on future developments which are highly uncertain and cannot be predicted.

The CARES Act provides an employee retention credit (“CARES Employee Retention credit”), which is a refundable tax credit against certain employment taxes of up to $5,000 per employee for eligible employers. The credit is equal to 50% of qualified wages paid to employees during a quarter, capped at $10,000 of qualified wages per employee through year end. The Company qualifies for the credit and expects to continue to receive additional credits for qualified wages through December 31, 2020. During the three and nine months ended June 26, 2020, the Company recorded $10.1 million related to the CARES Employee Retention credit in “Costs of services provided” in the Company’s Condensed Consolidated Statements of (Loss) Income and within “Accrued expenses and other current liabilities” in the Company's Condensed Consolidated Balance Sheets.

The CARES Act also provides for deferred payment of the employer portion of social security taxes through the end of calendar 2020, with 50% of the deferred amount due December 31, 2021 and the remaining 50% due December 31, 2022. This is expected to provide the Company with additional liquidity during the current year. The deferred amounts are recorded as a liability within “Accrued expenses and other current liabilities” on the Company’s Condensed Consolidated Balance Sheets as of June 26, 2020.

Within our FSS International and Uniform segments, many foreign jurisdictions in which the Company operates are also providing companies various forms of relief from the COVID-19 pandemic, including labor related credits. These labor related credits generally allow companies to receive credits if they retain employees on their payroll, rather than furloughing or terminating employees as a result of the business disruption caused by COVID-19. The Company qualifies for the credit and expects to continue to receive additional credits for qualified wages through at least fiscal year-end. The Company recorded approximately $61.1 million of labor related credits during the three and nine months ended June 26, 2020 in the Condensed Consolidated Statements of (Loss) Income.

The Company accounts for these labor related credits as a reduction to the expense that its intended to compensate in the period in which the corresponding expense is incurred and there is reasonable assurance the Company will both receive the credits and comply with all conditions attached to the credit.

NOTE 2. DIVESTITURES:

On November 9, 2018, the Company completed the sale of its wholly-owned Healthcare Technologies ("HCT") business for $293.7 million in cash. The transaction resulted in a pretax gain of $156.3 million (tax effected gain of $139.2 million) in the Condensed Consolidated Statements of (Loss) Income for the ~~six~~nine months ended ~~March 29,~~June 28, 2019.

NOTE 3. SEVERANCE:

In June 2020, the Company made changes to its organization as a result of COVID-19 to align its cost base to best support its clients' needs as the Company navigates the current environment and focuses on its long-term strategy. These actions included headcount reductions, which resulted in severance charges of approximately $124.9 million during the three and nine months ended June 26, 2020, which are recorded in both “Costs of services provided and “Selling and general corporate expenses” in the Condensed Consolidated Statements of (Loss) Income. These charges are expected to be paid out within two years.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The following table summarizes the severance charge by segment recognized in the Condensed Consolidated Statements of (Loss) Income for both the three and nine months ended June 26, 2020 (in millions):


FSS United States	$	48.2
FSS International	74.7
Uniform	0.3
Corporate	1.7
	$	124.9

During fiscal 2018, the Company commenced a new phase of strategic reinvestment and reorganization actions to streamline and improve efficiencies and effectiveness of its selling, general and administrative functions which resulted in a net severance charge of approximately ~~$22.0~~$19.8 million for the ~~six~~nine months ended ~~March 29,~~June 28, 2019. The Company completed this cost savings phase as of September 27, 2019. As of ~~March 27,~~June 26, 2020 and September 27, 2019, the Company had an accrual of approximately ~~$7.4~~$4.3 million and $11.9 million, respectively, related to unpaid severance ~~obligations.~~obligations under the fiscal 2018 actions. These obligations are expected to be paid through early fiscal ~~2020.~~2021.

NOTE 4. GOODWILL AND OTHER INTANGIBLE ASSETS:

Goodwill represents the excess of the fair value of consideration paid for an acquired entity over the fair value of assets acquired and liabilities assumed in a business combination. Goodwill is not amortized and is subject to an impairment test that the Company conducts annually or more frequently if a change in circumstances or the occurrence of events indicates that potential impairment exists, using discounted cash flows.

During the second quarter of fiscal 2020, the Company identified a triggering event from the ~~recent~~ decline in its stock price resulting from ~~the COVID-19 pandemic ("COVID-19").~~COVID-19. As a result, the Company performed an interim quantitative impairment test as of March 27, 2020. The Company performed its assessment of goodwill at the reporting unit level. Within the FSS International segment, each country or region was evaluated separately since such operating units are relatively autonomous and separate goodwill balances have been recorded for each entity. The Company compared the estimated fair value using discounted cash flow calculations of each reporting unit with its estimated book value. Based on the evaluation performed, the Company determined that goodwill was not impaired for all but one reporting unit, as the fair value of each reporting unit substantially exceeded its respective carrying amount. The one reporting unit within the FSS International segment for which goodwill was determined to be impaired was also tested for impairment using the quantitative approach during the Company's previous annual impairment test completed as of August 23, 2019. The reporting unit had a fair value that exceeded its carrying value by approximately 22% as of that date. As of March 27, 2020, the quantitative impairment test for this same reporting unit resulted in a fair value that was approximately 34% lower than its carrying value, which was driven most notably by the changes in underlying assumptions used for impairment calculation purposes, including the discount rate as well as the near term growth outlook of the reporting unit pre-COVID-19. As a result, the Company recognized a non-cash impairment charge of $198.6 million in the Condensed Consolidated Statements of (Loss) Income for ~~both~~ the ~~three and six~~nine months ended ~~March 27,~~June 26, 2020. For tax purposes, the impairment charge is not tax deductible. The impaired reporting unit has a remaining goodwill balance of ~~$86.2 million.~~

~~Table~~$86.3 million as of ~~Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

June 26, 2020. No triggering events were identified during the third quarter of fiscal 2020 that caused similar impairment testing to be performed.

The determination of fair value for each reporting unit includes assumptions, which are considered Level 3 inputs, that are subject to risk and uncertainty. The discounted cash flow calculations are dependent on several subjective factors including the timing of future cash flows, future growth rates and the discount rate. If assumptions or estimates in the fair value calculations change or if future cash flows or future growth rates vary from what was expected, including those assumptions relating to the duration and severity of COVID-19, this may impact the impairment analysis and could reduce the underlying cash flows used to estimate fair values and result in a decline in fair value that may trigger future impairment charges.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Changes in total goodwill during the ~~six~~nine months ended ~~March 27,~~June 26, 2020 are as follows (in thousands):


Segment	Segment	September 27, 2019		Acquisitions		Impairments		Translation		March 27, 2020		Segment	September 27, 2019		Acquisitions		Impairments		Translation		June 26, 2020
FSS United States	FSS United States	$	3,949,218	$	728	$	—	$	(58)	$	3,949,888	FSS United States	$	3,949,218	$	772	$	—	$	(35)	$	3,949,955
FSS International	FSS International	608,468		220		(198,600)		(4,187)		405,901		FSS International	608,468		220		(198,600)		483		410,571
Uniforms	Uniforms	961,114		3,223		—		(500)		963,837		Uniforms	961,114		3,713		—		(305)		964,522
		$	5,518,800	$	4,171	$	(198,600)	$	(4,745)	$	5,319,626		$	5,518,800	$	4,705	$	(198,600)	$	143	$	5,325,048

Other intangible assets consist of the following (in thousands):


		March 27, 2020										September 27, 2019											June 26, 2020				September 27, 2019
		Gross Amount		Accumulated Amortization		Net Amount		Gross Amount		Accumulated Amortization		Net Amount			Gross Amount		Accumulated Amortization		Net Amount		Gross Amount		Accumulated Amortization		Net Amount
Customer relationship assets	Customer relationship assets	$	2,190,980	$	(1,246,389)	$	944,591	$	2,183,492	$	(1,193,525)	$	989,967	Customer relationship assets	$	2,191,986	$	(1,275,234)	$	916,752	$	2,183,492	$	(1,193,525)	$	989,967
Trade names	Trade names	1,047,561		(6,073)		1,041,488		1,047,959		(4,360)		1,043,599		Trade names	1,048,228		(6,945)		1,041,283		1,047,959		(4,360)		1,043,599
		$	3,238,541	$	(1,252,462)	$	1,986,079	$	3,231,451	$	(1,197,885)	$	2,033,566		$	3,240,214	$	(1,282,179)	$	1,958,035	$	3,231,451	$	(1,197,885)	$	2,033,566

Amortization of intangible assets for the ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019 was approximately ~~$58.2~~$87.4 million and ~~$59.1~~$87.7 million, respectively. The Aramark, Avendra and a majority of the other trade names are indefinite lived intangible assets and are not amortizable but are evaluated for impairment at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. During the second quarter of fiscal 2020, the Company identified potential impairment indicators from the ~~recent~~ decline in its stock price resulting from ~~the COVID-19 pandemic.~~COVID-19. As a result, the Company completed an interim trade name impairment test for the Avendra and certain other trade names as of March 27, 2020. The Company utilized the "relief-from-royalty" method, which considers the discounted estimated royalty payments that are expected to be avoided as a result of the ~~trademarks~~trade names being owned. Based on the evaluation performed, the Company determined that none of the trade names were impaired, as the estimated fair value for each of the Avendra and certain other trade names exceeded their respective carrying amounts.

NOTE 5. BORROWINGS:

Long-term borrowings, net, are summarized in the following table (in thousands):


	June 26, 2020		September 27, 2019
Senior secured revolving credit facility, due October 2023	$	845,189	$	51,410
Senior secured term loan facility, due October 2023	483,739		507,887
Senior secured term loan facility, due March 2024	829,922		829,344
Senior secured term loan facility, due March 2025	1,658,882		1,658,026
Senior secured term loan facility, due January 2027	892,766		—
5.125% senior notes, due January 2024	—		902,351
5.000% senior notes, due April 2025	593,032		592,087
3.125% senior notes, due April 2025⁽¹⁾	361,748		352,363
6.375% senior notes, due May 2025	1,478,368		—
4.750% senior notes, due June 2026	495,239		494,731
5.000% senior notes, due February 2028	1,138,530		1,137,625
Receivables Facility, due June 2022	335,600		—
Finance leases	137,386		148,754
Other	9,213		7,589
	9,259,614		6,682,167
Less—current portion	(90,112)		(69,928)
	$	9,169,502	$	6,612,239


(1)			This is a Euro denominated borrowing.

As of June 26, 2020, there was approximately $901.8 million of outstanding foreign currency borrowings.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

~~NOTE 5. BORROWINGS:~~

~~Long-term borrowings, net, are summarized~~Beginning in ~~the following table (in thousands):~~

March 27, 2020 September 27, 2019
Senior secured revolving credit facility, due October 2023 $ 948,847 $ 51,410
Senior secured term loan facility, due October 2023 483,112 507,887
Senior secured term loan facility, due March 2024 829,728 829,344
Senior secured term loan facility, due March 2025 1,658,594 1,658,026
Senior secured term loan facility, due January 2027 892,513 —
5.125% senior notes, due January 2024 — 902,351
5.000% senior notes, due April 2025 592,713 592,087
3.125% senior notes, due April 2025⁽¹⁾
359,129 352,363
4.750% senior notes, due June 2026 495,067 494,731
5.000% senior notes, due February 2028 1,138,225 1,137,625
Receivables Facility, due May 2021 400,000 —
Finance leases 140,067 148,754
Other 27,998 7,589
7,965,993 6,682,167
Less—current portion (103,406) (69,928)
$ 7,862,587 $ 6,612,239


~~(1)~~			~~This is a Euro denominated borrowing.~~

~~As of March 27, 2020, there was approximately $921.0 million of outstanding foreign currency borrowings.~~

~~During~~ the second quarter of fiscal 2020, the Company increased its borrowings under the revolving credit facility ~~to $948.8 million~~ and ~~under~~ the Receivables Facility ~~to $400.0 million~~and also issued new senior unsecured notes (see below) in order to provide additional cash availability and maximize flexibility in response to uncertainty surrounding COVID-19. As of ~~March 27,~~June 26, 2020, the Company had ~~$1,203.0~~$845.2 million of borrowings under the revolving credit facility, $335.6 million of borrowings under the Receivables Facility, $2,417.3 million of cash and cash equivalents and approximately ~~$4.7~~$85.7 million of availability under the senior secured revolving credit facility.

Fiscal 2020 Refinancing Transactions

Receivables Facility

On June 22, 2020, the Company extended the scheduled maturity date of the Receivables Facility from May 2021 to June 2022. All other terms and conditions of the agreement remained largely unchanged.

6.375% Senior ~~Secured Credit Agreement~~Notes due 2025

On April ~~22,~~27, 2020, Aramark Services, Inc. ("ASI"), an indirect wholly owned subsidiary of the Company, entered into Amendment No. 9 ("Amendment No. 9") to the credit agreement dated as of March 28, 2017 (as supplemented or otherwise modified from time to time, the "Credit Agreement") and last amended by Amendment No. 8 ("Amendment No. 8") on January 15, 2020. Amendment No. 9 provides for a covenant waiver period which suspends the Consolidated Secured Debt Ratio debt covenant required under the credit agreement for four fiscal quarters, commencing with the fourth quarter of fiscal 2020 through the third quarter of fiscal 2021, subject to, among other things, ongoing compliance with a minimum liquidity condition of $400.0 million and restrictions on making certain restricted payments and investments in unrestricted subsidiaries, in each case, as set forth in Amendment No. 9. If ASI ceases to be in compliance with Amendment No. 9 at any time during the covenant waiver period, this will cause an event of default under the Credit Agreement, and if such non-compliance is not waived, certain lenders under the senior secured credit facilities could elect to declare all amounts outstanding under the senior secured credit facilities to be immediately due and payable and terminate all commitments to extend further credit under such facilities. When the Consolidated Secured Debt Ratio debt covenant is once again effective for ASI in the fourth quarter of fiscal 2021, the trailing twelve month period will consist of results from the third quarter of fiscal 2019 through the first quarter of fiscal 2020 plus the fourth quarter of fiscal 2021, excluding the results of the second quarter of fiscal 2020 through the third quarter of fiscal 2021. This exclusion is intended to prevent the effects of COVID-19 from impacting the covenant calculation.

On January 15, 2020, ASI entered into Amendment No. 8 to the Credit Agreement, which provides for an incremental, senior secured credit facility under the Credit Agreement comprised of a U.S. dollar denominated term loan made to ASI in an amount equal to $900.0 million, due January 15, 2027 (the "U.S. Term Loan B due 2027"). The U.S. Term Loan B due 2027 was borrowed with an original issue discount of 0.125%.

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

principal amount and to pay accrued interest, certain fees and related expenses. The Company recorded $20.9 million of charges to "Interest and Other Financing Costs, net" in the Condensed Consolidated Statements of (Loss) Income for both the three and six months ended March 27, 2020, consisting of the payment of a $23.1 million call premium and a $2.2 million non-cash gain for the write-off of unamortized deferred financing costs and the unamortized debt premium on the 2024 Notes. The Company capitalized third-party costs of approximately $6.6 million related to banker fees, rating agency fees and legal fees directly attributable to the U.S. Term Loan B due 2027, which are included in "Long-Term Borrowings" in the Condensed Consolidated Balance Sheets. Amounts paid for the call premium and capitalized third-party costs are included within "Other financing activities" on the Condensed Consolidated Statements of Cash Flows for the six months ended March 27, 2020.

The U.S. Term Loan B due 2027 bears interest at a rate equal to, at the Company’s option, either (a) a LIBOR rate determined by reference to the costs of funds for deposits in U.S. dollars for the interest period relevant to such borrowing adjusted for certain additional costs or (b) a base rate determined by reference to the highest of (1) the prime rate of the administrative agent, (2) the federal funds rate plus 0.50% and (3) the LIBOR rate plus 1.00% plus an applicable margin set initially at 1.75% for borrowings based on the LIBOR rate, subject to a LIBOR floor of 0.00% and 0.75% for borrowings based on the base rate, subject to a minimum base rate of 0.00%.

The Company is required to make quarterly principal repayments on the U.S. Term Loan B due 2027 in quarterly amounts of 1.00% per annum of the funded total principal amount on the initial funding date thereof and is subject to substantially similar terms relating to guarantees, collateral, mandatory prepayments and covenants that are applicable to the Company’s existing U.S. Term Loan B due 2024 and U.S. Term Loan B due 2025, in each case, outstanding under the Credit Agreement.

~~6.375% Senior Notes due 2025 (Subsequent to March 27, 2020)~~

~~On April 27, 2020, ASI~~ issued $1,500.0 million aggregate principal amount of 6.375% Senior Notes due May 1, 2025 (the "6.375% 2025 Notes"). ASI intends to use the net proceeds from the 6.375% 2025 Notes for general corporate purposes. The Company ~~incurred~~capitalized third-party costs of approximately ~~$21.3~~$22.3 million ~~of third-party costs~~ directly attributable to the 6.375% 2025 ~~Notes.~~Notes, which are included in "Long-Term Borrowings" in the Condensed Consolidated Balance Sheets and within "Other financing activities" on the Condensed Consolidated Statements of Cash Flows for the nine months ended June 26, 2020.

The 6.375% 2025 Notes were issued pursuant to an indenture, dated as of April 27, 2020 (the "6.375% 2025 Notes Indenture"), entered into by and among ASI, the Company and certain other Aramark entities, as guarantors, and the U.S. Bank National Association, as trustee. The 6.375% 2025 Notes were issued at par.

The 6.375% 2025 Notes are senior unsecured obligations of ASI. The 6.375% 2025 Notes rank equal in right of payment to all of the Issuer's existing and future senior indebtedness and will rank senior in right of payment to the Issuer's future subordinated indebtedness. The 6.375% 2025 Notes are guaranteed on a senior, unsecured basis by the Company and substantially all of the domestic subsidiaries of ASI. The guarantees of the 6.375% 2025 Notes rank equal in right of payment to all of the senior obligations of such guarantor. The 6.375% 2025 Notes are effectively subordinated to all of ASI's existing and future secured indebtedness, to the extent of the value of the assets securing that indebtedness, and structurally subordinated to all of the liabilities of any of ASI's subsidiaries that do not guarantee the 6.375% 2025 Notes. Interest on the 6.375% 2025 Notes is payable on May 1 and November 1 of each year, commencing on November 1, 2020.

In the event of certain types of changes of control, the holders of the 6.375% 2025 Notes may require ASI to purchase for cash all or a portion of their 6.375% 2025 Notes at a purchase price equal to 101% of the principal amount of such 6.375% 2025 Notes, plus accrued and unpaid interest, if any, to, but not including, the purchase date. At any time prior to May 1, 2022, ASI has the option to redeem all or a part of the 6.375% 2025 Notes at a purchase price equal to 100% of the principal amount of such 6.375% 2025 Notes plus an applicable premium and accrued and unpaid interest, if any, to but not including the date of redemption. In addition, prior to May 1, 2022, ASI has the option to redeem up to 40% of the aggregate principal amount of all 6.375% 2025 Notes at a purchase price equal to 106.375% of the principal amount of such 6.375% 2025 Notes plus accrued and unpaid interest, if any, to, but not including, the date of redemption, with the net cash proceeds of one or more equity offerings, provided that at least 50% of the sum of the aggregate principal amount of the 6.375% 2025 Notes originally issued remain outstanding immediately after the purchase and the redemption occurs within 90 days of the closing date of the equity offering.

The 6.375% 2025 Notes Indenture contains covenants limiting ASI's ability and the ability of its restricted subsidiaries to: incur additional indebtedness or issue certain preferred shares; pay dividends and make certain distributions, investments and other restricted payments; create certain liens; sell assets; enter into transactions with affiliates; limit the ability of restricted subsidiaries to make payments to ASI; enter into sale and leaseback transactions; merge, consolidate, sell or otherwise dispose of all or substantially all of ASI's and its restricted subsidiaries assets; and designate ASI's subsidiaries as unrestricted subsidiaries. The 6.375% 2025 Notes Indenture also provides for events of default which, if any of them occurs, would permit or require the principal of and accrued interest on the applicable series of 6.375% 2025 Notes to become or to be declared due and payable. Further, a failure to pay any obligations under the 6.375% 2025 Notes Indenture as they become due or any event causing amounts to become due prior to their stated maturity could result in a cross-default and potential acceleration of the Company’s other outstanding debt obligations.

Senior Secured Credit Agreement

On April 22, 2020, ASI entered into Amendment No. 9 ("Amendment No. 9") to the credit agreement dated as of March 28, 2017 (as supplemented or otherwise modified from time to time, the "Credit Agreement") and last amended by Amendment No. 8 ("Amendment No. 8") on January 15, 2020. Amendment No. 9 provides for a covenant waiver period which suspends the Consolidated Secured Debt Ratio debt covenant required under the credit agreement for four fiscal quarters, commencing with

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

the fourth quarter of fiscal 2020 through the third quarter of fiscal 2021, subject to, among other things, ongoing compliance with a minimum liquidity condition of $400.0 million and restrictions on making certain restricted payments and investments in unrestricted subsidiaries, in each case, as set forth in Amendment No. 9. If ASI ceases to be in compliance with Amendment No. 9 at any time during the covenant waiver period, this will cause an event of default under the Credit Agreement, and if such non-compliance is not waived, certain lenders under the senior secured credit facilities could elect to declare all amounts outstanding under the senior secured credit facilities to be immediately due and payable and terminate all commitments to extend further credit under such facilities. When the Consolidated Secured Debt Ratio debt covenant is once again effective for ASI in the fourth quarter of fiscal 2021, the trailing twelve month period will consist of results from the third quarter of fiscal 2019 through the first quarter of fiscal 2020 plus the fourth quarter of fiscal 2021, excluding the results of the second quarter of fiscal 2020 through the third quarter of fiscal 2021. This exclusion is intended to prevent the effects of COVID-19 from impacting the covenant calculation.

On January 15, 2020, ASI entered into Amendment No. 8 to the Credit Agreement, which provided for an incremental, senior secured credit facility under the Credit Agreement comprised of a U.S. dollar denominated term loan made to ASI in an amount equal to $900.0 million, due January 15, 2027 (the "U.S. Term Loan B due 2027"). The U.S. Term Loan B due 2027 was borrowed with an original issue discount of 0.125%.

The net proceeds from the U.S. Term Loan B due 2027 were used to redeem the aggregate $900.0 million principal amount outstanding on ASI’s 5.125% Senior Notes due 2024 (the “2024 Notes”) at a redemption price of 102.563% of the aggregate principal amount and to pay accrued interest, certain fees and related expenses. The Company recorded $20.9 million of charges to "Interest and Other Financing Costs, net" in the Condensed Consolidated Statements of (Loss) Income for the nine months ended June 26, 2020, consisting of the payment of a $23.1 million call premium and a $2.2 million non-cash gain for the write-off of unamortized debt premium and unamortized deferred financing costs on the 2024 Notes. The Company capitalized third-party costs of approximately $6.6 million related to banker fees, rating agency fees and legal fees directly attributable to the U.S. Term Loan B due 2027, which are included in "Long-Term Borrowings" in the Condensed Consolidated Balance Sheets. Amounts paid for the call premium and capitalized third-party costs are included within "Other financing activities" on the Condensed Consolidated Statements of Cash Flows for the nine months ended June 26, 2020.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 6. DERIVATIVE INSTRUMENTS:

The Company enters into contractual derivative arrangements to manage changes in market conditions related to interest on debt obligations, foreign currency exposures and exposure to fluctuating gasoline and diesel fuel prices. Derivative instruments utilized during the period include interest rate swap agreements, foreign currency forward exchange contracts and gasoline and diesel fuel agreements. All derivative instruments are recognized as either assets or liabilities on the balance sheet at fair value at the end of each quarter. The counterparties to the Company's contractual derivative agreements are all major international financial institutions. The Company is exposed to credit loss in the event of nonperformance by these counterparties. The Company continually monitors its positions and the credit ratings of its counterparties and does not anticipate nonperformance by the counterparties. For designated hedging relationships, the Company formally documents the hedging relationship and its risk management objective and strategy for undertaking the hedge, the hedging instrument, the hedged item, the nature of the risk being hedged, and how the hedging instrument's effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively for designated hedges. The Company also formally assesses, both at the hedge's inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting cash flows of hedged items.

Cash Flow Hedges

The Company has approximately $3.3 billion notional amount of outstanding interest rate swap agreements as of ~~March 27,~~June 26, 2020, which fixes the rate on a like amount of variable rate borrowings through January of fiscal 2025. During the ~~six~~nine months ended ~~March 27,~~June 26, 2020, the Company entered into approximately $800.0 million notional amount of ~~forward starting~~ interest rate swap agreements to hedge the cash flow risk of variability in interest payments on variable rate borrowings.

Changes in the fair value of a derivative that is designated as and meets all the required criteria for a cash flow hedge are recorded in accumulated other comprehensive income (loss) and reclassified into earnings as the underlying hedged item affects earnings. Amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. As of ~~March 27,~~June 26, 2020 and September 27, 2019, approximately ($~~90.2)~~97.9) million and ($31.1) million, respectively, of unrealized net of tax losses related to the interest rate swaps were included in "Accumulated other comprehensive loss."

The following table summarizes the effect of our derivatives designated as cash flow hedging instruments on Other comprehensive income (loss) (in thousands):

Three Months Ended
March 27, 2020 March 29, 2019
Interest rate swap agreements¹
$ (92,256) $ (21,524)


	Three Months Ended
	June 26, 2020		June 28, 2019
Interest rate swap agreements	$	(22,688)	$	(33,975)

Six Months Ended
March 27, 2020 March 29, 2019
Interest rate swap agreements¹
$ (85,330) $ (52,525)


	Nine Months Ended
	June 26, 2020		June 28, 2019
Interest rate swap agreements¹	$	(108,018)	$	(86,500)


(1)						Unrealized losses during the ~~three and six~~nine month ~~periods~~period of fiscal 2020 were impacted by changes in interest rates ~~partially offset by~~due to actions taken by the federal government in response to COVID-19.

Derivatives not Designated in Hedging Relationships

The Company entered into a series of pay fixed/receive floating gasoline and diesel fuel agreements based on the Department of Energy weekly retail on-highway index in order to limit its exposure to price fluctuations for gasoline and diesel fuel. As of ~~March 27,~~June 26, 2020, the Company has contracts for approximately ~~20.7~~16.7 million gallons outstanding through fiscal 2021. The Company does not record its gasoline and diesel fuel agreements as hedges for accounting purposes. The impact on earnings related to the change in fair value of these unsettled contracts was a ~~loss~~gain of approximately ~~$12.1~~$5.0 million and a loss of approximately ~~$9.0~~$4.0 million for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020, respectively. The impact on earnings related to the change in fair value of these unsettled contracts was a gain of approximately ~~$4.9~~$1.1 million and a loss of approximately ~~$4.3~~$3.2 million for the three and ~~six~~nine months ended ~~March 29,~~June 28, 2019, respectively. The change in fair value for unsettled contracts is included in "Selling and general corporate expenses" in the Condensed Consolidated Statements of (Loss) Income. When the contracts settle, the gain or loss is recorded to "Costs of services provided" in the Condensed Consolidated Statements of (Loss) Income.

As of ~~March 27,~~June 26, 2020, the Company had no material foreign currency forward exchange contracts outstanding to mitigate the risk of changes in foreign currency exchange rates on short-term intercompany loans to international subsidiaries. Gains and losses

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

on foreign currency exchange contracts are recognized in earnings as the contracts were not designated as hedging instruments, substantially offsetting currency transaction gains and losses on ~~the~~ short-term intercompany loans.

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

The following table summarizes the location and fair value, using Level 2 inputs (see Note 15 for a description of the fair value levels), of the Company's derivatives designated and not designated as hedging instruments in the Condensed Consolidated Balance Sheets (in thousands):


		Balance Sheet Location	March 27, 2020		September 27, 2019			Balance Sheet Location	June 26, 2020		September 27, 2019
ASSETS	ASSETS						ASSETS

Not designated as hedging instruments:	Not designated as hedging instruments:						Not designated as hedging instruments:
Foreign currency forward exchange contracts	Foreign currency forward exchange contracts	Prepayments and other current assets	$	—	$	64	Foreign currency forward exchange contracts	Prepayments and other current assets	$	—	$	64

LIABILITIES	LIABILITIES						LIABILITIES
Designated as hedging instruments:	Designated as hedging instruments:						Designated as hedging instruments:
Interest rate swap agreements	Interest rate swap agreements	Accounts payable	7,574		—		Interest rate swap agreements	Accounts payable	5,377		—
Interest rate swap agreements	Interest rate swap agreements	Other Noncurrent Liabilities	114,944		43,112		Interest rate swap agreements	Other Noncurrent Liabilities	127,234		43,112
			122,518		43,112				132,611		43,112

Not designated as hedging instruments:	Not designated as hedging instruments:						Not designated as hedging instruments:
Foreign currency forward exchange contracts	Foreign currency forward exchange contracts	Accounts payable	5		—		Foreign currency forward exchange contracts	Accounts payable	49		—
Gasoline and diesel fuel agreements	Gasoline and diesel fuel agreements	Accounts payable	9,426		462		Gasoline and diesel fuel agreements	Accounts payable	4,424		462
			$	131,949	$	43,574			$	137,084	$	43,574

The following table summarizes the location of the (gain) loss reclassified from "Accumulated other comprehensive loss" into earnings for derivatives designated as hedging instruments and the location of the (gain) loss for the Company's derivatives not designated as hedging instruments in the Condensed Consolidated Statements of (Loss) Income (in thousands):


			Three Months Ended								Three Months Ended
		Income Statement Location	March 27, 2020		March 29, 2019			Income Statement Location	June 26, 2020		June 28, 2019
Designated as hedging instruments:	Designated as hedging instruments:						Designated as hedging instruments:
Interest rate swap agreements	Interest rate swap agreements	Interest and Other Financing Costs, net	$	3,173	$	(2,327)	Interest rate swap agreements	Interest and Other Financing Costs, net	$	12,319	$	(2,114)
Not designated as hedging instruments:	Not designated as hedging instruments:						Not designated as hedging instruments:
Gasoline and diesel fuel agreements	Gasoline and diesel fuel agreements	Costs of services provided / Selling and general corporate expenses	12,703		(3,675)		Gasoline and diesel fuel agreements	Costs of services provided / Selling and general corporate expenses	(2,013)		(792)
Foreign currency forward exchange contracts	Foreign currency forward exchange contracts	Interest and Other Financing Costs, net	170		66		Foreign currency forward exchange contracts	Interest and Other Financing Costs, net	45		(6)
			12,873		(3,609)				(1,968)		(798)
			$	16,046	$	(5,936)			$	10,351	$	(2,912)

Six Months Ended
Income Statement Location March 27, 2020 March 29, 2019
Designated as hedging instruments:
Interest rate swap agreements Interest and Other Financing Costs, net $ 5,373 $ (4,029)
Not designated as hedging instruments:
Gasoline and diesel fuel agreements Costs of services provided / Selling and general corporate expenses 8,905 5,469
Foreign currency forward exchange contracts Interest and Other Financing Costs, net 68 244
8,973 5,713
$ 14,346 $ 1,684

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~


		Nine Months Ended
	Income Statement Location	June 26, 2020		June 28, 2019
Designated as hedging instruments:
Interest rate swap agreements	Interest and Other Financing Costs, net	$	17,692	$	(6,143)
Not designated as hedging instruments:
Gasoline and diesel fuel agreements	Costs of services provided / Selling and general corporate expenses	6,892		4,677
Foreign currency forward exchange contracts	Interest and Other Financing Costs, net	113		238
		7,005		4,915
		$	24,697	$	(1,228)

At ~~March 27,~~June 26, 2020, the net of tax loss expected to be reclassified from "Accumulated other comprehensive loss" into earnings over the next twelve months based on current market rates is approximately ~~$36.0~~$39.4 million.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 7. REVENUE RECOGNITION:

The Company generates revenue through sales of food, facility and uniform services to customers based on written contracts at the locations it serves. Within the FSS United States and FSS International segments, the Company provides food and beverage services, including catering and retail services, or facilities services, including plant operations and maintenance, custodial, housekeeping, landscaping and other services. Within the Uniform segment, the Company provides a full service uniform solution, including delivery, cleaning and maintenance. In accordance with Accounting Standards Codification 606 ("ASC 606"), the Company accounts for a customer contract when both parties have approved the arrangement and are committed to perform their respective obligations, each party's rights can be identified, payment terms can be identified, the contract has commercial substance and it is probable the Company will collect substantially all of the consideration to which it is entitled. Revenue is recognized upon the transfer of control of the promised product or service to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods and services.

Performance Obligations

The Company recognizes revenue when its performance obligation is satisfied. Each contract generally has 1 performance obligation, which is satisfied over time. The Company primarily accounts for its performance obligations under the series guidance, using the as-invoiced practical expedient when applicable. The Company applies the right to invoice practical expedient to record revenue as the services are provided, given the nature of the services provided and the frequency of billing under the customer contracts. Under this practical expedient, the Company recognizes revenue in an amount that corresponds directly with the value to the customer of the Company’s performance completed to date and for which the Company has the right to invoice the customer. Certain arrangements include performance obligations which include variable consideration (primarily per transaction fees). For these arrangements, the Company does not need to estimate the variable consideration for the contract and allocate to the entire performance obligation; therefore, the variable fees are recognized in the period they are earned.

Disaggregation of Revenue

The following table presents revenue disaggregated by revenue source (in millions):


		Three Months Ended						Six Months Ended							Three Months Ended				Nine Months Ended
		March 27, 2020		March 29, 2019		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019		June 26, 2020		June 28, 2019
FSS United States:	FSS United States:									FSS United States:
Business & Industry	Business & Industry	$	369.2	$	394.8	$	774.7	$	794.7	Business & Industry	$	160.9	$	404.4	$	935.6	$	1,199.1
Education	Education	805.5		901.6		1,806.6		1,917.9		Education	207.1		707.6		2,013.7		2,625.5
Healthcare	Healthcare	221.0		221.4		448.2		484.7		Healthcare	176.6		224.0		624.8		708.7
Sports, Leisure & Corrections	Sports, Leisure & Corrections	444.4		504.7		1,053.3		1,099.0		Sports, Leisure & Corrections	194.3		681.4		1,247.6		1,780.4
Facilities & Other	Facilities & Other	391.0		394.5		787.3		781.0		Facilities & Other	328.7		396.1		1,116.0		1,177.1
Total FSS United States	Total FSS United States	2,231.1		2,417.0		4,870.1		5,077.3		Total FSS United States	1,067.6		2,413.5		5,937.7		7,490.8

FSS International:	FSS International:									FSS International:
Europe	Europe	445.5		512.0		948.2		1,032.2		Europe	225.4		527.0		1,173.6		1,559.2
Rest of World	Rest of World	408.0		430.0		851.5		863.0		Rest of World	291.7		422.9		1,143.2		1,285.9
Total FSS International	Total FSS International	853.5		942.0		1,799.7		1,895.2		Total FSS International	517.1		949.9		2,316.8		2,845.1

Uniform	Uniform	647.0		641.0		1,315.4		1,292.8		Uniform	567.5		647.4		1,882.9		1,940.2

Total Revenue	Total Revenue	$	3,731.6	$	4,000.0	$	7,985.2	$	8,265.3	Total Revenue	$	2,152.2	$	4,010.8	$	10,137.4	$	12,276.1

Contract Balances

Deferred income is recognized in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets when the Company has received consideration, or has the right to receive consideration, in advance of the transfer of the performance obligation of the contract to the customer, primarily prepaid meal plans. The consideration received remains a

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

liability until the goods or services have been provided to the customer. The Company classifies deferred income as current as the arrangement is short term in nature. If the Company cannot render its performance obligation according to contract terms after receiving the consideration in advance, amounts may be required contractually to be refunded to the customer.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

During the ~~six~~nine months ended ~~March 27,~~June 26, 2020, deferred income increased related to customer prepayments and decreased related to income recognized during the period as a result of satisfying the performance ~~obligation. Below is a summary~~obligation or return of funds related to non-performance. For the nine months ended June 26, 2020, the Company recognized $266.5 million of revenue that was included in deferred income at the beginning of the ~~changes~~period. Deferred income opening and closing balances are summarized in the following table (in millions):

Balance, September 27, 2019 Add: Net increase in current period deferred income Less: Recognition of deferred income Balance, March 27, 2020
Deferred income $ 319.0 682.2 (748.0) $ 253.2


	June 26, 2020		September 27, 2019
Deferred income⁽¹⁾	$	168.2	$	319.0


(1)			Due to the impact of COVID-19, the Company has refunded approximately $34.0 million of advanced payments for meal plans to clients during the third quarter of fiscal 2020. As of June 26, 2020, the Company expects to refund an additional $15.2 million of advanced payments included within deferred income for meal plans to clients by the end of fiscal 2020.

NOTE 8. LEASES:

The Company has lease arrangements primarily related to real estate, vehicles and equipment, which generally have terms of one to 30 years. Finance leases primarily relate to vehicles and certain real estate. In addition, there can be leases identified in the Company's revenue contracts with customers, which generally include variable lease payments. The Company assesses whether an arrangement is a lease, or contains a lease, upon inception of the related contract. Certain of the Company's lease arrangements, primarily vehicle leases, with terms of one to eight years, contain provisions related to residual value guarantees. The maximum potential liability to the Company under such arrangements was approximately ~~$26.9~~$28.9 million at ~~March 27,~~June 26, 2020 if the terminal fair value of vehicles coming off lease was 0. Consistent with past experience, management does not expect any significant payments will be required pursuant to these arrangements. NaN amounts have been accrued for guarantee arrangements at ~~March 27,~~June 26, 2020.

As a result of adopting ASC 842 on September 28, 2019 (first day of fiscal 2020), the Company recognized $416.1 million of operating lease liabilities and $558.5 million of operating lease right-of-use assets on its Condensed Consolidated Balance Sheets. Operating lease right-of-use assets represent the Company’s right to use the underlying assets for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease liabilities and operating lease right-of-use assets are recognized at the lease commencement date based on the estimated present value of the lease payments over the lease term. Operating lease right-of-use assets include adjustments for deferred rent, tenant improvement allowances and prepaid rent. Lease expense is recognized on a straight-line basis over the expected lease term.

Variable lease payments, which primarily consist of leases associated with the Company's revenue contracts with customers, real estate taxes, common area maintenance charges, insurance costs and other operating expenses, are not included in the operating lease right-of-use asset or operating lease liability balances and are recognized in the period in which the expenses are incurred. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain they will be exercised or not, respectively. Options to extend lease terms that are reasonably certain of exercise are recognized as part of the operating lease right-of-use asset and operating lease liability balances.

As permitted under the transition guidance upon adoption of ASC 842, the Company elected the following practical expedients:

•the simplified approach to not recast comparative periods and to apply the new lease standard on a prospective basis beginning in the year of initial adoption;

•the package of practical expedients to not reassess the lease determination, lease classification or initial direct costs for leases commenced prior to adoption;

•the component election to not separate lease and nonlease components in all arrangements that contain a lease; and

•the short-term lease recognition exemption whereby lease-related assets and liabilities are not recognized for arrangements with initial lease terms of one year or less.

The Company did not elect the use of the hindsight expedient for determining the lease term.

The Company is required to discount its future minimum lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. The Company uses its incremental borrowing rate as the discount rate. The Company uses a portfolio approach to determine the incremental borrowing rate based on the geographic location of the lease and the remaining lease term. The incremental borrowing rate is calculated using a base line rate plus an applicable margin.

1719

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

The following table summarizes the location of the operating and finance leases in the Company’s Condensed Consolidated Balance Sheets as of ~~March 27,~~June 26, 2020 (in thousands), as well as the weighted average remaining lease term and weighted average discount rate:

Leases

Balance Sheet Location

~~March 27,~~June 26, 2020

Assets:

Operating¹

Operating Lease Right-of-use Assets

~~579,719~~551,002

Finance

Property and Equipment, net

~~132,993~~130,935

Total lease assets

~~712,712~~681,937

Liabilities:

Current

Operating¹

Current operating lease liabilities

~~75,705~~74,971

Finance

Current maturities of long-term borrowings

~~30,146~~29,929

Noncurrent

Operating¹

Noncurrent Operating Lease Liabilities

~~354,833~~336,915

Finance

Long-term borrowings

~~109,921~~107,457

Total lease liabilities

~~570,605~~549,272

Weighted average remaining lease term (in years)

Operating leases

~~9.0~~8.7

Finance leases

8.4

Weighted average discount rate

Operating leases

3.6

Finance leases

4.1


(1)			Includes the write-down of certain rental properties from disposal by abandonment during the third quarter of fiscal 2020 (see Note 1).

The following table summarizes the location of lease related costs in the Condensed Consolidated Statements of (Loss) Income for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 (in thousands):


			Three Months Ended		Six Months Ended				Three Months Ended		Nine Months Ended
Lease Cost	Lease Cost	Income Statement Location	March 27, 2020		March 27, 2020		Lease Cost	Income Statement Location	June 26, 2020		June 26, 2020
Operating lease cost¹:	Operating lease cost¹:						Operating lease cost¹:
Fixed lease costs	Fixed lease costs	Cost of services provided	$	30,326	$	59,855	Fixed lease costs	Cost of services provided	$	29,734	$	89,589
Variable lease costs²	Variable lease costs²	Cost of services provided	131,068		327,693		Variable lease costs²	Cost of services provided	17,785		345,478
Short-term lease costs	Short-term lease costs	Cost of services provided	19,457		40,787		Short-term lease costs	Cost of services provided	10,092		50,879
Finance lease cost³:	Finance lease cost³:						Finance lease cost³:
Amortization of right-of-use-assets	Amortization of right-of-use-assets	Depreciation and amortization	8,478		15,565		Amortization of right-of-use-assets	Depreciation and amortization	7,875		23,440
Interest on lease liabilities	Interest on lease liabilities	Interest and Other Financing Costs, net	1,324		2,615		Interest on lease liabilities	Interest and Other Financing Costs, net	1,356		3,971
Net lease cost	Net lease cost		$	190,653	$	446,515	Net lease cost		$	66,842	$	513,357


(1)		Excludes sublease income, which is immaterial.
(2)		Includes ~~$128.6~~$12.2 million and ~~$322.2~~$334.4 million of costs related to leases associated with revenue contracts with customers for the three and ~~six~~nine month periods of fiscal 2020, respectively. These costs represent the rent the Company pays its clients to operate at their locations, typically based on a percentage of sales. The significant decrease in variable lease costs during the third quarter of fiscal 2020 was due to COVID-19's impact on certain of our businesses.
(3)	Excludes variable lease costs, which are immaterial.

1820

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Supplemental cash flow information related to leases for the period reported is as follows (in thousands):


	~~Six~~Nine Months Ended
	~~March 27,~~June 26, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases⁽¹⁾	$	~~67,908~~101,366
Operating cash flows from finance leases	~~2,594~~3,908
Financing cash flows from finance leases	~~17,262~~25,956
Right-of-use lease assets obtained in exchange for lease obligations:
Operating leases	$	~~59,612~~69,825
Finance leases	~~8,782~~14,383


(1)						Excludes cash paid for variable and short-term lease costs of $373.4 million and $50.9 million, respectively, that are not included within the measurement of lease ~~liabilities of $329.8 million and $40.8 million, respectively.~~liabilities..

Future minimum lease payments under non-cancelable leases as of ~~March 27,~~June 26, 2020 are as follows (in thousands):


		Operating leases		Finance leases		Total			Operating leases		Finance leases		Total
Remainder of 2020	Remainder of 2020	$	46,998	$	18,107	$	65,105	Remainder of 2020	$	23,603	$	8,532	$	32,135
2021	2021	81,644		27,311		108,955		2021	84,816		29,917		114,733
2022	2022	64,181		22,593		86,774		2022	66,621		23,228		89,849
2023	2023	51,698		17,522		69,220		2023	53,634		18,247		71,881
2024	2024	43,600		14,727		58,327		2024	46,306		15,511		61,817
Thereafter	Thereafter	223,733		54,467		278,200		Thereafter	212,710		56,562		269,272
Total future minimum lease payments	Total future minimum lease payments	511,854		154,727		666,581		Total future minimum lease payments	487,690		151,997		639,687
Less: Interest	Less: Interest	(81,316)		(14,660)		(95,976)		Less: Interest	(75,804)		(14,611)		(90,415)
Present value of lease liabilities	Present value of lease liabilities	$	430,538	$	140,067	$	570,605	Present value of lease liabilities	$	411,886	$	137,386	$	549,272

Following is a schedule of the future minimum rental and similar commitments under all non-cancelable operating leases as of September 27, 2019 (in thousands):


2020	$	101,061
2021	74,908
2022	56,765
2023	43,795
2024	36,215
2025-Thereafter	214,818
Total minimum rental obligations	$	527,562

NOTE 9. INCOME TAXES:

On March 27, 2020, the ~~Coronavirus Aid, Relief, and Economic Security~~CARES Act ~~(the "CARES Act")~~ was enacted in response to COVID-19. The CARES Act, among other things, permits net operating losses ("NOLs") incurred in fiscal 2019, 2020 and 2021 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. NOLs arising in fiscal 2019, 2020, or 2021 are created in years that have a 21.0% federal income tax rate. If these NOLs are carried back to years prior to fiscal 2018, the resulting refund would be in years with a 35.0% federal income tax rate.

The CARES Act contains modifications on the limitation of business interest for fiscal years 2020 and 2021 to increase the allowable business interest deduction from 30.0% of adjusted taxable income to 50.0% of adjusted taxable income. The CARES Act also includes a technical correction to the Tax Cut and Jobs Act (the "TCJA") that provides that Qualified Improvement Property ("QIP"), which includes almost any improvement to the interior of leased or owned space, is eligible for bonus depreciation retroactively to the January 1, 2018 effective date of the TCJA.

1921

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

As a result of the CARES Act, the Company recorded ~~an income tax expense~~a benefit to the (Benefit) Provision for Income Taxes of approximately ~~$3.7~~$68.1 million and $58.8 million for ~~both~~ the three and ~~six~~nine month periods of fiscal ~~2020. While~~2020, respectively. These benefits reflect the ~~Company's estimated annual effective tax rate reflects a benefit from the CARES Act, the application of that rate~~NOLs expected to be carried back to Pre-TCJA years during fiscal 2020, which are benefited at 35.0% as opposed to the ~~ordinary pretax income~~current year rate of 21.0%. The NOL carryback generated for the nine months ended June 26, 2020 resulted in ~~an expense~~the Company establishing a $62.6 million income tax receivable, along with re-establishing $106.3 million of foreign tax credits and $28.9 million of general business credits that will be used to offset future federal income tax liabilities. The Company also recorded a valuation allowance to the (Benefit) Provision for Income Taxes of $17.4 million and $11.8 million for the three ~~months~~and nine month periods ended ~~March 27, 2020.~~June 26, 2020, respectively, against certain foreign tax credits that were re-established via the NOL carryback. The Company will continue to monitor and assess the impact the CARES Act and similar legislation in other countries may have on the Company's business and financial results.

As of each reporting date, the Company considers existing evidence, both positive and negative, that could impact the need for valuation allowances against deferred tax assets ("DTAs"). Based on cumulative losses and goodwill impairment recorded in the FSS International segment during the second quarter of fiscal 2020 (see Note 4) as negative evidence, the Company recorded a valuation allowance against DTAs of certain subsidiaries ~~in the amount~~ of approximately $8.6 million in the ~~quarter~~nine month period ending ~~March 27,~~June 26, 2020.

The effective tax rate for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 also includes an income tax ~~benefits~~benefit of approximately ~~$26.9~~$0.6 million and ~~$45.5~~$46.1 million, respectively, as a result of an excess tax benefit recognized in relation to equity awards exercised during the ~~first and second quarters of~~ fiscal ~~2020,~~year, including by the former Chairman, President and Chief Executive Officer.

The (Loss) Income Before Income Taxes for the ~~three and six~~nine month ~~periods~~period of fiscal 2020 includes a non-cash impairment charge of goodwill for $198.6 million, which is nondeductible for income tax purposes (see Note 4).

NOTE 10. STOCKHOLDERS' EQUITY:

During the ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, the Company paid cash dividends of approximately ~~$55.3~~$83.1 million and ~~$54.2~~$81.3 million to its stockholders, respectively. On ~~May 4,~~August 3, 2020, the Company's Board declared a $0.11 dividend per share of common stock, payable on ~~June~~September 2, 2020, to shareholders of record on the close of business on ~~May~~August 19, 2020.

During the second quarter of fiscal 2020, the Company repurchased 0.3 million shares of its common stock for $6.5 million under the fiscal 2019 share repurchase program which will expire in July 2022. During the first quarter of fiscal 2019, the Company completed a repurchase of 1.6 million shares of its common stock for $50.0 million under the fiscal 2017 share repurchase program, which expired on February 1, 2019. In accordance with Amendment No. 9 to the Credit Agreement entered into in the third quarter of fiscal 2020, the Company cannot make any future share repurchases as long as the covenant compliance waiver remains in effect.

On January 29, 2020, the Company's stockholders approved the Second Amended and Restated 2013 Stock Incentive Plan, which ~~amends~~amended and ~~restates~~restated the Company's 2013 Incentive Plan. The Second Amended and Restated 2013 Stock Incentive Plan provides for up to 7.5 million of new shares authorized for issuance to participants, in addition to the shares that remained available for issuance under the 2013 Incentive Plan as of January 29, 2020 that are not subject to outstanding awards under the 2013 Incentive Plan.

During the second quarter of fiscal 2020, MR BridgeStone Advisor LLC (“Mantle Ridge”), on behalf of itself and its affiliated funds (such funds, together with Mantle Ridge, collectively, the “Mantle Ridge Group”), transferred cash proceeds of $14.8 million to the Company to fulfill obligations deriving from the short-swing profit provisions of Section 16(b) of the Securities Exchange Act of 1934. These obligations related to the Mantle Ridge Group's trading activity in the Company's common stock during the quarter. The cash proceeds were recorded to "Capital Surplus" in the Condensed Consolidated Balance Sheets as of ~~March 27,~~June 26, 2020 and are reflected in "Other financing activities" in the Condensed Consolidated Statements of Cash Flows for the ~~six~~nine months ended ~~March 27,~~June 26, 2020. The cash proceeds resulted in the Company recording an income tax provision of $4.1 million in the Condensed Consolidated Statements of (Loss) Income for ~~both~~ the ~~three and six month periods~~nine months ended of ~~fiscal~~June 26, 2020.

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 11. SHARE-BASED COMPENSATION:

The following table summarizes the share-based compensation expense (reduction) and related information for Time-Based Options ("TBOs"), Time-Based Restricted Stock Units ("RSUs"), Performance Stock Units ("PSUs"), and Deferred Stock Units classified as "Selling and general corporate expenses" in the Condensed Consolidated Statements of (Loss) Income (in millions).


		Three Months Ended						Six Months Ended							Three Months Ended				Nine Months Ended
		March 27, 2020		March 29, 2019		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019		June 26, 2020		June 28, 2019
TBOs	TBOs	$	2.1	$	3.1	$	5.0	$	8.4	TBOs	$	2.0	$	2.8	$	7.0	$	11.2
RSUs	RSUs	7.6		7.2		15.7		16.1		RSUs	7.4		7.2		23.1		23.3
PSUs ⁽¹⁾	PSUs ⁽¹⁾	(19.9)		3.9		(17.3)		7.7		PSUs ⁽¹⁾	1.1		4.8		(16.2)		12.5
Deferred Stock Units	Deferred Stock Units	0.4		0.4		0.9		1.0		Deferred Stock Units	0.5		0.4		1.4		1.4
		$	(9.8)	$	14.6	$	4.3	$	33.2		$	11.0	$	15.2	$	15.3	$	48.4

Taxes related to share-based compensation	Taxes related to share-based compensation	$	(2.6)	$	3.6	$	0.9	$	8.2	Taxes related to share-based compensation	$	2.6	$	3.8	$	3.5	$	12.0
Cash Received from Option Exercises	Cash Received from Option Exercises	58.9		9.3		85.0		10.4		Cash Received from Option Exercises	3.6		10.9		88.6		21.3
Tax Benefit on Share Deliveries⁽²⁾	Tax Benefit on Share Deliveries⁽²⁾	26.9		1.0		45.5		2.3		Tax Benefit on Share Deliveries⁽²⁾	0.6		0.7		46.1		3.0


(1)	Share-based compensation expense was reduced during the second quarter of fiscal 2020 based on lower than estimated target attainment on plan metrics for both the fiscal 2018 and fiscal 2019 PSU grants, resulting in the reversal of previously recognized share-based compensation expense of $22.6 million.
(2)		The tax benefit on option exercises and restricted stock unit deliveries is included in "Prepayments and Other Current Assets" in the Condensed Consolidated Statements of Cash Flows.

The below table summarizes the number of shares granted and the weighted-average grant-date fair value per unit during the ~~six~~nine months ended ~~March 27,~~June 26, 2020:


		Shares Granted (in millions)	Weighted-Average Grant-Date Fair Value (dollars per share)			Shares Granted (in millions)	Weighted-Average Grant-Date Fair Value (dollars per share)
TBOs	TBOs	1.7	$	9.47	TBOs	1.8	$	9.32
RSUs	RSUs	1.1	$	42.36	RSUs	1.2	$	40.86
PSUs⁽¹⁾⁽²⁾	PSUs⁽¹⁾⁽²⁾	0.9	$	44.88	PSUs⁽¹⁾⁽²⁾	0.9	$	43.59
Deferred Stock Units	Deferred Stock Units	0.1	$	45.77	Deferred Stock Units	0.1	$	43.05
		3.8				4.0


(1)				Includes approximately 0.3 million shares resulting from the payout of the 2017 PSU grants due to exceeding the adjusted earnings per share target.
(2)				During the first quarter of fiscal 2020, the Company granted PSUs subject to the level of achievement of adjusted revenue growth, adjusted operating income growth, return on invested capital and a total shareholder return multiplier for the cumulative performance period over three years and the participant's continued employment with the Company. The Company is accounting for this award as a market-based award which was valued utilizing the Monte Carlo Simulation pricing model, which calculates multiple potential outcomes for an award and establishes fair value based on the most likely outcome.

2123

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 12. EARNINGS (LOSS) PER SHARE:

Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.

The following table sets forth the computation of basic and diluted earnings (loss) per share attributable to the Company's stockholders (in thousands, except per share data):


		Three Months Ended						Six Months Ended							Three Months Ended				Nine Months Ended
		March 27, 2020		March 29, 2019		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019		June 26, 2020		June 28, 2019
Earnings (Loss):
(Loss) Earnings:										(Loss) Earnings:
Net (loss) income attributable to Aramark stockholders	Net (loss) income attributable to Aramark stockholders	$	(202,260)	$	29,353	$	(56,499)	$	280,037	Net (loss) income attributable to Aramark stockholders	$	(256,440)	$	82,955	$	(312,939)	$	362,992
Shares:	Shares:									Shares:
Basic weighted-average shares outstanding	Basic weighted-average shares outstanding	252,354		246,217		250,543		246,540		Basic weighted-average shares outstanding	252,943		246,928		251,343		246,665
Effect of dilutive securities⁽¹⁾	Effect of dilutive securities⁽¹⁾	—		4,130		—		4,815		Effect of dilutive securities⁽¹⁾	—		4,219		—		4,606
Diluted weighted-average shares outstanding	Diluted weighted-average shares outstanding	252,354		250,347		250,543		251,355		Diluted weighted-average shares outstanding	252,943		251,147		251,343		251,271

Basic (Loss) Earnings Per Share:	Basic (Loss) Earnings Per Share:									Basic (Loss) Earnings Per Share:
Net (loss) income attributable to Aramark stockholders	Net (loss) income attributable to Aramark stockholders	$	(0.80)	$	0.12	$	(0.23)	$	1.14	Net (loss) income attributable to Aramark stockholders	$	(1.01)	$	0.34	$	(1.25)	$	1.47
Diluted (Loss) Earnings Per Share:	Diluted (Loss) Earnings Per Share:									Diluted (Loss) Earnings Per Share:
Net (loss) income attributable to Aramark stockholders	Net (loss) income attributable to Aramark stockholders	$	(0.80)	$	0.12	$	(0.23)	$	1.11	Net (loss) income attributable to Aramark stockholders	$	(1.01)	$	0.33	$	(1.25)	$	1.44


(1)			Incremental shares of ~~2.1~~0.8 million and ~~3.8~~2.6 million have been excluded from the computation of diluted weighted-average shares outstanding for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020, respectively, because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during both periods.

Share-based awards to purchase ~~5.0~~8.8 million and ~~8.6~~7.3 million shares were outstanding for the three months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, respectively, but were not included in the computation of diluted (loss) earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to ~~1.7~~1.6 million shares were outstanding for both the three months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, respectively, but were not included in the computation of diluted (loss) earnings per common share, as the performance targets were not yet met.

Share-based awards to purchase ~~4.1~~5.3 million and ~~7.2~~7.8 million shares were outstanding for the ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, respectively, but were not included in the computation of diluted (loss) earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to ~~1.7~~1.6 million shares were outstanding for both the ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, respectively, but were not included in the computation of diluted (loss) earnings per common share, as the performance targets were not yet met.

NOTE 13. COMMITMENTS AND CONTINGENCIES:

From time to time, the Company and its subsidiaries are a party to various legal actions, proceedings and investigations involving claims incidental to the conduct of their business, including actions by clients, consumers, employees, government entities and third parties, including under federal, state, international, national, provincial and local employment laws, wage and hour laws, discrimination laws, immigration laws, human health and safety laws, import and export controls and customs laws, environmental laws, false claims or whistleblower statutes, minority, women and disadvantaged business enterprise statutes, tax codes, antitrust and competition laws, consumer protection statutes, procurement regulations, intellectual property laws, food safety and sanitation laws, cost and accounting principles, the Foreign Corrupt Practices Act, the U.K. Bribery Act, other anti-corruption laws, lobbying laws, motor carrier safety laws, data privacy and security laws and alcohol licensing and service laws, or alleging negligence and/or breaches of contractual and other obligations. Based on information currently available, advice of counsel, available insurance coverage, established reserves and other resources, the Company does not believe that any such actions are likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or cash flows. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company's business, financial condition, results of operations or cash flows.

2224

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

During fiscal 2019, Eric J. Foss, the Company's former Chairman, President and Chief Executive Officer, stepped down and $10.4 million of cash compensation related charges were recognized related to his separation from the Company. As of ~~March 27,~~June 26, 2020, the Company had ~~$7.9~~$6.7 million of remaining unpaid obligations related to his separation, which are recorded in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets. These remaining unpaid obligations are expected to be paid through fiscal 2021.

During fiscal 2019, the Company was a defendant in 2 class action lawsuits alleging breach of contract, promissory estoppel, unjust enrichment and various state law claims for failure to pay employee annual incentive bonuses related to the 2018 fiscal year. In November 2019, the Company settled the lawsuits with the plaintiffs for approximately $21.0 million, which includes payments to the class members, attorneys' fees and other expenses. The settlement was recorded as a charge to the Condensed Consolidated Statements of (Loss) Income during the fourth quarter of fiscal 2019. The unpaid settlement charge of $21.0 million is recorded in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets as of ~~March 27,~~June 26, 2020 and is expected to be paid during the fourth quarter of fiscal 2020.

NOTE 14. BUSINESS SEGMENTS:

The Company reported its operating results in 3 reportable segments: FSS United States, FSS International and Uniform. Corporate includes general expenses not specifically allocated to an individual segment and share-based compensation expense (see Note 11). In the Company's food and support services segments, approximately 78% of the global revenue is related to food services and 22% is related to facilities services. During the ~~six~~third quarter of fiscal 2020, each reportable segment recorded severance charges adding up to approximately $124.9 million (see Note 3). During the nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, the Company received proceeds of approximately $15.3 million and $16.2 million, respectively, relating to the recovery of the Company's investment (possessory interest) at one of the National Park Service sites within the FSS United States segment. The Company recorded a gain related to the recovery of its investment, which is included in "Cost of services provided" in the Condensed Consolidated Statements of (Loss) Income. Revenue and operating income during both the three and ~~six~~nine month periods of fiscal 2020 were negatively impacted by COVID-19. During the second quarter of fiscal 2020, the Company recognized an impairment charge related to one reporting unit in its FSS International segment (see Note 4). Financial information by segment follows (in millions):


		Revenue							Revenue
		Three Months Ended							Three Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
FSS United States	FSS United States	$	2,231.1	$	2,417.0	FSS United States	$	1,067.6	$	2,413.5
FSS International	FSS International	853.5		942.0		FSS International	517.1		949.9
Uniform	Uniform	647.0		641.0		Uniform	567.5		647.4
		$	3,731.6	$	4,000.0		$	2,152.2	$	4,010.8


		Operating Income							Operating (Loss) Income
		Three Months Ended							Three Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
FSS United States	FSS United States	$	65.8	$	68.8	FSS United States	$	(193.8)	$	127.8
FSS International	FSS International	(191.2)		41.9		FSS International	(138.3)		40.2
Uniform	Uniform	46.8		38.2		Uniform	21.9		53.6
		(78.6)		148.9			(310.2)		221.6
Corporate	Corporate	(19.1)		(26.1)		Corporate	(17.4)		(32.8)
Operating (Loss) Income	Operating (Loss) Income	(97.7)		122.8		Operating (Loss) Income	(327.6)		188.8
Interest and Other Financing Costs, net	Interest and Other Financing Costs, net	99.8		84.2		Interest and Other Financing Costs, net	94.2		82.2
(Loss) Income Before Income Taxes	(Loss) Income Before Income Taxes	$	(197.5)	$	38.6	(Loss) Income Before Income Taxes	$	(421.8)	$	106.6

2325

Table of Contents

ARAMARK AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)


		Revenue							Revenue
		Six Months Ended							Nine Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
FSS United States	FSS United States	$	4,870.1	$	5,077.3	FSS United States	$	5,937.7	$	7,490.8
FSS International	FSS International	1,799.7		1,895.2		FSS International	2,316.8		2,845.1
Uniform	Uniform	1,315.4		1,292.8		Uniform	1,882.9		1,940.2
		$	7,985.2	$	8,265.3		$	10,137.4	$	12,276.1


		Operating Income							Operating (Loss) Income
		Six Months Ended							Nine Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
FSS United States	FSS United States	$	251.7	$	432.6	FSS United States	$	57.9	$	560.4
FSS International	FSS International	(147.5)		53.3		FSS International	(285.8)		93.5
Uniform	Uniform	100.1		90.9		Uniform	122.0		144.5
		204.3		576.8			(105.9)		798.4
Corporate	Corporate	(47.7)		(80.6)		Corporate	(65.1)		(113.4)
Operating Income		156.6		496.2
Operating (Loss) Income						Operating (Loss) Income	(171.0)		685.0
Interest and Other Financing Costs, net	Interest and Other Financing Costs, net	179.4		167.2		Interest and Other Financing Costs, net	273.6		249.4
(Loss) Income Before Income Taxes	(Loss) Income Before Income Taxes	$	(22.8)	$	329.0	(Loss) Income Before Income Taxes	$	(444.6)	$	435.6

NOTE 15. FAIR VALUE OF FINANCIAL ASSETS AND FINANCIAL LIABILITIES:

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value are classified based upon the level of judgment associated with the inputs used to measure their fair value. The hierarchical levels related to the subjectivity of the valuation inputs are defined as follows:

• Level 1—inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets

• Level 2—inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument

• Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement

Recurring Fair Value Measurements

The Company's financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, borrowings and derivatives. Management believes that the carrying value of cash and cash equivalents, accounts receivable and accounts payable are representative of their respective fair values. In conjunction with the fair value measurement of the derivative instruments, the Company made an accounting policy election to measure the credit risk of its derivative instruments that are subject to master netting agreements on a net basis by counterparty portfolio, the gross values would not be materially different. The fair value of the Company's debt at ~~March 27,~~June 26, 2020 and September 27, 2019 was ~~$7,438.6~~$9,104.9 million and $6,851.2 million, respectively. The carrying value of the Company's debt at ~~March 27,~~June 26, 2020 and September 27, 2019 was ~~$7,966.0~~$9,259.6 million and $6,682.2 million, respectively. The fair values were computed using market quotes, if available, or based on discounted cash flows using market interest rates as of the end of the respective periods. The inputs utilized in estimating the fair value of the Company's debt has been classified as Level 2 in the fair value hierarchy levels.

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~NOTE 16. CONDENSED CONSOLIDATING FINANCIAL STATEMENTS OF ARAMARK AND SUBSIDIARIES:~~

~~The following condensed consolidating financial statements of the Company have been prepared pursuant to Rule 3-10 of Regulation S-X.~~

The condensed consolidating financial statements are presented for: (i) Aramark (the "Parent"); (ii) ASI and Aramark International Finance S.à r.l. (the "Issuers"); (iii) the guarantors; (iv) the non guarantors; (v) elimination entries necessary to consolidate the Parent with the Issuers, the guarantors and non guarantors; and (vi) the Company on a consolidated basis. Each of the guarantors is wholly-owned, directly or indirectly, by the Company. The 5.000% Senior Notes due April 1, 2025 (the "5.000% 2025 Notes"), 3.125% Senior Notes due April 1, 2025 (the "3.125% 2025 Notes" and, together with the 5.000% 2025 Notes, the "2025 Notes"), 4.75% Senior Notes due June 1, 2026 ("2026 Notes") and 5.000% Senior Notes due February 1, 2028 (the "2028 Notes") are obligations of the Company's wholly-owned subsidiary, ASI, (other than the 3.125% 2025 Notes, which are obligations of the Company's wholly owned subsidiary, Aramark International Finance S.a.r.l) and are each jointly and severally guaranteed on a senior unsecured basis by the Company and substantially all of the Company's existing and future domestic subsidiaries (excluding the Receivables Facility subsidiary) ("Guarantors"). All other subsidiaries of the Company, either direct or indirect, are non-guarantors and do not guarantee the 2025 Notes, 2026 Notes or 2028 Notes ("Non Guarantors"). The Guarantors also guarantee certain other debt. These condensed consolidating financial statements have been prepared from the Company's financial information on the same basis of accounting as the condensed consolidated financial statements. Interest expense and certain other costs are partially allocated to all of the subsidiaries of the Company. Goodwill and other intangible assets have been allocated to the subsidiaries based on management's estimates.

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING BALANCE SHEETS~~

~~March 27, 2020~~

~~(in thousands)~~

Aramark
(Parent)
Issuers Guarantors Non Guarantors Eliminations Consolidated
ASSETS
Current Assets:
Cash and cash equivalents $ 5 $ 925,933 $ 14,447 $ 262,579 $ — $ 1,202,964
Receivables — 1,275 522,767 1,326,938 — 1,850,980
Inventories — 15,063 291,145 97,591 — 403,799
Prepayments and other current assets — 50,916 72,744 74,932 — 198,592
Total current assets 5 993,187 901,103 1,762,040 — 3,656,335
Property and Equipment, net — 46,986 1,748,603 333,717 — 2,129,306
Goodwill — 173,104 4,698,444 448,078 — 5,319,626
Investment in and Advances to Subsidiaries 3,169,440 6,429,972 — 717,942 (10,317,354) —
Other Intangible Assets — 29,684 1,772,561 183,834 — 1,986,079
Operating Lease Right-of-use Assets — 24,061 474,989 80,669 — 579,719
Other Assets — 17,664 797,653 363,118 (2,002) 1,176,433
$ 3,169,445 $ 7,714,658 $ 10,393,353 $ 3,889,398 $ (10,319,356) $ 14,847,498
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Current maturities of long-term borrowings $ — $ 16,255 $ 26,957 $ 60,194 $ — $ 103,406
Current operating lease liabilities — — 57,153 18,552 — 75,705
Accounts payable — 109,355 417,054 267,055 — 793,464
Accrued expenses and other current liabilities — 169,767 813,669 341,758 88 1,325,282
Total current liabilities — 295,377 1,314,833 687,559 88 2,297,857
Long-term Borrowings — 6,922,575 76,097 863,915 — 7,862,587
Noncurrent Operating Lease Liabilities — 25,151 267,323 62,359 — 354,833
Deferred Income Taxes and Other Noncurrent Liabilities — 418,455 553,380 180,715 — 1,152,550
Intercompany Payable — — 4,213,629 481,280 (4,694,909) —
Redeemable Noncontrolling Interest — — 10,226 — — 10,226
Total Stockholders' Equity 3,169,445 53,100 3,957,865 1,613,570 (5,624,535) 3,169,445
$ 3,169,445 $ 7,714,658 $ 10,393,353 $ 3,889,398 $ (10,319,356) $ 14,847,498

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING BALANCE SHEETS~~

~~September 27, 2019~~

~~(in thousands)~~

Aramark
(Parent) Issuers
Guarantors
Non Guarantors Eliminations Consolidated
ASSETS
Current Assets:
Cash and cash equivalents $ 5 $ 33,510 $ 40,544 $ 172,584 $ — $ 246,643
Receivables — 1,966 522,627 1,282,371 — 1,806,964
Inventories — 15,804 301,091 94,424 — 411,319
Prepayments and other current assets — 27,164 82,666 83,631 — 193,461
Total current assets 5 78,444 946,928 1,633,010 — 2,658,387
Property and Equipment, net — 43,329 1,784,410 354,023 — 2,181,762
Goodwill — 173,104 4,694,549 651,147 — 5,518,800
Investment in and Advances to Subsidiaries 3,320,042 6,649,119 — 717,228 (10,686,389) —
Other Intangible Assets — 29,684 1,819,315 184,567 — 2,033,566
Other Assets — 20,382 979,350 346,076 (2,002) 1,343,806
$ 3,320,047 $ 6,994,062 $ 10,224,552 $ 3,886,051 $ (10,688,391) $ 13,736,321
LIABILITIES AND
STOCKHOLDERS' EQUITY
Current Liabilities:
Current maturities of long-term borrowings $ — $ 6,256 $ 27,924 $ 35,748 $ — $ 69,928
Accounts payable — 127,640 507,903 363,974 — 999,517
Accrued expenses and other current liabilities — 241,523 1,030,074 364,168 88 1,635,853
Total current liabilities — 375,419 1,565,901 763,890 88 2,705,298
Long-term Borrowings — 6,090,487 82,394 439,358 — 6,612,239
Deferred Income Taxes and Other Noncurrent Liabilities — 380,453 569,409 138,960 — 1,088,822
Intercompany Payable — — 4,187,591 726,464 (4,914,055) —
Redeemable Noncontrolling Interest — — 9,915 — — 9,915
Total Stockholders' Equity 3,320,047 147,703 3,809,342 1,817,379 (5,774,424) 3,320,047
$ 3,320,047 $ 6,994,062 $ 10,224,552 $ 3,886,051 $ (10,688,391) $ 13,736,321

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING STATEMENTS OF (LOSS) INCOME AND COMPREHENSIVE (LOSS) INCOME~~

~~For the three months ended March 27, 2020~~

~~(in thousands)~~

Aramark
(Parent) Issuers
Guarantors
Non Guarantors Eliminations Consolidated
Revenue $ — $ 242,524 $ 2,482,563 $ 1,006,472 $ — $ 3,731,559
Costs and Expenses:
Cost of services provided — 216,008 2,219,994 971,587 — 3,407,589
Depreciation and amortization — 4,413 117,667 25,895 — 147,975
Selling and general corporate expenses — 20,374 46,783 7,914 — 75,071
Goodwill impairment — — — 198,600 — 198,600
Interest and other financing costs, net — 93,396 661 5,765 — 99,822
Expense allocations — (85,395) 82,327 3,068 — —
— 248,796 2,467,432 1,212,829 — 3,929,057
Income (Loss) before Income Tax — (6,272) 15,131 (206,357) — (197,498)
Provision (Benefit) for Income Taxes — 4,277 (11,040) 11,286 — 4,523
Equity in Net Income of Subsidiaries (202,260) — — — 202,260 —
Net (loss) income (202,260) (10,549) 26,171 (217,643) 202,260 (202,021)
Less: Net income attributable to noncontrolling interest — — 239 — — 239
Net (loss) income attributable to Aramark stockholders (202,260) (10,549) 25,932 (217,643) 202,260 (202,260)
Other comprehensive loss, net of tax (108,245) (67,199) (2,055) (60,482) 129,736 (108,245)
Comprehensive (loss) income attributable to Aramark stockholders $ (310,505) $ (77,748) $ 23,877 $ (278,125) $ 331,996 $ (310,505)

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING STATEMENTS OF (LOSS) INCOME AND COMPREHENSIVE (LOSS) INCOME~~

~~For the six months ended March 27, 2020~~

~~(in thousands)~~

Aramark
(Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated
Revenue $ — $ 510,959 $ 5,322,619 $ 2,151,578 $ — $ 7,985,156
Costs and Expenses:
Cost of services provided — 462,316 4,693,171 2,020,215 — 7,175,702
Depreciation and amortization — 16,357 226,904 52,650 — 295,911
Selling and general corporate expenses — 50,553 93,023 14,750 — 158,326
Goodwill impairment — — — 198,600 — 198,600
Interest and other financing costs, net — 168,165 1,306 9,936 — 179,407
Expense allocations — (154,994) 147,705 7,289 — —
— 542,397 5,162,109 2,303,440 — 8,007,946
(Loss) Income before Income Tax — (31,438) 160,510 (151,862) — (22,790)
(Benefit) Provision for Income Taxes — (3,075) 11,169 25,254 — 33,348
Equity in Net Income of Subsidiaries (56,499) — — — 56,499 —
Net (loss) income (56,499) (28,363) 149,341 (177,116) 56,499 (56,138)
Less: Net income attributable to noncontrolling interest — — 361 — — 361
Net (loss) income attributable to Aramark stockholders (56,499) (28,363) 148,980 (177,116) 56,499 (56,499)
Other comprehensive loss, net of tax (87,045) (59,181) (569) (23,938) 83,688 (87,045)
Comprehensive (loss) income attributable to Aramark stockholders $ (143,544) $ (87,544) $ 148,411 $ (201,054) $ 140,187 $ (143,544)

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)~~

~~For the three months ended March 29, 2019~~

~~(in thousands)~~

Aramark
(Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated
Revenue $ — $ 260,057 $ 2,629,407 $ 1,110,523 $ — $ 3,999,987
Costs and Expenses:
Cost of services provided — 234,485 2,375,337 1,030,137 — 3,639,959
Depreciation and amortization — 3,817 118,261 25,830 — 147,908
Selling and general corporate expenses — 35,870 45,374 7,041 — 88,285
Gain on sale of Healthcare Technologies — — 1,000 — — 1,000
Interest and other financing costs, net — 78,353 1,036 4,789 — 84,178
Expense allocations — 85,651 (89,505) 3,854 — —
— 438,176 2,451,503 1,071,651 — 3,961,330
(Loss) Income before Income Taxes — (178,119) 177,904 38,872 — 38,657
(Benefit) Provision for Income Taxes — (35,757) 35,298 9,806 — 9,347
Equity in Net Income of Subsidiaries 29,353 — — — (29,353) —
Net income (loss) 29,353 (142,362) 142,606 29,066 (29,353) 29,310
Less: Net loss attributable to noncontrolling interest — — (43) — — (43)
Net income (loss) attributable to Aramark stockholders 29,353 (142,362) 142,649 29,066 (29,353) 29,353
Other comprehensive loss, net of tax (8,655) (17,074) — (5,890) 22,964 (8,655)
Comprehensive income (loss) attributable to Aramark stockholders $ 20,698 $ (159,436) $ 142,649 $ 23,176 �� $ (6,389) $ 20,698

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)~~

~~For the six months ended March 29, 2019~~

~~(in thousands)~~

Aramark
(Parent) Issuers Guarantors Non Guarantors Eliminations Consolidated
Revenue $ — $ 528,579 $ 5,478,334 $ 2,258,423 $ — $ 8,265,336
Costs and Expenses:
Cost of services provided — 481,094 4,839,939 2,113,371 — 7,434,404
Depreciation and amortization — 8,289 239,243 51,097 — 298,629
Selling and general corporate expenses — 91,612 86,926 13,877 — 192,415
Gain on sale of Healthcare Technologies — — (156,309) — — (156,309)
Interest and other financing costs, net — 156,912 2,007 8,236 — 167,155
Expense allocations — (144,938) 136,296 8,642 — —
— 592,969 5,148,102 2,195,223 — 7,936,294
(Loss) Income before Income Taxes — (64,390) 330,232 63,200 — 329,042
(Benefit) Provision for Income Taxes — (27,017) 60,298 15,773 — 49,054
Equity in Net Income of Subsidiaries 280,037 — — — (280,037) —
Net income (loss) 280,037 (37,373) 269,934 47,427 (280,037) 279,988
Less: Net loss attributable to noncontrolling interest — — (49) — — (49)
Net income (loss) attributable to Aramark stockholders 280,037 (37,373) 269,983 47,427 (280,037) 280,037
Other comprehensive loss, net of tax (50,428) (44,425) — (50,841) 95,266 (50,428)
Comprehensive income (loss) attributable to Aramark stockholders $ 229,609 $ (81,798) $ 269,983 $ (3,414) $ (184,771) $ 229,609

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS~~

~~For the six months ended March 27, 2020~~

~~(in thousands)~~

Aramark
(Parent) Issuers
Guarantors
Non Guarantors Eliminations Consolidated
Net cash (used in) provided by operating activities $ — $ (122,174) $ 112,309 $ (75,404) $ (6,357) $ (91,626)
Cash flows from investing activities:
Purchases of property and equipment and other — (23,291) (158,754) (31,524) — (213,569)
Disposals of property and equipment — 506 4,257 3,475 — 8,238
Acquisitions of businesses, net of cash acquired — — (10,407) (4,515) — (14,922)
Proceeds from governmental agencies related to property and equipment — — 23,550 — — 23,550
Other investing activities — (413) 1,019 (491) — 115
Net cash used in investing activities — (23,198) (140,335) (33,055) — (196,588)
Cash flows from financing activities:
Proceeds from long-term borrowings — 1,743,875 — 79,080 — 1,822,955
Payments of long-term borrowings — (902,485) (15,567) (17,206) — (935,258)
Net change in funding under the Receivables Facility — — — 400,000 — 400,000
Payments of dividends — (55,257) — — — (55,257)
Proceeds from issuance of common stock — 85,048 — — — 85,048
Repurchase of common stock — (6,540) — — — (6,540)
Other financing activities — (64,197) (1,461) — — (65,658)
Change in intercompany, net — 237,351 18,957 (262,665) 6,357 —
Net cash provided by financing activities — 1,037,795 1,929 199,209 6,357 1,245,290
Effect of foreign exchange rates on cash and cash equivalents — — — (755) — (755)
Increase (decrease) in cash and cash equivalents — 892,423 (26,097) 89,995 — 956,321
Cash and cash equivalents, beginning of period 5 33,510 40,544 172,584 — 246,643
Cash and cash equivalents, end of period $ 5 $ 925,933 $ 14,447 $ 262,579 $ — $ 1,202,964

~~Table of Contents~~

~~ARAMARK AND SUBSIDIARIES~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)~~

~~CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS~~

~~For the six months ended March 29, 2019~~

~~(in thousands)~~

Aramark
(Parent) Issuers
Guarantors
Non Guarantors Eliminations Consolidated
Net cash (used in) provided by operating activities $ — $ (84,943) $ 133,213 $ 52,030 $ (11,317) $ 88,983
Cash flows from investing activities:
Purchases of property and equipment and other — (6,680) (183,367) (40,355) — (230,402)
Disposals of property and equipment — 5,081 903 1,572 — 7,556
Proceeds from divestiture — — 293,711 — — 293,711
Acquisitions of businesses, net of cash acquired — — (9,443) (21,672) — (31,115)
Proceeds from governmental agencies related to property and equipment — — 16,200 — — 16,200
Other investing activities — 178 3,098 (1,031) — 2,245
Net cash (used in) provided by investing activities — (1,421) 121,102 (61,486) — 58,195
Cash flows from financing activities:
Proceeds from long-term borrowings — — — 100,071 — 100,071
Payments of long-term borrowings — (279,557) (16,800) (49,101) — (345,458)
Net change in funding under the Receivables Facility — — — 205,000 — 205,000
Payments of dividends — (54,220) — — — (54,220)
Proceeds from issuance of common stock — 10,372 — — — 10,372
Repurchase of common stock — (50,000) — — — (50,000)
Other financing activities — (27,533) (1,474) (113) — (29,120)
Change in intercompany, net — 468,094 (242,131) (237,280) 11,317 —
Net cash provided by (used in) financing activities — 67,156 (260,405) 18,577 11,317 (163,355)
Effect of foreign exchange rates on cash and cash equivalents — — — (3,461) — (3,461)
(Decrease) increase in cash and cash equivalents — (19,208) (6,090) 5,660 — (19,638)
Cash and cash equivalents, beginning of period 5 50,716 29,844 134,460 — 215,025
Cash and cash equivalents, end of period $ 5 $ 31,508 $ 23,754 $ 140,120 $ — $ 195,387

Table of Contents

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS

OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of Aramark's (the "Company," "we," "our" and "us") financial condition and results of operations for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019 should be read in conjunction with our audited consolidated financial statements, and the notes to those statements for the fiscal year ended September 27, 2019 included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission ("SEC") on November 26, 2019.

Our discussion contains forward-looking statements, such as our plans, objectives, opinions, expectations, anticipations, intentions and beliefs, that are based upon our current expectations but that involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in those forward-looking statements as a result of a number of factors, including those described under the heading "Special Note About Forward-Looking Statements" and elsewhere in this Quarterly Report on Form 10-Q. In the following discussion and analysis of financial condition and results of operations, certain financial measures may be considered "non-GAAP financial measures" under SEC rules. These rules require supplemental explanation and reconciliation, which is provided elsewhere in this Quarterly Report on Form 10-Q.

Overview

We are a leading global provider of food, facilities and uniform services to education, healthcare, business & industry and sports, leisure & corrections clients. Our core market is the United States, which is supplemented by an additional 18-country footprint. Through our established brand, broad geographic presence and employees, we anchor our business in our partnerships with thousands of education, healthcare, business, sports, leisure and corrections clients. Through these partnerships we serve millions of consumers including students, patients, employees, sports fans and guests worldwide. We operate our business in three reportable segments: Food and Support Services United States ("FSS United States"), Food and Support Services International ("FSS International") and Uniform and Career Apparel ("Uniform").

Our Food and Support Services operations focus on serving clients in five principal sectors: Business & Industry, Education, Healthcare, Sports, Leisure & Corrections and Facilities & Other. Our FSS International reportable segment provides a similar range of services as those provided to our FSS United States clients and operates in the same sectors. Administrative expenses not allocated to our three reportable segments are presented separately as corporate expenses.

During fiscal 2018, we acquired Avendra, LLC ("Avendra") and AmeriPride Services, Inc. ("AmeriPride") in separate transactions. Our earnings have been impacted and we expect to continue to be impacted for some period following the closings as a result of these acquisitions, due to, among other factors, merger and integration costs as well as depreciation and amortization resulting from purchase accounting and higher interest expense as a result of the new debt to finance the transactions. As a part of the integration of Avendra and AmeriPride, we have incurred ~~$109~~$114 million of charges and expect to incur approximately ~~$15 million to $20~~$7 million of additional charges over the next ~~six~~three months.

During fiscal 2019, Eric J. Foss, our former Chairman, President and Chief Executive Officer, stepped down and $12.1 million of charges related to his separation from us were recognized during the fourth quarter ~~ended September 27,~~of fiscal 2019, of which $10.4 million were cash compensation related charges. As of ~~March 27,~~June 26, 2020, we had ~~$7.9~~$6.7 million of remaining unpaid obligations related to his separation, which are recorded in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets. These remaining unpaid obligations are expected to be paid through fiscal 2021.

Impact of COVID-19 on our Business

The COVID-19 pandemic ("COVID-19") has adversely affected global economies, financial markets and the overall environment for our business, and the extent to which it may impact our future results of operations and overall financial performance remains uncertain.

In response to COVID-19, we ~~are~~remain principally focused on the safety and well-being of our employees, clients and everyone we serve, while simultaneously taking timely, proactive measures to adapt to the current environment. We ~~remain fully prepared~~continue to ~~perform strongly~~modify our business model in ~~the recovery. We believe that we are well-positioned~~response to ~~withstand~~ the disruption ~~to our business~~ caused by COVID-19 ~~due to~~by strengthening our ~~strong~~ liquidity position, ~~our~~focusing on flexible, low fixed-cost ~~operating model~~operations and diversifying our ~~diversified~~ service offerings, geographic mix and client portfolio.

While certain of our ~~business~~operating sectors have been significantly impacted to date, we continue to work toward mitigating these negative impacts. These efforts have and continue to include significant cost reduction efforts toward variable and fixed costs, including furlough and permanent reductions of labor. These efforts have also included contractual negotiations and efforts to provide additional products and services arising in the current environment. While some businesses are ~~working~~beginning to ~~resolve near-term disruptions~~reopen, to the extent the number of COVID-19 cases continue to rise and the government and private businesses shut down again, our

Table of Contents

recovery efforts could be further hindered. As our operating sectors re-open, we ~~are starting~~have and will continue to ~~see an increase in demand for those businesses significantly impacted by~~incur certain expenses as we take actions to ensure the ~~COVID-19 closures.~~safety of employees, clients and consumers.

In the FSS United States segment, the impacts to our operating sectors are further described as follows:

•Education – While ~~impacted by recent closures,~~ a ~~vast majority~~substantial number of accounts ~~continue~~continued to operate on a limited basis (for example, alternative meals in K-12 and supporting reduced populations in Higher Education)~~. For those~~, most accounts never fully re-opened operations, which resulted in significant negative impacts to the business. While some clients ~~who~~

~~Table of Contents~~

~~closed early,~~have announced an on-line approach to beginning classes in the Fall, we ~~accelerated~~are actively engaged with our Education clients about how each will return and how to create the ~~standard end-of-semester summer wind down of those locations in an effort to manage our costs to appropriate levels.~~best environment for their students.

•Sports, Leisure & Corrections – Sports & Entertainment has been and continues to be significantly impacted by the suspension of professional sports seasons and postponement of concerts and events. Sports has begun to proceed with the Major League Baseball, National Hockey League and National Basketball Association playing without fans as an interim solution. The National Football League is taking measures to include fans in some capacity based on local jurisdiction as their season begins in the coming weeks. We are actively engaged with our NFL clients to help bring fans safely back to the stadiums as appropriate. Leisure has also been impacted due to closures and restrictions in our parks, attractions and conference ~~centers.~~centers; however, we are beginning to see parks reopening across the country with modified and enhanced operations to meet the safety and hygiene standards required in today’s environment. Corrections ~~has~~continues to not ~~been~~be materially impacted.

•Business & Industry – Office closures and remote working resulting from stay-at-home orders and similar government mandates, have reduced catering and overall volumes. However, we continue to serve businesses and geographies that still require service, including financial, manufacturing and pharmaceutical industries.

•Facilities & Other – Although this sector has experienced some impact resulting from facility closures, we are providing more frequent and comprehensive services and products at ~~a number of~~certain locations ~~that require enhanced sanitization and deep cleaning, enabling a safer environment for existing and returning employees.~~as well.

•Healthcare – ~~We are working closely with clients to meet their heightened needs.~~While this sector has also experienced some disruption based on facility restrictions of patient services and visitation, we expect relative stability as the return of elective procedures and the demand for environmental services help provide support.

InWithin the FSS International segment, we ~~operate in 18 countries, with the largest presence in Canada, Chile,~~are at various stages of response depending on geography. China ~~Germany, Ireland and the United Kingdom. Our business in China, which is primarily in Healthcare,~~ has largely recovered and ~~been awarded~~we continue to have new ~~contracts. The impacts~~client wins—particularly in Healthcare—due to our efforts on the frontlines. Europe and Canada are exhibiting initial encouraging activation trends across some lines of business, while balancing country-specific government mandates. We are experiencing a delayed COVID-19 impact in ~~these countries is similar to what we are seeing in the FSS U.S. segment.~~South America.

In the Uniform segment, our business serves a range of clients. Operations continue for essential businesses, ~~with an increased focus~~and we are now seeing several of our non-essential clients restarting operations as well, although in certain areas of the country, due to worsening conditions of the pandemic, some of these businesses have been forced to shut down again. In addition, we continue to be a solution-oriented service focusing on ~~hygienic products~~safety and ~~services.~~hygiene, including a heightened demand for personal protective equipment ("PPE") materials amongst our clients. We ~~recently began redeploying~~have redeployed production lines in order to manufacture essential ~~personal protective equipment ("PPE")~~PPE for hospital employees and ~~others serving in critical roles~~other clients across the United States.

~~At this stage, it~~We began experiencing a significant decline in our operations due to COVID-19 towards the end of our second quarter of fiscal 2020, which has continued through our third quarter of fiscal 2020 and is ~~too early~~expected to ~~determine~~continue into our fourth quarter of fiscal 2020. The decline in our operations from COVID-19 caused a material deterioration in our revenues, operating income (loss) and net income (loss) for the ~~full~~three and nine months ended June 26, 2020. The ongoing impact of COVID-19 on the Company's longer-term operational and financial performance will depend on future developments, many of which are outside of our ~~operational results. For the three~~control, and ~~six months ended March 27, 2020, we estimated the COVID-19 impact on revenue~~all of which are highly uncertain and ~~operating income during these periods to~~cannot be $325 million and $70 million (net of lower personnel costs and share-based compensation expense), respectively. The estimated impact of COVID-19 on revenue and operating income was derived based on comparing actuals to forecasts and identifying and analyzing specific components of growth within each of the business segments, including pricing, new and lost business. predicted. In all business segments, we ~~are leveraging~~continue to leverage our flexible operating model to execute cost mitigation plans while continuing to support our clients. WeAs noted earlier, we have implemented several cost reduction initiatives, including renegotiations of client contracts, salary and other compensation adjustments, and reductions to general corporate expenses. In June 2020, we made changes to our organization to align our cost base to best support our clients' needs as we navigate the current environment and focus on our long-term strategy. These actions included headcount reductions that will allow us to emerge stronger when the pandemic is behind us. As a result, we incurred severance charges of approximately $124.9 million during the three and nine months ended June 26, 2020, which are recorded in both “Costs of services provided" and “Selling and general corporate expenses” in the Condensed Consolidated Statements of (Loss) Income. These charges are expected to be paid out within two years.

COVID-19 has disrupted and is expected to continue to disrupt our business, which has and could continue to materially affect our operating results, cash flows and/or financial condition for an extended period of time. The ~~scale and scope of COVID-19 may heighten the potential adverse effects on our business, operating results, cash flows and/or financial condition. The~~ Company has undertaken many actions as it relates to its liquidity position in response to COVID-19. See "Liquidity and Capital Resources" within Item 2. in

Table of Contents

this Quarterly Report on Form 10-Q for additional disclosure around these actions taken. Also, see “Item 1A. Risk Factors” in this Quarterly Report on Form 10-Q for an additional discussion of risks and potential risks of COVID-19 on our business, financial condition and results of operations.

Divestitures

On November 9, 2018, we completed the sale of our wholly-owned Healthcare Technologies ("HCT") business for $293.7 million in cash. The transaction resulted in a pretax gain of $156.3 million (tax effected gain of $139.2 million) in the Condensed Consolidated Statements of (Loss) Income for the ~~six~~nine months ended ~~March 29,~~June 28, 2019.

Seasonality

Our revenue and operating results have varied from quarter to quarter as a result of different factors. Historically, within our FSS United States segment, there has been a lower level of activity during our first and second fiscal quarters in operations that provide services to sports and leisure clients. This lower level of activity, historically, has been partially offset during our first and second fiscal quarters by the increased activity levels in our educational operations. Conversely, historically there has been a significant increase in the provision of services to sports and leisure clients during our third and fourth fiscal quarters, which is partially offset by the effect of summer recess at colleges, universities and schools in our educational operations. As described above, during the pendency of COVID-19 and in following periods, our business and results of operations may not experience our historically typical patterns of ~~seasonality in our business.~~seasonality.

Foreign Currency Fluctuations

The impact from foreign currency translation assumes constant foreign currency exchange rates based on the rates in effect for the prior year period being used in translation for the comparable current year period. We believe that providing the impact of fluctuations in foreign currency rates on certain financial results can facilitate analysis of period-to-period comparisons of business performance.

~~Table of Contents~~

Fiscal Year

Our fiscal year is the fifty-two or fifty-three week period which ends on the Friday nearest September 30th. The fiscal year ended October 2, 2020 is a fifty-three week period and the fiscal year ended September 27, 2019 is a fifty-two week period.

Results of Operations

The following tables present an overview of our results on a consolidated and segment basis with the amount of and percentage change between periods for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019 (dollars in millions).


		Three Months Ended						Change							Three Months Ended				Change
		March 27, 2020		March 29, 2019		$		%			June 26, 2020		June 28, 2019		$		%
Revenue	Revenue	$	3,731.6	$	4,000.0	$	(268.4)	(6.7)	%	Revenue	$	2,152.2	$	4,010.8	$	(1,858.6)	(46.3)	%
Costs and Expenses:	Costs and Expenses:									Costs and Expenses:
Cost of services provided	Cost of services provided	3,407.6		3,640.0		(232.4)		(6.4)	%	Cost of services provided	2,265.6		3,595.0		(1,329.4)		(37.0)	%
Other operating expenses	Other operating expenses	223.1		236.2		(13.1)		(5.5)	%	Other operating expenses	214.2		227.0		(12.8)		(5.6)	%
Goodwill impairment		198.6		—		198.6		100.0	%
Gain on sale of Healthcare Technologies		—		1.0		(1.0)		(100.0)	%

		3,829.3		3,877.2		(47.9)		(1.2)	%		2,479.8		3,822.0		(1,342.2)		(35.1)	%
Operating (loss) income	Operating (loss) income	(97.7)		122.8		(220.5)		(179.6)	%	Operating (loss) income	(327.6)		188.8		(516.4)		(273.5)	%
Interest and Other Financing Costs, net	Interest and Other Financing Costs, net	99.8		84.2		15.6		18.5	%	Interest and Other Financing Costs, net	94.2		82.2		12.0		14.6	%
(Loss) Income Before Income Taxes	(Loss) Income Before Income Taxes	(197.5)		38.6		(236.1)		(611.7)	%	(Loss) Income Before Income Taxes	(421.8)		106.6		(528.4)		***
Provision for Income Taxes		4.5		9.3		(4.8)		(51.6)	%
(Benefit) Provision for Income Taxes										(Benefit) Provision for Income Taxes	(165.5)		23.5		(189.0)		***
Net (loss) income	Net (loss) income	$	(202.0)	$	29.3	$	(231.3)	(789.4)	%	Net (loss) income	$	(256.3)	$	83.1	$	(339.4)	***

*** Not meaningful										*** Not meaningful

Table of Contents


		Three Months Ended						Change							Three Months Ended				Change
Revenue by Segment⁽¹⁾	Revenue by Segment⁽¹⁾	March 27, 2020		March 29, 2019		$		%		Revenue by Segment⁽¹⁾	June 26, 2020		June 28, 2019		$		%
FSS United States	FSS United States	$	2,231.1	$	2,417.0	$	(185.9)	(7.7)	%	FSS United States	$	1,067.6	$	2,413.5	$	(1,345.9)	(55.8)	%
FSS International	FSS International	853.5		942.0		(88.5)		(9.4)	%	FSS International	517.1		949.9		(432.8)		(45.6)	%
Uniform	Uniform	647.0		641.0		6.0		0.9	%	Uniform	567.5		647.4		(79.9)		(12.3)	%
		$	3,731.6	$	4,000.0	$	(268.4)	(6.7)	%		$	2,152.2	$	4,010.8	$	(1,858.6)	(46.3)	%

		Three Months Ended						Change							Three Months Ended				Change
Operating Income (Loss) by Segment⁽¹⁾	Operating Income (Loss) by Segment⁽¹⁾	March 27, 2020		March 29, 2019		$		%		Operating Income (Loss) by Segment⁽¹⁾	June 26, 2020		June 28, 2019		$		%
FSS United States	FSS United States	$	65.8	$	68.8	$	(3.0)	(4.4)	%	FSS United States	$	(193.8)	$	127.8	$	(321.6)	(251.6)	%
FSS International	FSS International	(191.2)		41.9		(233.1)		(556.3)	%	FSS International	(138.3)		40.2		(178.5)		***
Uniform	Uniform	46.8		38.2		8.6		22.5	%	Uniform	21.9		53.6		(31.7)		(59.1)	%
Corporate	Corporate	(19.1)		(26.1)		7.0		(26.8)	%	Corporate	(17.4)		(32.8)		15.4		(47.0)	%
		$	(97.7)	$	122.8	$	(220.5)	(179.6)	%		$	(327.6)	$	188.8	$	(516.4)	(273.5)	%

*** Not meaningful.

(1) As a percentage of total revenue, FSS United States represented ~~59.8%~~49.6% and ~~60.4%~~60.2%, FSS International represented ~~22.9%~~24.0% and ~~23.6%~~ 23.7% and Uniform represented ~~17.3%~~26.4% and ~~16.0%~~16.1% for the three month periods ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, respectively. Revenue and operating income (loss) for all segments were impacted by COVID-19 in the three month period of fiscal 2020.


	Nine Months Ended						Change
	June 26, 2020		June 28, 2019		$		%
Revenue	$	10,137.4	$	12,276.1	$	(2,138.7)	(17.4)	%
Costs and Expenses:
Cost of services provided	9,441.3		11,029.4		(1,588.1)		(14.4)	%
Other operating expenses	668.5		718.0		(49.5)		(6.9)	%
Goodwill impairment	198.6		—		198.6		100.0	%
Gain on sale of Healthcare Technologies	—		(156.3)		156.3		(100.0)	%
	10,308.4		11,591.1		(1,282.7)		(11.1)	%
Operating (loss) income	(171.0)		685.0		(856.0)		(125.0)	%
Interest and Other Financing Costs, net	273.6		249.4		24.2		9.7	%
(Loss) Income Before Income Taxes	(444.6)		435.6		(880.2)		(202.1)	%
(Benefit) Provision for Income Taxes	(132.2)		72.5		(204.7)		(282.3)	%
Net (loss) income	$	(312.4)	$	363.1	$	(675.5)	(186.0)	%

Table of Contents

Six Months Ended Change
March 27, 2020 March 29, 2019 $ %
Revenue $ 7,985.2 $ 8,265.3 $ (280.1) (3.4) %
Costs and Expenses:
Cost of services provided 7,175.7 7,434.4 (258.7) (3.5) %
Other operating expenses 454.3 491.0 (36.7) (7.5) %
Goodwill impairment 198.6 — 198.6 100.0 %
Gain on sale of Healthcare Technologies — (156.3) 156.3 (100.0) %
7,828.6 7,769.1 59.5 0.8 %
Operating income 156.6 496.2 (339.6) (68.4) %
Interest and Other Financing Costs, net 179.4 167.2 12.2 7.3 %
(Loss) Income Before Income Taxes (22.8) 329.0 (351.8) (106.9) %
Provision for Income Taxes 33.3 49.0 (15.7) (32.0) %
Net (loss) income $ (56.1) $ 280.0 $ (336.1) (120.0) %


		Six Months Ended						Change							Nine Months Ended				Change
Revenue by Segment⁽²⁾	Revenue by Segment⁽²⁾	March 27, 2020		March 29, 2019		$		%		Revenue by Segment⁽²⁾	June 26, 2020		June 28, 2019		$		%
FSS United States	FSS United States	$	4,870.1	$	5,077.3	$	(207.2)	(4.1)	%	FSS United States	$	5,937.7	$	7,490.8	$	(1,553.1)	(20.7)	%
FSS International	FSS International	1,799.7		1,895.2		(95.5)		(5.0)	%	FSS International	2,316.8		2,845.1		(528.3)		(18.6)	%
Uniform	Uniform	1,315.4		1,292.8		22.6		1.7	%	Uniform	1,882.9		1,940.2		(57.3)		(3.0)	%
		$	7,985.2	$	8,265.3	$	(280.1)	(3.4)	%		$	10,137.4	$	12,276.1	$	(2,138.7)	(17.4)	%

		Six Months Ended						Change							Nine Months Ended				Change
Operating Income (Loss) by Segment⁽²⁾	Operating Income (Loss) by Segment⁽²⁾	March 27, 2020		March 29, 2019		$		%		Operating Income (Loss) by Segment⁽²⁾	June 26, 2020		June 28, 2019		$		%
FSS United States	FSS United States	$	251.7	$	432.6	$	(180.9)	(41.8)	%	FSS United States	$	57.9	$	560.4	$	(502.5)	(89.7)	%
FSS International	FSS International	(147.5)		53.3		(200.8)		(376.7)	%	FSS International	(285.8)		93.5		(379.3)		***
Uniform	Uniform	100.1		90.9		9.2		10.1	%	Uniform	122.0		144.5		(22.5)		(15.6)	%
Corporate	Corporate	(47.7)		(80.6)		32.9		(40.8)	%	Corporate	(65.1)		(113.4)		48.3		(42.6)	%
		$	156.6	$	496.2	$	(339.6)	(68.4)	%		$	(171.0)	$	685.0	$	(856.0)	(125.0)	%

*** Not meaningful.

(2) As a percentage of total revenue, FSS United States represented ~~61.0%~~58.6% and ~~61.4%~~61.0%, FSS International represented ~~22.5%~~22.8% and ~~22.9%~~23.2% and Uniform represented ~~16.5%~~18.6% and ~~15.6%~~15.8% for the ~~six~~nine month periods ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019, respectively. Revenue and operating income (loss) for all segments were impacted by the COVID-19 in the ~~six~~nine month period of fiscal 2020.

Consolidated Overview

Revenue decreased by approximately ~~6.7%~~46.3% and ~~3.4%~~17.4% during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively, which was mainly due to COVID-19, primarily from our clients either reducing or ceasing operations at certain locations in our FSS United States and FSS International segments. Foreign currency translation also negatively impacted both the three and nine month periods of fiscal 2020 (approximately 1.0% and 1.1%).

The following table presents the cost of services provided by segment and as a percent of revenue for the three and nine month periods ended June 26, 2020 and June 28, 2019.


	Three Months Ended														Nine Months Ended
	June 26, 2020						June 28, 2019						June 26, 2020				June 28, 2019
Cost of services provided	$		% of Revenue		$		% of Revenue		$		% of Revenue		$		% of Revenue
FSS United States	$	1,140.8	106.9	%	$	2,170.5	89.9	%	$	5,505.4	92.7	%	$	6,719.4	89.7	%
FSS International	633.1		122.4	%	888.6		93.5	%	2,336.8		100.9	%	2,686.8		94.4	%
Uniform	491.7		86.6	%	535.9		82.8	%	1,599.1		84.9	%	1,623.2		83.7	%
	$	2,265.6	105.3	%	$	3,595.0	89.6	%	$	9,441.3	93.1	%	$	11,029.4	89.8	%

The following table presents the percentages attributable to the components in cost of services provided for the three and nine month periods ended June 26, 2020 and June 28, 2019.


	Three Months Ended						Nine Months Ended
Cost of services provided components	June 26, 2020		June 28, 2019		June 26, 2020		June 28, 2019
Food and support service costs	21.3	%	27.9	%	26.5	%	28.1	%
Personnel costs¹	54.4	%	46.9	%	49.1	%	46.9	%
Other direct costs	24.3	%	25.2	%	24.5	%	25.0	%
	100.0	%	100.0	%	100.1	%	100.0	%

(1) Severance charges related to COVID-19 increased this percentage by 5.4% and 1.3% during the three and nine month periods of fiscal 2020, respectively.

Operating income decreased by approximately $516.4 million and $856.0 million during the three and nine month periods of fiscal 2020 compared to the prior year periods, respectively. ~~Revenue~~Operating income was negatively impacted during both the three and ~~six~~nine month periods of fiscal 2020 due to COVID-19, primarily attributable to clients either reducing or ceasing operations at certain locations in our FSS United States and FSS International segments. ~~We estimate the total decline in revenue related to~~The negative impact of COVID-19 was ~~approximately $325 million (approximately 8.1%~~partially offset by both U.S. and ~~3.9%) across all segments for both~~non-U.S. governmental labor related credits (see Note 1 to the ~~three and six month periods of fiscal 2020. Foreign currency translation also negatively impacted both the three and six month periods of fiscal 2020 (approximately 1.3% and 1.1%).~~

condensed consolidated financial

3731

Table of Contents

~~The following table presents the cost of services provided by segment and as a percent of revenue for the three and six month periods ended March 27, 2020 and March 29, 2019.~~

Three Months Ended Six Months Ended
March 27, 2020 March 29, 2019 March 27, 2020 March 29, 2019
Cost of services provided $ % of Revenue $ % of Revenue $ % of Revenue $ % of Revenue
FSS United States $ 2,033.0 91.1 % $ 2,216.7 91.7 % $ 4,364.6 89.6 % $ 4,548.9 89.6 %
FSS International 823.2 96.4 % 877.8 93.2 % 1,703.7 94.7 % 1,798.2 94.9 %
Uniform 551.4 85.2 % 545.5 85.1 % 1,107.4 84.2 % 1,087.3 84.1 %
$ 3,407.6 91.3 % $ 3,640.0 91.0 % $ 7,175.7 89.9 % $ 7,434.4 89.9 %

~~The following table presents the percentages attributable~~statements). COVID-19 also led to ~~the components in cost of services provided for the three and six month periods ended March 27, 2020 and March 29, 2019.~~

Three Months Ended Six Months Ended
Cost of services provided components March 27, 2020 March 29, 2019 March 27, 2020 March 29, 2019
Food and support service costs 27.4 % 27.8 % 28.1 % 28.2 %
Personnel costs 49.0 % 48.2 % 47.4 % 46.9 %
Other direct costs 23.6 % 24.0 % 24.5 % 24.9 %
100.0 % 100.0 % 100.0 % 100.0 %

Operating income decreased by approximately $220.5 million and $339.6 million during the three and six month periods of fiscal 2020 compared to the prior year periods, respectively. Operating income was negatively impacted during both the three and six month periods of fiscal 2020 due to COVID-19, primarily attributable to clients either reducing or ceasing operations at certain locations in our FSS United States and FSS International segments. We estimate the total decline in operating income related to COVID-19 is approximately $70 million, which is net of lower personnel costs and share-based compensation expense (see Note 11 to the condensed consolidated financial statements). Personnel costs include employee incentive expenses related to the annual bonus and employer retirement matching contributions. The decrease in operating income during the three ~~month~~ and ~~six~~nine month periods of fiscal 2020 was also attributable to:

•~~a goodwill impairment charge in the FSS International segment~~severance charges related to COVID-19 (approximately ~~$198.6~~$124.9 million for both periods) ~~(see Note 4 to the condensed consolidated financial statements)~~;

•~~an increase~~non-cash charge related to operating lease right-of-use assets, property and equipment and other assets from ~~the change in fair value~~disposal by abandonment of certain ~~gasoline~~rental properties in the FSS United States segment (approximately $28.5 million in both periods);

•non-cash charge related to information technology assets in the FSS United States segment due to discontinued use and ~~diesel agreements~~non-renewal or expiration of contracts with specific vendors (approximately ~~$16.7~~$17.8 million and ~~$4.5~~$21.9 million); and

•personnel and consulting costs related to sales growth initiatives (approximately ~~$7.4~~$3.7 million and ~~$16.1~~$19.8 million); which more than offset

•gain from the insurance proceeds received related to property damage from a tornado in Nashville in the Uniform segment (approximately $16.3 million in both periods); and

•prior year compensation expenses for employee reinvestments funded by benefits from U.S. tax reform (approximately ~~$65.5~~$5.1 million and ~~$64.0~~$69.1 million).

During the ~~six~~nine month period of fiscal 2020, the decrease in operating income also was due to a non-cash goodwill impairment charge in the FSS International segment (approximately $198.6 million) (see Note 4 to the condensed consolidated financial statements) and the prior year gain from the divestiture of the HCT business (approximately $156.3 million)~~, offset by lower severance costs (approximately $15.1 million)~~.

Interest and Other Financing Costs, net, increased ~~18.5%~~14.6% and ~~7.3%~~9.7% during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. The increase was primarily due to ~~charges~~the issuance of ~~$20.9~~$1,500.0 million ~~related to refinancing activities~~of 6.375% Senior Notes, due 2025 during the third quarter of fiscal 2020 (see Note 5 to the condensed consolidated financial statements), partially offset by lower outstanding term loan borrowings resulting from optional prepayments made during fiscal 2019. The nine month period of fiscal 2020 includes $20.9 million of net expense related to the refinancing during the second quarter of fiscal 2020.

The ~~effective~~ income tax ~~rate~~benefit for the three and ~~six~~nine month periods of fiscal 2020 was ~~(2.3)%~~recorded at an effective rate of 39.2% and ~~(146.3)%~~29.7%, respectively, compared to ~~24.2%~~income tax expense recorded at an effective rate of 22.1% and ~~14.9%~~16.7% in the prior year periods, respectively. As a result of the Coronavirus Aid, Relief and Economic Security Act ("CARES ~~Act, the Company~~Act"), we recorded an income tax ~~expense~~benefit of approximately ~~$3.7~~$68.1 million and $58.8 million for ~~both~~ the three and ~~six~~nine month periods of fiscal ~~2020. While~~2020, respectively. These benefits reflect the ~~Company's estimated annual~~Net Operating Losses ("NOLs") expected to be carried back to Pre-Tax Cut and Jobs Act years during fiscal 2020, which are benefited at 35.0% as opposed to the current year rate of 21.0%. We also recorded a valuation allowance of $17.4 million and $11.8 million in the three and nine month periods ended June 26, 2020, respectively, against certain foreign tax credits that were re-established via the NOL carryback. The effective tax rate ~~reflects a benefit from the CARES Act, the application of that rate to the ordinary pretax income resulted in an expense~~ for the three ~~month period~~and nine months ended ~~March 27, 2020. As~~June 26, 2020 also includes an income tax benefit of ~~each reporting date, we consider existing evidence, both positive~~approximately $0.6 million and ~~negative, that could impact~~$46.1 million as a result of an excess tax benefit recognized in relation to equity awards exercised during the ~~need for~~fiscal year, including by the former Chairman, President and Chief Executive Officer. We also recorded a valuation ~~allowances~~allowance against deferred tax assets ~~("DTAs"). Based~~in certain subsidiaries of approximately $8.6 million during the nine months ended June 26, 2020, which was based on the negative evidence of cumulative losses and the $198.6 million non-cash goodwill impairment recorded in the FSS International segment (see Note 4 to the condensed consolidated financial statements) ~~as negative evidence, we recorded valuation allowances against DTAs of certain subsidiaries in the amount of approximately $8.6 million in the quarter ending March 27, 2020.~~. The ~~effective tax rate for the three and six months ended March 27, 2020 also includes tax benefits of approximately $26.9 million and $45.5 million as a~~

~~Table of Contents~~

result of an excess tax benefit recognized in relation to equity awards exercised during the first and second quarters of fiscal 2020, including by the former Chairman, President and Chief Executive Officer. The (Loss) Income Before Income Taxes for the three and six month periods of fiscal 2020 includes a non-cash impairment charge of goodwill for $198.6 million ~~which is nondeductible~~was non-deductible for income tax purposes.

Segment Results

FSS United States Segment

The FSS United States reportable segment consists of five operating sectors which have similar economic characteristics and are aggregated into a single operating segment. The five operating sectors of the FSS United States reportable segment are Business & Industry, Education, Healthcare, Sports, Leisure & Corrections and Facilities & Other.

Table of Contents

Revenue for each of these sectors are summarized as follows (in millions):


		Three Months Ended						Change		Six Months Ended								Change	Three Months Ended						Change		Nine Months Ended	Change
		March 27, 2020		March 29, 2019		%		March 27, 2020		March 29, 2019		%			June 26, 2020		June 28, 2019		%		June 26, 2020		June 28, 2019		%
Business & Industry	Business & Industry	$	369.2	$	394.8	(6.5)	%	$	774.7	$	794.7	(2.5)	%	Business & Industry	$	160.9	$	404.4	(60.2)	%	$	935.6	$	1,199.1	(22.0)	%
Education	Education	805.5		901.6		(10.7)	%	1,806.6		1,917.9		(5.8)	%	Education	207.1		707.6		(70.7)	%	2,013.7		2,625.5		(23.3)	%
Healthcare	Healthcare	221.0		221.4		(0.2)	%	448.2		484.7		(7.5)	%	Healthcare	176.6		224.0		(21.2)	%	624.8		708.7		(11.8)	%
Sports, Leisure & Corrections	Sports, Leisure & Corrections	444.4		504.7		(11.9)	%	1,053.3		1,099.0		(4.2)	%	Sports, Leisure & Corrections	194.3		681.4		(71.5)	%	1,247.6		1,780.4		(29.9)	%
Facilities & Other	Facilities & Other	391.0		394.5		(0.9)	%	787.3		781.0		0.8	%	Facilities & Other	328.7		396.1		(17.0)	%	1,116.0		1,177.1		(5.2)	%
		$	2,231.1	$	2,417.0	(7.7)	%	$	4,870.1	$	5,077.3	(4.1)	%		$	1,067.6	$	2,413.5	(55.8)	%	$	5,937.7	$	7,490.8	(20.7)	%

The Healthcare, Education and Facilities & Other sectors generally have high-single digit operating income margins and the Business & Industry and Sports, Leisure & Corrections sectors generally have mid-single digit operating income margins. As described above, during the pendency of COVID-19 and in following periods, operating income margins in the FSS United States sectors ~~may~~ differ from our historically typical patterns.

FSS United States segment revenue decreased by approximately ~~7.7%~~55.8% and ~~4.1%~~20.7% during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. The decrease during the three and ~~six~~nine month periods of fiscal 2020 was primarily attributable to COVID-19, ~~(approximately 9.4% and 4.5% of the FSS United States segment),~~ which significantly impacted our Sports, Leisure & Corrections sector due to the suspension of professional sports seasons, ~~and~~ our Education sector where clients either have reduced or ceased operations at certain ~~locations.~~locations and our Business & Industry sector due to many clients working from home instead of the office. During the ~~six~~nine month period of fiscal 2020, revenue also decreased in the Healthcare sector resulting from the divestiture of HCT (approximately ~~9.0%~~5.8% of the Healthcare sector).

Operating income decreased by approximately ~~$3.0~~$321.6 million and ~~$180.9~~$502.5 million during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. ~~The decrease~~Operating income was negatively impacted during both the three and nine month ~~period~~periods of fiscal 2020 ~~was attributable to:~~

•~~the estimated profit decline~~ due to COVID-19, ~~net of~~partially offset by labor related credits from the CARES Act legislation and lower personnel costs, including employee incentive expenses related to the annual bonus and employer retirement matching ~~contributions~~contributions. The negative profit decline from COVID-19 is primarily attributable to clients either reducing or ceasing operations at certain locations. The decrease during the three and nine month periods of fiscal 2020 was also attributable to:

•severance charges related to COVID-19 (approximately ~~$50.0 million)~~$48.2 million in both periods);

•~~profit decline~~non-cash charge related to operating lease right-of-use assets, property and equipment and other assets from disposal by abandonment of certain rental properties (approximately $28.5 million in ~~the Education sector;~~both periods);

•a non-cash ~~asset write-down~~charge related to information technology assets due to discontinued use and non-renewal or expiration of contracts with specific vendors (approximately ~~$4.1~~$17.8 million and $21.9 million); and

•personnel costs and consulting costs related to sales growth initiatives (approximately ~~$3.7~~$1.7 million and $10.4 million); which more than offset

•prior year compensation expenses for employee reinvestments funded by benefits from U.S. tax reform (approximately ~~$51.8 million);~~$3.6 million and

•~~prior year settlement charges related to exiting a joint venture arrangement (approximately $4.5~~ $54.0 million).

The decrease during the ~~six~~nine month period was also attributable ~~to:~~

•to the prior year gain from the divestiture of the HCT business (approximately $156.3 million);

•the estimated profit decline due to COVID-19, net of lower personnel costs, including employee incentive expenses related to the annual bonus and employer retirement matching contributions (approximately $50.0 million);

•~~profit decline in the Education sector;~~

•~~personnel costs and consulting costs related to sales growth initiatives (approximately $8.7 million);~~

~~Table of Contents~~

•~~a non-cash asset impairment charge related to information technology assets (approximately $4.1 million); and~~

•~~profit decline from the prior year divestiture of HCT (approximately $3.8 million); which more than~~, partially offset

•~~prior year compensation expenses for employee reinvestments funded~~ by ~~benefits from U.S. tax reform (approximately $50.4 million);~~

•~~the~~ prior year duplicate rent charges to build out and ready our new headquarters while occupying our previous headquarters, impairment costs while exiting our previous headquarters and moving costs associated with the relocation to the new headquarters (approximately $6.8 million);

• and prior year settlement charges related to exiting a joint venture arrangement (approximately $4.5 million)~~; and~~.

•~~lower severance charges (approximately $3.5 million).~~

FSS International Segment

FSS International segment revenue decreased by approximately ~~9.4%~~45.6% and ~~5.0%~~18.6% during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. The decrease during both the three and ~~six~~nine month periods of fiscal 2020 was primarily attributable to COVID-19, ~~(estimated to be approximately 8.3% and 4.1% of the FSS International segment), as Germany and Spain were particularly affected~~ due to government imposed shutdowns. The decrease was also attributable to the negative impact of foreign currency translation (approximately ~~5.3%~~4.2% and ~~4.6%~~4.5%).

Operating income decreased by approximately ~~$233.1~~$178.5 million and ~~$200.8~~$379.3 million during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. The decrease was attributable ~~to:~~to the estimated profit decline due to COVID-19, partially offset by labor related credits provided from government assistance programs and lower personnel costs,

•Table of Contents

including employee incentive expenses related to the annual bonus. The three and nine month periods of fiscal 2020 were impacted by severance charges related to COVID-19 (approximately $74.7 million for both periods). Operating income for the three and nine month periods of fiscal 2020 was positively impacted by foreign currency translation (approximately $7.1 million and $15.2 million) and prior year closing costs mainly related to customer contracts (approximately $8.5 million and $10.5 million).

The nine month period of fiscal 2020 also includes a goodwill impairment charge (approximately $198.6 ~~million for both periods)~~million) (see Note 4 to the condensed consolidated financial statements)~~; and~~

•~~the estimated profit decline due to COVID-19, net of lower personnel costs, including employee incentive expenses related to the annual bonus (approximately $33.0 million for both periods)~~.

~~For the three~~ The nine month period of fiscal ~~2020, there were~~2019 also includes severance charges related to streamlining and improving efficiencies and effectiveness around our selling, general and administrative functions of approximately ~~$3.7 million unrelated to COVID-19. For the six month period of fiscal 2020, there was a decrease in severance charges of approximately $14.2 million compared to the six month period of fiscal 2019.~~$17.9 million.

Uniform Segment

Uniform segment revenue ~~increased~~decreased by approximately ~~0.9%~~12.3% and ~~1.7%~~3.0% during the three and ~~six~~nine month period of fiscal 2020 compared to the prior year periods. The ~~increase~~decrease was primarily from ~~new business and improved pricing, partially offset by~~ the estimated decline due to COVID-19, ~~(approximately 3.1% and 1.5%~~partially offset by new business from the sale of ~~the Uniform segment).~~PPE.

Operating income ~~increased~~decreased by approximately ~~$8.6~~$31.7 million and ~~$9.2~~$22.5 million during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. The ~~increase~~decrease was attributable to the estimated profit decline due to COVID-19, partially offset by labor related credits provided by government assistance programs and lower personnel costs, including employee incentive expenses related to the annual bonus and employer matching contributions. The decrease was also attributable to:

•personnel costs related to sales growth initiatives (approximately $2.0 million and $9.4 million); which more than offset

•gain from the insurance proceeds received related to property damage from a tornado in Nashville (approximately $16.3 million in both periods);

•an increase in ~~revenue and~~ synergies from the AmeriPride acquisition;

•prior year compensation expenses for employee reinvestments funded by benefits from U.S. tax reform (approximately ~~$11.9~~$1.4 million ~~for both periods)~~and $13.3 million); and

•lower merger and integration charges from the AmeriPride acquisition (approximately ~~$2.3~~$1.1 million and ~~$1.3 million); which more than offset~~

•~~personnel costs related to sales growth initiatives (approximately $3.7 million and $7.4~~$2.4 million).

~~Table of Contents~~

Corporate

Corporate expenses, those administrative expenses not allocated to the business segments, decreased by approximately ~~$7.0~~$15.4 million and ~~$32.9~~$48.3 million during the three and ~~six~~nine month periods of fiscal 2020 compared to the prior year periods, respectively. The decrease for the three and nine month periods of fiscal 2020 was attributable to:

•expense reductions as a result of COVID-19, including ~~the reversal of previously recognized~~lower share-based compensation expense based on ~~lower than~~the second quarter fiscal 2020 reduction in the estimated target attainment on plan metrics for both the fiscal 2018 and fiscal 2019 PSU grants (approximately ~~$22.6~~$3.0 million ~~for both periods)~~and $25.6 million);

•lower personnel costs, including employee incentive expenses related to the annual bonus (approximately ~~$1.4~~$1.6 million ~~in both periods)~~and $3.0 million); and

•~~prior year~~lower share-based compensation ~~expenses for employee reinvestments funded by benefits from U.S. tax reform~~expense (approximately ~~$1.4~~$1.1 million ~~in both periods)~~and $7.5 million); which more than offset

•~~an increase~~severance charges related to COVID-19 (approximately $1.7 million for both periods).

The three month period of fiscal 2020 also includes a decrease from the change in fair value of certain gasoline and diesel agreements (approximately ~~$16.7 million~~$4.8 million) and lower consulting costs (approximately $4.5 million)~~; and~~

•. For the nine month period of fiscal 2020, there was an increase in severance and other costs associated with the departure of the Company's former chief financial officer (approximately $3.2 ~~million for both periods)~~million).

The ~~six~~nine month period of fiscal 2019 ~~also~~ included banker fees related to the divestiture of HCT (approximately $6.1 million) and compensation expenses for employee reinvestments funded by benefits from U.S. tax reform (approximately $1.4 million).

Liquidity and Capital Resources

Overview

Our principal sources of liquidity are cash generated from operating activities, funds from borrowings and existing cash on hand. As of ~~March 27,~~June 26, 2020, we had ~~$1,203.0~~$2,417.3 million of cash and cash equivalents and approximately ~~$4.7~~$85.7 million of availability under our senior secured revolving credit facility. A significant portion of our cash and cash equivalents is held in

Table of Contents

mature, liquid geographies where we have operations. As of ~~March 27,~~June 26, 2020, there was approximately ~~$921.0~~$901.8 million of outstanding foreign currency borrowings.

On January 15, 2020, we entered into a new U.S. dollar denominated term loan due January 15, 2027 (the "U.S. Term Loan B due 2027"), in an aggregate principal amount of $900.0 million. The U.S. Term Loan B due 2027 was borrowed with an original issue discount of 0.125%. The net proceeds from the U.S. Term Loan B due 2027 were used to redeem the aggregate $900.0 million principal amount outstanding on the 5.125% Senior Notes due 2024 (the "2024 Notes") at a redemption price of 102.563% of the aggregate principal amount and to pay accrued interest, certain fees and related expenses, including a $23.1 million call premium on the 2024 Notes and approximately $6.6 million related to banker fees, rating agency fees and legal fees (see Note 5 to the condensed consolidated financial statements).

In response to the COVID-19 pandemic, we undertook a number of actions to enhance our cash position, ~~as of March 27, 2020,~~ including increasing borrowings ~~of $948.8 million~~ under our revolving credit facility and ~~$400.0 million~~ under our Receivables Facility. In addition, on April 27, 2020, Aramark Services Inc. (“ASI”), our indirect wholly owned subsidiary, issued $1,500.0 million aggregate principal amount of 6.375% Senior Notes due May 1, 2025 (the "6.375% 2025 Notes"). ASI intends to use the net proceeds from the 6.375% 2025 Notes for general corporate purposes (see Note 5 to the condensed consolidated financial statements). We have also implemented several cost reduction initiatives in response to COVID-19, including renegotiations of client contracts, salary and other compensation adjustments and reductions to general corporate expenses. In June 2020, we made changes to our organization to align our cost base to best support our clients' needs as we navigate the current environment and focus on our long-term strategy. These actions included headcount reductions, which resulted in severance charges of approximately $124.9 million during the three and nine months ended June 26, 2020. These charges are expected to be paid out within two years.

While the full impact of COVID-19 on our long-term liquidity remains uncertain, we currently believe that our cash and cash equivalents, including funds from our additional borrowings, will be adequate to meet anticipated cash requirements to fund working capital, capital spending, debt service obligations, refinancings, dividends and other cash needs. We have no significant debt maturities due until 2023 and, with the additional funds from ~~our recent debt offering~~the 6.375% 2025 Notes and our recent credit agreement amendment, we believe we have sufficient flexibility to manage the impact of COVID-19, based on our current assumptions. We also have flexibility to optimize working capital and defer certain capital expenditures as appropriate without a material impact to the business. While we believe that our assumptions used to estimate our liquidity and working capital requirements are reasonable, we cannot assure that they will be correct because as the current environment is unprecedented and as a consequence, our ability to be predictive is uncertain. For information regarding the impact of COVID-19, including on our liquidity and capital resources, see Part II, Item 1A, "Risk Factors" in this Quarterly Report on Form 10-Q.

On February 5, 2019, we announced as a result of tax savings from U.S. tax reform that we would invest $90 million in our workforce through targeted wage adjustments, retirement contributions and special recognition awards, as well as employee training programs and scholarships. We funded a majority of these investments during fiscal 2019. Through ~~March 27,~~June 26, 2020, we have invested approximately $84 million in special recognition awards, employee training programs, retirement

~~Table of Contents~~

contributions and educational assistance. We expect to spend approximately $6$1 million during the remainder of fiscal 2020 related to the tax reform funded investment in our workforce.

The table below summarizes our cash activity (in millions):


		Six Months Ended							Nine Months Ended
		March 27, 2020		March 29, 2019			June 26, 2020		June 28, 2019
Net cash (used in) provided by operating activities	Net cash (used in) provided by operating activities	$	(91.6)	$	89.0	Net cash (used in) provided by operating activities	$	(74.8)	$	208.2
Net cash (used in) provided by investing activities		(196.6)		58.2
Net cash used in investing activities						Net cash used in investing activities	(251.3)		(49.4)
Net cash provided by (used in) financing activities	Net cash provided by (used in) financing activities	1,245.3		(163.4)		Net cash provided by (used in) financing activities	2,496.2		(150.7)

Reference to the Condensed Consolidated Statements of Cash Flows will facilitate understanding of the discussion that follows.

Cash Flows (Used in) Provided by Operating Activities

During the ~~six~~nine month period of fiscal 2020, as discussed in "Results of Operations" above, net income decreased and non-cash charges increased compared to the ~~six~~nine month period of fiscal 2019, which was impacted by the current year net loss from COVID-19, offset by the current year non-cash goodwill impairment ~~charge related to goodwill~~and asset write-downs of approximately ~~$198.6~~$245.0 million and the prior year gain from the divestiture of the HCT business of approximately $139.2 million. The change in cash flows used in operating activities during the six month period of fiscal 2020 compared to cash flows provided by operating activities during the six month period of fiscal 2019 was primarily due to the unfavorable change in operating assets and liabilities ($236.6 million). The change in operating assets and liabilities compared to the prior year period was primarily due to the following:

Table of Contents

•Receivables were a source of cash by $444.6 million in the nine month period of fiscal 2020 compared to a use of cash in the nine month period of fiscal 2019 due to timing of collections and lower revenue from the impact of COVID-19; which more than offset

•Accounts payable were a greater use of cash ($208.2) million due to timing of disbursements and lower purchasing levels from the impact of COVID-19, mainly in our Sports, Business & Industry and Higher Education businesses and our FSS International segment; and

•Accrued expenses were a greater use of cash ($~~203.2~~141.4 million) primarily due to the following: change in annual bonus accrual generating more of a use of cash in the current year compared to the prior year period; higher commission payments in our Sports business and other accrued expense payments both from lower current year activity from the impact of COVID-19; and change in annual employer retirement matching contribution accrual generating more of a use of cash in the current year compared to the prior year period; ~~the timing of deferred income;~~partially offset by higher payroll and ~~higher commission payments with lower new activity~~benefit related expenses from the ~~impact~~severance charge recorded in the quarter and deferral of ~~COVID-19 in our Sports business;~~the employer portion of social security taxes as permitted under the CARES Act; and

•~~Accounts payable~~Prepayments were a greater use of cash ($~~132.1 million) due to timing of disbursements and lower purchasing levels from the impact of COVID-19, mainly in our Higher Education and Sports businesses; which more than offset~~

•~~Receivables were less of a use of cash by $64.1~~54.8) million due to ~~timing of collections and lower revenue~~being in an income tax receivable position from ~~the impact of COVID-19; and~~

•Inventories were a source of cash by $41.4 million in the six month period of fiscal 2020 compared to a use of cash in the six month period of fiscal 2019 due to lower purchases in the Uniform segment.current year net loss.

During the ~~six~~nine month periods of fiscal 2020 and fiscal 2019, we received income of approximately $12.5 million and $14.6 million, respectively, related to favorable loss experience in older insurance years under our general liability, automobile liability and workers' compensation programs. The "Other operating activities" caption ~~reflects~~reflects: adjustments to net (loss) income in the current year and prior year periods related to noncash charges; adjustments to non-operating cash gains and losses, including ~~financing~~the call premium expense of $23.1 million from the repayment of the aggregate principal amount of the 5.125% Senior Notes, due 2024 and the gain from the insurance proceeds related ~~charges~~to the property damaged from a tornado in Nashville of $16.3 million; and ~~includes fluctuations~~the change in ~~certain non-current liabilities (insurance).~~noncurrent assets of $64.8 million, mainly related to in-service rental merchandise as activity lower due to less customer installations from the impact of COVID-19.

Cash Flows ~~(Used in) Provided by~~Used in Investing Activities

The change in net cash flows used in investing activities during the ~~six~~nine month period of fiscal 2020 compared to the ~~net cash flows provided by investing activities during the six~~nine month period of fiscal 2019 relates primarily to the proceeds from the sale of Healthcare Technologies in the first quarter of fiscal 2019 of $293.7 million and lower levels of capital expenditures. The "Disposals of property and equipment" caption includes approximately $21.5 million of insurance proceeds related to a tornado at one of our Uniform locations in Nashville. The "Proceeds from governmental agencies related to property and equipment" caption includes approximately $15.3 million and $16.2 million of proceeds during fiscal 2020 and 2019, respectively, relating to the recovery of our investment (possessory interest) at one of the National Park Service sites within our Sports, Leisure & Corrections ~~sector during each of the six month periods of fiscal 2020 and 2019.~~sector. The ~~six~~nine month period of fiscal 2020 also includes approximately $8.3 million of proceeds from government grants related to the relocation to our new headquarters.

Cash Flows Provided by (Used in) Financing Activities

During the ~~six~~nine month period of fiscal 2020, cash provided by financing activities was impacted by the following:

•issuance of 6.375% senior unsecured notes due 2025 ($1,500.0 million);

•issuance of a new U.S. denominated term loan due January 2027, net of original issue discount ($898.9 million);

•an increase in borrowings under the revolving credit facility ($~~948.8~~845.2 million);

•an increase in funding under the Receivables Facility ($~~400.0~~335.6 million);

•an increase in proceeds from issuance of common stock as a result of higher stock option exercises ($~~85.0~~88.6 million); and

~~Table of Contents~~

•cash proceeds received from a stockholder in connection with short-swing profits earned through transactions in our common stock, which are included in "Other financing activities" ($14.8 million); which more than offset

•repayment of the aggregate principal amount of the 5.125% Senior Notes, due 2024 ($~~900~~900.0 million); and

•payment of fees and expenses related to refinancing activities, which is included in "Other financing activities," including a call premium ($23.1 million) and ~~capitalized third party~~debt issuance costs ($~~6.6~~29.3 million).

During the ~~six~~nine month period of fiscal 2019, cash used in financing activities was impacted by the following:

•~~an increase in funding under the Receivables Facility ($205.0 million); and~~

•a repayment of borrowings on term loans and the revolving credit facility ($~~290.3~~297.0 million, which includes $200.0 million of optional prepayments from the proceeds of the HCT divestiture); and

Table of Contents

•an increase in funding under the Receivables Facility ($255.0 million).

During fiscal 2019, the Board of Directors authorized a new share repurchase program providing for purchases of up to $200.0 million of Aramark common stock which will ~~expired~~expire in July 2022. During the second quarter of fiscal 2020, we repurchased 0.3 million shares of our common stock for $6.5 million under this program. During the ~~six~~nine month period of fiscal 2019, we completed a repurchase of 1.6 million shares of our common stock for $50.0 million under the fiscal 2017 share repurchase program, which expired on February 1, 2019. In accordance with Amendment No. 9 to the Credit Agreement entered into in the third quarter of fiscal 2020, we cannot make any future share repurchases as long as the covenant compliance waiver remains in effect (see below).

The "Other financing activities" caption also reflects a use of cash during the ~~six~~nine month periods of fiscal 2020 and fiscal 2019, primarily related to taxes paid by us when we withhold shares upon an employee's exercise or vesting of equity awards to cover income taxes.

Covenant Compliance

The Credit Agreement contains a number of covenants that, among other things, restrict, subject to certain exceptions, our ability and the ability of our subsidiaries to: incur additional indebtedness; issue preferred stock or provide guarantees; create liens on assets; engage in mergers or consolidations; sell assets; pay dividends; make distributions or repurchase our capital stock; make investments, loans or advances; repay or repurchase any subordinated debt, except as scheduled or at maturity; create restrictions on the payment of dividends or other amounts to us from our restricted subsidiaries; make certain acquisitions; engage in certain transactions with affiliates; amend material agreements governing our subordinated debt (or any indebtedness that refinances our subordinated debt); and fundamentally change our business. The indentures governing our senior notes contain similar provisions. As of ~~March 27,~~June 26, 2020, we were in compliance with these covenants.

As stated above, the Credit Agreement and the indentures governing our senior notes contain provisions that restrict our ability to pay dividends and repurchase stock (collectively, “Restricted Payments”). In addition to customary exceptions, the Credit Agreement and indentures permit Restricted Payments in the aggregate up to an amount that increases quarterly by 50% of our Consolidated Net Income, as such term is defined in these debt agreements, subject to being in compliance with the interest coverage ratio described below.

Under the Credit Agreement, we are required to satisfy and maintain specified financial ratios and other financial condition tests and covenants. The indentures governing our senior notes also require us to comply with certain financial ratios in order to take certain actions. Our continued ability to meet those financial ratios, tests and covenants can be affected by events beyond our control, and there can be no assurance that we will meet those ratios, tests and covenants.

On April 22, 2020, ASI entered into Amendment No. 9 to the Credit Agreement. Amendment No. 9 provides for a covenant waiver period which suspends the Consolidated Secured Debt Ratio debt covenant required under the credit agreement for four fiscal quarters, commencing with the fourth quarter of fiscal 2020 and ending after the third quarter of fiscal 2021, subject to, among other things, ongoing compliance with a minimum liquidity condition of $400.0 million and restrictions on making certain restricted payments and investments in unrestricted subsidiaries, in each case, as set forth in Amendment No. 9. If ASI ceases to be in compliance with Amendment No. 9 at any time during the covenant waiver period, this will cause an event of default under the Credit Agreement. If such non-compliance is not waived, certain lenders under the senior secured credit facilities could elect to declare all amounts outstanding under the senior secured credit facilities to be immediately due and payable and terminate all commitments to extend further credit under such facilities. When the Consolidated Secured Debt Ratio debt covenant is once again effective for ASI in the fourth quarter of fiscal 2021, the trailing twelve month period will consist of results from the third quarter of fiscal 2019 through the first quarter of fiscal 2020 plus the fourth quarter of fiscal 2021, excluding the results of the second quarter of fiscal 2020 through the third quarter of fiscal 2021. This exclusion is intended to prevent the effects of COVID-19 from impacting the covenant calculation. In accordance with Amendment No. 9 to the Credit Agreement entered into in the third quarter of fiscal 2020, we cannot make any future share repurchases as long as the covenant compliance waiver remains in effect.

These financial ratios, tests and covenants involve the calculation of certain measures that we refer to in this discussion as "Covenant Adjusted EBITDA." Covenant Adjusted EBITDA is not a measurement of financial performance under U.S. GAAP.

~~Table of Contents~~

Covenant Adjusted EBITDA is defined as net income (loss) of ASI and its restricted subsidiaries plus interest and other financing costs, net, provision (benefit) for income taxes, and depreciation and amortization, further adjusted to give effect to adjustments required in calculating covenant ratios and compliance under our Credit Agreement and the indentures governing our senior notes.

Our presentation of these measures has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. You should not consider these measures as alternatives to net income or operating income determined in accordance with U.S. GAAP. Covenant Adjusted EBITDA, as presented by us,

Table of Contents

may not be comparable to other similarly titled measures of other companies because not all companies use identical calculations.

The following is a reconciliation of net income attributable to ASI stockholder, which is a U.S. GAAP measure of ASI's operating results, to Covenant Adjusted EBITDA as defined in our debt agreements. The terms and related calculations are defined in the Credit Agreement and the indentures governing our senior notes. Covenant Adjusted EBITDA is a measure of ASI and its restricted subsidiaries only and does not include the results of Aramark.


	Twelve Months Ended
(in millions)	~~March 27,~~June 26, 2020
Net ~~income~~loss attributable to ASI stockholder	$	~~112.0~~ (227.4)
Interest and other financing costs, net	~~347.2~~359.3
~~Provision~~Benefit for income taxes	~~92.0~~ (97.1)
Depreciation and amortization	~~589.9~~589.1
Share-based compensation expense⁽¹⁾	~~26.3~~22.2
Unusual or non-recurring (gains) and losses⁽²⁾	198.6
Pro forma EBITDA for equity method investees⁽³⁾	~~6.7~~5.5
Pro forma EBITDA for certain transactions⁽⁴⁾	~~15.7~~12.3
Other⁽⁵⁾	~~204.0~~452.8
Covenant Adjusted EBITDA	$	~~1,592.4~~1,315.3

(1) Represents share-based compensation expense resulting from the application of accounting for stock options, restricted stock units, performance stock units and deferred stock unit awards (see Note 11 to the condensed consolidated financial statements).

(2) Represents non-cash impairment charge related to goodwill (see Note 4 to the condensed consolidated financial statements).

(3) Represents our estimated share of EBITDA, primarily from our AIM Services Co., Ltd. equity method investment, not already reflected in our Net income attributable to ASI stockholder. EBITDA for this equity method investee is calculated in a manner consistent with consolidated Covenant Adjusted EBITDA but does not represent cash distributions received from this investee.

(4) Represents the annualizing of net EBITDA from acquisitions made during the period.

(5) "Other" for the twelve months ended ~~March 27,~~June 26, 2020, includes labor charges, incremental expenses and other expenses associated with closed or partially closed client locations resulting from the COVID-19 pandemic, net of U.S. and non-U.S. governmental labor related credits ($~~41.1~~150.9 million), severance charges ($129.3 million), non-cash charge related to asset write-downs ($36.7 million), expenses related to merger and integration related charges ($~~35.2~~32.2 million), non-cash charge related to operating lease right-of-use assets, property and equipment and other assets from disposal by abandonment of certain rental properties ($28.5 million), charges related to certain legal settlements ($~~27.9~~27.4 million), adjustments to remove the impact attributable to the adoption of certain ~~new~~ accounting standards in accordance with the Credit Agreement and indentures ($~~24.1~~24.0 million), ~~non-cash impairment~~gain from the insurance proceeds received related to property damage from a tornado in Nashville ($16.3 million gain), cash compensation charges associated with the retirement of our former chief executive officer ($~~18.9~~10.4 million), advisory fees related to shareholder matters ($7.7 million), the impact of hyperinflation in Argentina ($6.0 million), compensation expense for retirement contributions and employee training programs funded by benefits from U.S. tax reform ($~~10.9 million), cash compensation charges associated with the retirement of our former chief executive officer ($10.4~~5.8 million), the impact of the change in fair value related to certain gasoline and diesel agreements ($~~9.2~~4.4 million loss), advisory fees related to shareholder matters ($7.7 million), closing costs mainly related to customer contracts ($7.2 million), the impact of hyperinflation in Argentina ($6.0 million), severance charges ($4.3 million) and other miscellaneous expenses.

Our covenant requirements and actual ratios for the twelve months ended ~~March 27,~~June 26, 2020 are as follows:

~~Table of Contents~~


	Covenant Requirements	Actual Ratios
Consolidated Secured Debt Ratio⁽¹⁾	5.125x	~~2.62~~2.12
Interest Coverage Ratio (Fixed Charge Coverage Ratio)⁽²⁾	2.000x	~~5.05~~3.26

Table of Contents

(1) The Credit Agreement requires ASI to maintain a maximum Consolidated Secured Debt Ratio, defined as consolidated total indebtedness secured by a lien to Covenant Adjusted EBITDA, of 5.125x. Consolidated total indebtedness secured by a lien is defined in the Credit Agreement as total indebtedness consisting of debt for borrowed money, finance leases, debt in respect of sale-leaseback transactions, disqualified and preferred stock and advances under the Receivables Facility secured by a lien reduced by the amount of cash and cash equivalents on the condensed consolidated balance sheet that is free and clear of any lien. Non-compliance with the maximum Consolidated Secured Debt Ratio could result in the requirement to immediately repay all amounts outstanding under our Credit Agreement, which, if ASI's lenders under our Credit Agreement (other than the lenders in respect of ASI's U.S. Term Loan B, which lenders do not benefit from the maximum Consolidated Secured Debt Ratio covenant) failed to waive any such default, would also constitute a default under the indentures governing our senior notes. Commencing in the fourth fiscal quarter of fiscal 2020, subject to compliance with the additional minimum liquidity and other requirements set forth in Amendment No. 9 to the Credit Agreement, compliance with this covenant is waived through the third fiscal quarter of fiscal 2021.

(2) Our Credit Agreement establishes an incurrence-based minimum Interest Coverage Ratio, defined as Covenant Adjusted EBITDA to consolidated interest expense, the achievement of which is a condition for us to incur additional indebtedness and to make certain restricted payments. If we do not maintain this minimum Interest Coverage Ratio calculated on a pro forma basis for any such additional indebtedness or restricted payments, we could be prohibited from being able to incur additional indebtedness, other than the incremental capacity provided for under our Credit Agreement and pursuant to specified exceptions, and make certain restricted payments, other than pursuant to certain exceptions. The minimum Interest Coverage Ratio is 2.000x for the term of the Credit Agreement. Consolidated interest expense is defined in our Credit Agreement as consolidated interest expense excluding interest income, adjusted for acquisitions and dispositions, further adjusted for certain non cash or nonrecurring interest expense and our estimated share of interest expense from one equity method investee. The indentures governing our senior notes include a similar requirement which is referred to as a Fixed Charge Coverage Ratio.

WeSubject to restrictions imposed upon us during the covenant waiver period in accordance with Amendment No. 9 to the Credit Agreement, we and our subsidiaries and affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt securities (including any publicly issued debt securities), in privately negotiated or open market transactions, by tender offer or otherwise, or extend or refinance any of our outstanding indebtedness.

Our business activities do not include the use of unconsolidated special purpose entities and there are no significant business transactions that have not been reflected in the accompanying financial statements. Beginning in fiscal 2019, we began insuring portions of our general liability, automobile liability and workers’ compensation risks through a wholly owned captive insurance subsidiary (the "Captive") to enhance our risk financing strategies. The Captive is subject to the regulations within its domicile, including regulations relating to levels of liquidity and solvency as such concepts are defined by the regulator. The Captive was in compliance with these regulations as of ~~March 27,~~June 26, 2020. These regulations may have the effect of limiting our ability to access certain cash and cash equivalents held by the Captive for uses other than for the payment of our general liability, automobile liability and workers’ compensation claims and related Captive costs. As of ~~March 27,~~June 26, 2020, cash and cash equivalents at the Captive was ~~$68.7~~$59.9 million. We are self-insured for a portion of general liability, automobile liability and workers’ compensation claims under our insurance arrangements. Self-insurance reserves are recorded based on actuarial analyses.

On January 29, 2020, our stockholders approved the Second Amended and Restated 2013 Stock Incentive Plan, which amends and restates our 2013 Incentive Plan. The Second Amended and Restated 2013 Stock Incentive Plan provides for up to 7.5 million of new shares authorized for issuance to participants, in addition to the shares that remained available for issuance under the 2013 Incentive Plan as of January 29, 2020 that are not subject to outstanding awards under the 2013 Incentive Plan.

On June 22, 2020, we extended the scheduled maturity date of the Receivables Facility from May 2021 to June 2022. All other terms and conditions of the agreement remained largely unchanged.

Supplemental Consolidating Information

Pursuant to Regulation S-X Rule 13-01, which simplifies certain disclosure requirements for guarantors and issuers of guaranteed securities, and which we have early adopted, we are no longer required to provide condensed consolidating financial statements for Aramark and its subsidiaries, including the guarantors and non-guarantors under our Credit Agreement and the indentures governing our senior notes. ASI, the borrower under our Credit Agreement and the indentures governing our senior notes, and its restricted subsidiaries together comprise substantially all of our assets, liabilities and operations, and there are no material differences between the consolidating information related to Aramark and Aramark Intermediate Holdco Corporation, the direct parent of ASI and a guarantor under our Credit Agreement, on the one hand, and ASI and its restricted subsidiaries on a standalone basis, on the other hand.

Table of Contents

Critical Accounting Policies and Estimates

Our significant accounting policies are described in the notes to the consolidated financial statements included in our Form 10-K filed with the SEC on November 26, 2019. As described in such notes, we recognize revenue in the period in which the performance obligation is satisfied. For a more complete discussion of the critical accounting policies and estimates that we have identified in the preparation of our condensed consolidated financial statements, please refer to our Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Form 10-K filed with the SEC on November 26, 2019.

~~Table of Contents~~

In preparing our financial statements, management is required to make estimates and assumptions that, among other things, affect the reported amounts of assets, liabilities, revenue and expenses. These estimates and assumptions are most significant where they involve levels of subjectivity and judgment necessary to account for highly uncertain matters or matters susceptible to change, and where they can have a material impact on our financial condition and operating performance. If actual results were to differ materially from the estimates made, the reported results could be materially affected.

Critical accounting estimates and the related assumptions are evaluated periodically as conditions warrant, and changes to such estimates are recorded as new information or changed conditions require.

New Accounting Standard Updates

See Note 1 to the condensed consolidated financial statements for a full description of recent accounting standard updates, including the expected dates of adoption.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

We are exposed to the impact of interest rate changes and manage this exposure through the use of variable-rate and fixed-rate debt and by utilizing interest rate swaps. We do not enter into contracts for trading purposes and do not use leveraged instruments. The market risk associated with debt obligations as of ~~March 27,~~June 26, 2020 has ~~not materially~~ changed from September 27, 2019 (see Item 7A "Quantitative and Qualitative Disclosure About Market Risk" in our Form 10-K for the fiscal year ended September 27, 2019 filed with the SEC on November 26, 2019)., due to the repayment of the $900.0 million principal amount outstanding on 5.125% Senior Notes due 2024 with a variable rate term loan due 2027 during the second quarter of fiscal 2020. To offset this exposure, the Company entered into $800.0 million of variable rate interest rate swaps. See Note 5 to the condensed consolidated financial statements related to the changes in our debt levels. See Note 6 to the condensed consolidated financial statements for a discussion of our derivative instruments and Note 15 for the disclosure of the fair value and related carrying value of our debt obligations as of ~~March 27,~~June 26, 2020.

Item 4. Controls and Procedures

The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based on that evaluation, management, with the participation of the Chief Executive Officer and Chief Financial Officer, concluded that the Company's disclosure controls and procedures, as of the end of the period covered by this report, are functioning effectively to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, to allow timely decisions regarding required disclosures. A controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. No change in the Company's internal control over financial reporting occurred during the Company's ~~second~~third quarter of fiscal 2020 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

4640

Table of Contents

PART II

Item 1. Legal Proceedings

Our business is subject to various federal, state and local laws and regulations governing, among other things, the generation, handling, storage, transportation, treatment and disposal of water wastes and other substances. We engage in informal settlement discussions with federal, state, local and foreign authorities regarding allegations of violations of environmental laws in connection with our operations or businesses conducted by our predecessors or companies that we have acquired, the aggregate amount of which and related remediation costs we do not believe should have a material adverse effect on our financial condition or results of operations as of ~~March 27,~~June 26, 2020.

From time to time, we and our subsidiaries are party to various legal actions, proceedings and investigations involving claims incidental to the conduct of our business, including those brought by clients, consumers, employees, government entities and third parties under, among others, federal, state, international, national, provincial and local employment laws, wage and hour laws, discrimination laws, immigration laws, human health and safety laws, import and export controls and customs laws, environmental laws, false claims or whistleblower statutes, minority, women and disadvantaged business enterprise statutes, tax codes, antitrust and competition laws, consumer protection statutes, procurement regulations, intellectual property laws, food safety and sanitation laws, cost and accounting principles, the Foreign Corrupt Practices Act, the U.K. Bribery Act, other anti-corruption laws, lobbying laws, motor carrier safety laws, data privacy and security laws and alcohol licensing and service laws, or alleging negligence and/or breaches of contractual and other obligations. Based on information currently available, advice of counsel, available insurance coverage, established reserves and other resources, we do not believe that any such actions, proceedings or investigations are likely to be, individually or in the aggregate, material to our business, financial condition, results of operations or cash flows. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to our business, financial condition, results of operations or cash flows.

Item 1A. Risk Factors

For information regarding factors that could affect the Company's results of operations, financial condition and liquidity, see the risk factors discussed in Part I, Item 1A "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 27, 2019 and filed with the SEC on November 26, 2019.

In light of developments relating to the coronavirus (COVID-19) pandemic occurring subsequent to the filing of our Annual Report on Form 10-K, the Company is supplementing the risk factors discussed in our Annual Report with the following risk factor, which should be read in conjunction with the risk factors contained in our Annual ~~Report~~.Report.

The scale and scope of the recent coronavirus (COVID-19) outbreak and resulting pandemic is unknown and is expected to continue to adversely impact our business for an extended period. The overall impact on our business, operating results, cash flows and/or financial condition ~~is anticipated~~has been material and we anticipate it will continue to be material.

The COVID-19 pandemic has disrupted and is expected to continue to disrupt our business, depending on the prolonged period of the COVID-19 pandemic, which has and is anticipated to continue to materially affect our operating results, cash flows and/or financial condition for an extended period of time. The scale and scope of the COVID-19 pandemic has, in some cases, and may continue to heighten the potential adverse effects on our business, operating results, cash flows and/or financial condition described in certain of the risk factors contained in our Annual Report on Form 10-K. In addition, the COVID-19 pandemic has, in some cases, and may continue to adversely impact our business and financial condition in specific ways, including its impact on:

•overall economic conditions, which have and will likely continue to be adversely impacted by the COVID-19 pandemic and related global shutdowns;

•our ability to maintain sufficient qualified personnel due to employee illness, quarantine, worker absenteeism or other social-distancing, travel or other restrictions;

•the financial health of our clients and consumers and their demand and ability to pay for certain of our services;

•our ability to obtain new business, expand or otherwise execute on strategic plans;

•our ability to restart operations in an effective manner after COVID-19 related ~~shut-downs;~~shutdowns;

•our ability to comply with new legal or regulatory requirements enacted in connection with the COVID-19 pandemic in a cost-effective manner;

•legal actions or proceedings related to COVID-19;

•our ability to continue to affect our cost savings initiatives and achieve synergies from the Avendra and AmeriPride acquisitions;

•partial or full closure of client premises ~~over an~~for unknown ~~period~~periods of time resulting in non-provision of services to the client and reduced or no revenue generation in those ~~units;~~units and further headcount reductions;

•postponement of large events leading to postponement of revenue and a decrease in our margin;

•the willingness of end customers to go to the facilities where we operate during the pandemic or for some period thereafter;

•our ability to maintain a safe and cost-effective supply chain as COVID-19 may continue to adversely affect our suppliers;

•ability to service our indebtedness; and

•if assumptions or estimates in the fair value calculations change or if future cash flows or future growth rates vary from what was expected, including those assumptions relating to the duration and severity of COVID-19, this may impact the impairment analysis and could reduce the underlying cash flows used to estimate fair values and result in a decline in fair value that may trigger future impairment charges.

The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of governmental responses and other containment actions and the impact of these and other factors on our employees, clients, customers, suppliers and partners. ~~Such~~We anticipate such impact on our business, operating results, cash flows and/or financial condition ~~is anticipated~~will continue to be material.

~~Item 2. Unregistered Sales of Equity Securities and Use of Proceeds~~

~~c) Issuer Purchases of Equity Securities~~

~~The following table provides information about the Company's share repurchase activity during the second fiscal quarter:~~

(a) (b) (c) (d)
Period Total Number of Shares (or Units) Purchased Average Price Paid per Share (or Unit)
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs⁽¹⁾
Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs⁽¹⁾
Month 1
December 28, 2019 - January 24, 2020 N/A N/A N/A $ 200,000,000
Month 2
January 25, 2020 - February 21, 2020 N/A N/A N/A $ 200,000,000
Month 3
February 22, 2020 - March 27, 2020 282,652 $ 23.14 282,652 $ 193,460,635
Total 282,652 $ 23.14 282,652 $ 193,460,635

~~(1) On August 6, 2019, we announced a share repurchase program allowing us to repurchase up to $200.0 million of our common stock through July 2022.~~

Item 6. Exhibits

See the Exhibit Index which is incorporated herein by reference.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on ~~May 5,~~August 4, 2020.

Aramark

By:

/s/ THOMAS G. ONDROF

Name:

Thomas G. Ondrof

Title:

Executive Vice President and Chief Financial Officer (Principal Financial Officer, Principal Accounting Officer and Authorized Signatory)

4943

Exhibit Index


Exhibit No.						Description
4.1						Indenture, dated as of April 27, 2020, among Aramark Services, Inc., as issuer, Aramark Intermediate Holdco Corporation, as parent guarantor, the subsidiary guarantors named therein and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 of Aramark’s Current Report on Form 8-K filed with the SEC on April 28, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.1						Amendment No. 9, dated as of April 22, 2020, among Aramark Services, Inc., as borrower, Aramark Intermediate Holdco Corporation, as parent guarantor. each other borrower party thereto, each lender party thereto and JPMorgan Chase Bank, N.A. as administrative agent (incorporated by reference to Exhibit 10.1 of Aramark’s Current Report on Form 8-K filed with the SEC on April 28, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.2†						Amended and Restated Agreement Relating to Employment and Post-Employment Competition dated July 16, 2020 between Aramark and John J. Zillmer (incorporated by reference to Exhibit 10.1 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.3†						Amended and Restated Agreement Relating to Employment and Post-Employment Competition dated July 16, 2020 between Aramark and Thomas Ondrof (incorporated by reference to Exhibit 10.2 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.4†						Amended and Restated Agreement Relating to Employment and Post-Employment Competition dated July 16, 2020 between Aramark and Lynn B. McKee (incorporated by reference to Exhibit 10.3 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.5†						Amended and Restated Agreement Relating to Employment and Post-Employment Competition dated July 16, 2020 between Aramark and Keith Bethel (incorporated by reference to Exhibit 10.4 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.6†						Amended and Restated Agreement Relating to Employment and Post-Employment Competition dated July 16, 2020 between Aramark and Lauren A. Harrington (incorporated by reference to Exhibit 10.5 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.7†						Amended and Restated Form of Non-Qualified Stock Option Award dated July 16, 2020 between Aramark and John J. Zillmer (incorporated by reference to Exhibit 10.6 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.8†						Amended and Restated Restricted Stock Unit Award (Time Vesting) dated July 16, 2020 between Aramark and John J. Zillmer (incorporated by reference to Exhibit 10.7 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
10.9†						Amended and Restated Form of Performance Stock Unit Award dated July 16, 2020 between Aramark and John J. Zillmer (incorporated by reference to Exhibit 10.8 of Aramark’s Current Report on Form 8-K filed with the SEC on July 17, 2020, pursuant to the Exchange Act (file number 001-36223)).
31.1*						Certification of John J. Zillmer, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*						Certification of Thomas G. Ondrof, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*						Certification of John J. Zillmer, Chief Executive Officer, and Thomas G. Ondrof, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101						The following financial information from Aramark's Quarterly Report on Form 10-Q for the period ended ~~March 27,~~June 26, 2020 formatted in inline XBRL: (i) Condensed Consolidated Balance Sheets as of ~~March 27,~~June 26, 2020 and September 27, 2019; (ii) Condensed Consolidated Statements of (Loss) Income for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019; (iii) Condensed Consolidated Statements of Comprehensive (Loss) Income for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019; (iv) Condensed Consolidated Statements of Cash Flows for the ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019; (v) Condensed Consolidated Statements of Stockholders' Equity for the three and ~~six~~nine months ended ~~March 27,~~June 26, 2020 and ~~March 29,~~June 28, 2019; and (vi) Notes to condensed consolidated financial statements.
104						Inline XBRL for the cover page of this Quarterly Report on Form 10-Q; included in Exhibit 101 Inline XBRL document set.

* Filed herewith.

† Identifies exhibits that consist of management contract or compensatory arrangement.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and should not be relied upon for that purpose. In particular, any representations and warranties made by the Company in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

The XBRL instance document does not appear in the interactive data file because the XBRL tags are embedded within the inline XBRL document.

5045


	Balance, September 27, 2019		Add: Net increase in current period deferred income	Less: Recognition of deferred income	Balance, March 27, 2020
Deferred income	$	319.0	682.2	(748.0)	$	253.2


	Aramark (Parent)		Issuers		Guarantors		Non Guarantors		Eliminations		Consolidated
ASSETS
Current Assets:
Cash and cash equivalents	$	5	$	925,933	$	14,447	$	262,579	$	—	$	1,202,964
Receivables	—		1,275		522,767		1,326,938		—		1,850,980
Inventories	—		15,063		291,145		97,591		—		403,799
Prepayments and other current assets	—		50,916		72,744		74,932		—		198,592
Total current assets	5		993,187		901,103		1,762,040		—		3,656,335
Property and Equipment, net	—		46,986		1,748,603		333,717		—		2,129,306
Goodwill	—		173,104		4,698,444		448,078		—		5,319,626
Investment in and Advances to Subsidiaries	3,169,440		6,429,972		—		717,942		(10,317,354)		—
Other Intangible Assets	—		29,684		1,772,561		183,834		—		1,986,079
Operating Lease Right-of-use Assets	—		24,061		474,989		80,669		—		579,719
Other Assets	—		17,664		797,653		363,118		(2,002)		1,176,433
	$	3,169,445	$	7,714,658	$	10,393,353	$	3,889,398	$	(10,319,356)	$	14,847,498
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Current maturities of long-term borrowings	$	—	$	16,255	$	26,957	$	60,194	$	—	$	103,406
Current operating lease liabilities	—		—		57,153		18,552		—		75,705
Accounts payable	—		109,355		417,054		267,055		—		793,464
Accrued expenses and other current liabilities	—		169,767		813,669		341,758		88		1,325,282
Total current liabilities	—		295,377		1,314,833		687,559		88		2,297,857
Long-term Borrowings	—		6,922,575		76,097		863,915		—		7,862,587
Noncurrent Operating Lease Liabilities	—		25,151		267,323		62,359		—		354,833
Deferred Income Taxes and Other Noncurrent Liabilities	—		418,455		553,380		180,715		—		1,152,550
Intercompany Payable	—		—		4,213,629		481,280		(4,694,909)		—
Redeemable Noncontrolling Interest	—		—		10,226		—		—		10,226
Total Stockholders' Equity	3,169,445		53,100		3,957,865		1,613,570		(5,624,535)		3,169,445
	$	3,169,445	$	7,714,658	$	10,393,353	$	3,889,398	$	(10,319,356)	$	14,847,498


	(a)	(b)		(c)	(d)
Period	Total Number of Shares (or Units) Purchased	Average Price Paid per Share (or Unit)		Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs⁽¹⁾	Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs⁽¹⁾
Month 1 December 28, 2019 - January 24, 2020	N/A	N/A		N/A	$	200,000,000
Month 2 January 25, 2020 - February 21, 2020	N/A	N/A		N/A	$	200,000,000
Month 3 February 22, 2020 - March 27, 2020	282,652	$	23.14	282,652	$	193,460,635
Total	282,652	$	23.14	282,652	$	193,460,635